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Introduction
Innovations regarding surgical techniques and instruments (henceforth called 
technology) play a major role in enhancing the efficacy and safety of surgical procedures. 
Technological developments in the past have enabled a minimally invasive approach 
to surgical procedures that were previously performed via laparotomy. For instance, 
the laparoscopic approach is currently the scientific standard in appendectomy, 
cholecystectomy and hemicolectomy. In gynecology, hysterectomy is increasingly 
performed via minimally invasive surgery (MIS) and studies have demonstrated 
that 25% up to 37% of all hysterectomies are currently performed via MIS.[1,2] The 
importance of the developments leading to MIS was recently acknowledged anew by 
confirming the advantages of MIS over laparotomy regarding surgical outcomes and 
patient benefits. [3] 
However, since the efficacy and safety of a new technology has usually not been 
established on a large scale before introduction in the field, innovations may consequently 
go hand in hand with an impairment of patient safety. Short and long term adverse events 
have been described after the introduction of new surgical techniques in daily practice. 
An example of a short term adverse event was the rise in major complications such as 
major hemorrhage and ureteric injury during the early introduction of laparoscopic 
hysterectomy (LH).[4] However, these complications could be attributed to learning 
curve issues. Combined with improvements made in technologies such as electrosurgery, 
major complications in LH declined and this technique is now considered superior to 
laparotomy. [5] 
And on the other end of the spectrum, adverse events caused by new technology may 
be only observed long after its introduction in clinical practice. In 2014, 21 years after its 
introduction in US market, the electromechanical (or power) morcellator was discredited. 
The power morcellator is a surgical device that allows the removal of an enlarged uterus 
or fibroid via laparoscopic trocars by shredding the tissue into fragments which are small 
enough to fit through these trocars. However, when reports were published regarding 
the accidental morcellation of preoperatively undiagnosed uterine sarcoma resulting in 
a possible upstaging of the malignancy, the U.S. Food and Drug Administration (FDA)
decided to discourage the further use of this device. [6]
In this light, the industry driven approach to innovations (i.e. coming from medical devices 
manufacturing companies) and the clinically driven approach (based on analyses of 
problems encountered in daily surgical practice) should be considered. Unequivocally the 
introduction of the power morcellator has played a role in the successful implementation 
of the laparoscopic approach to hysterectomy and myomectomy. By manufacturing 
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more powerful devices, even very large uteri and myoma were eligible for removal via 
laparoscopy. Yet, an analysis with respect to clinical indications and possible risks of 
the device was not performed, although early warnings regarding the occurrence of 
malignant tissue spill were issued in scientific literature.[7-12] The vast majority of all 
publications regarding power morcellators discussed industry driven specifications such 
as morcellation speed.[13] 
To minimize the chance of unforeseen adverse events, efforts have been made in the 
past century to regulate the introduction of new technologies. In a research setting 
human subjects are protected by several medical ethical legal entities, in particular by 
the 1947 Nuremberg Code, the 1964 Declaration of Helsinki and the 1978 Belmont 
Report.[14-16] In contrast, in daily surgical practice adaptations and innovations 
aiming to provide the best care for the individual patient are considered “standard” 
care. Unfortunately, the distinction between daily surgical practice and research 
is not always clear. The Belmont report defines daily practice as “interventions that 
are designed solely to enhance the well-being of an individual patient or client and that 
have a reasonable expectation of success” and research as “an activity designed to test 
a hypothesis, permit conclusions to be drawn, and thereby to develop or contribute to 
generalizable knowledge”.[16] However it is also stated that “the fact that a procedure 
is ‘experimental’, in the sense of new, untested or different, does not automatically 
place it in the category of research”.[16] As a result a grey area exists between daily 
practice and research, meaning that surgeons may circumvent research regulations 
by declaring that the innovation is aimed to improve the health of the individual 
patient. [17,18] Laparoscopic cholecystectomy was introduced in such a fashion. In 
gynecology, ample experience existed with laparoscopy. In fact, the first laparoscopic 
appendectomy was performed by a gynecologist.[19] Since the laparoscopic approach 
to appendectomy was successful and appeared safe, together with the introduction 
of videoscopy, it was suggested that this approach to cholecystectomy must also 
be safe. The first laparoscopic cholecystectomy performed in The Netherlands was 
supervised by a gynecologist since the surgeon was unexperienced with MIS.[20] The 
laparoscopic route quickly became the new standard in surgery, although comparative 
trials were lacking. Finally, when larger case series were published it became apparent 
that complications were significantly higher during laparoscopy due to bile duct 
lesions.[18,21] Another example is robotic surgery, which quickly became an accepted 
alternative to routine laparoscopy and open surgery after it was initially introduced 
in a research setting.[17] In the U.S. alone the number of procedures performed 
robotically increased by more than 500%, even though convincing evidence preferring 
robotic surgery over laparoscopy does not exist and learning curve issues as well as 
patient safety have been questioned.[17]   
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The bodies responsible for the admittance of new medical devices are the Conformité 
Européenne (CE) for Europe and the Food and Drug Administration (FDA) for the United 
States of America. The CE-marking on a product is a declaration of a manufacturer 
that the device meets the essential requirements of European health, safety and 
environmental protection legislation.[22] However it is important to realise that the CE 
mark does not evaluate or guarantee the clinical safety of a device. The FDA has two 
objectives: providing the public reasonable assurances of safe and effective de- vices 
while avoiding overregulation of the industry.[23] A premarket approval process was 
installed for new devices in which the safety and effectiveness  for the devices  intended 
use has to be demonstrated by standard scientific methods.[23] However, the FDA has 
been criticized for its methods. Firstly, to avoid overregulation an alternative for the 
premarket approval process was installed, called the 510(k) provision (named after 
section 510(k) of the Food, Drug and Cosmetic Act). It states that new versions of 
existing (and deemed safe) devices are exempt from the premarket approval process. In 
the meantime, the criteria for the 510(k) provision were broadened, which has resulted 
in an increase of new medical devices on the market that were not extensively tested for 
their safety and effectiveness. For example, approval of the radiofrequency ablation of 
liver tumors was granted merely by proving that this technique could actually ablate liver 
tissue. However, no evidence existed regarding the clinical efficacy of this treatment 
compared to standard treatment at that time.[21] Moreover, it was shown that the 
majority of devices that were withdrawn from the market due to safety issues, were FDA 
approved based on the 510(k) provision.[23] Secondly, the FDA does not regulate the 
manner in which a device is used in daily clinical practice, meaning that devices may be 
used off-label without FDA surveillance.[17]
In the Netherlands, the shortcomings of current regulations regarding the introduction 
of new technology were also acknowledged. In 2014, a cooperation between de Orde 
van Medisch Specialisten, het Zorginstituut Nederland, and het Kennisinstituut van 
Medisch Specialisten, resulted in a guideline called Leidraad Nieuwe Interventies in de 
Klinische Praktijk (NIKP).[24] This guideline aims to structure the introduction of new 
technology in health care interventions (such as surgery) to better warrant patient 
safety. Interestingly, emphasis is put on the preclinical stage of the development of new 
technology, before it is applied in human subjects. In general, 5 stages are considered 
in surgical innovation, yet only the very first stage (stage 0) concerns in-vitro tests.
[18] (table 1) In all other stages the new technology is applied in human subjects. The 
Dutch guideline provides methods that can be applied in this first stage when evidence 
regarding safety and efficacy does not yet exist.  
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Table 1: 5 stages of surgical innovation
Stage Title Setting
0 Innovation Pre-human
1 Innovation In human
2 a Development In human
b Early dispersion and exploration In human
3 Assessment In human
4 Long-term implementation and monitoring In human
With this in mind this thesis was initiated to explore a range of possible assessment 
methods, including those suggested by the NIKP,  that can be used in stage 0 of surgical 
innovation. Using LH as a starting point, two medical devices acted as a template for the 
assessments used in this thesis. To begin, the NIKP guideline was applied to the technical 
development of a new prototype for a uterine manipulator that is designed to facilitate 
the manipulation of the uterus and its separation from the vagina during LH. Next, the 
controversies regarding the use of a power morcellator were addressed. This device is 
currently a highlight in minimally invasive gynecological research topics. With the new 
design of the manipulator and the morcellator in mind, several studies were undertaken 
combining a clinical and technical point of view. The main objective of this thesis is to 
assess different methods and tools that are available in stage 0 of surgical innovations. It 
was hypothesized that ideally, major hazards to patient safety can be identified before 
new technology is introduced in daily surgical practice. 
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A new approach to simplify surgical colpotomy 
in laparoscopic hysterectomy
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Abstract
New surgical techniques and technology have simplified laparoscopic hysterectomy and 
have enhanced the safety of this  procedure. However, the surgical colpotomy step has 
not been addressed. This study evaluates the surgical colpotomy step in laparoscopic 
hysterectomy with respect to difficulty and duration. Furthermore, it proposes an 
alternative route that may simplify this step in laparoscopic hysterectomy. A structured 
interview, a prospective cohort study and a problem analysis were performed regarding 
experienced difficulty and duration of surgical colpotomy in laparoscopic hysterectomy. 
Sixteen experts in minimally invasive gynecologic surgery from 12 hospitals participated 
in the structured interview using a 5-point Likert Scale. The colpotomy in LH received 
highest scores for complexity (2.8 ± 1.2), compared to AH and VH. Colpotomy in LH 
was estimated as more difficult than in AH (2.8 vs 1.4, p <.001). In the cohort study, 
107 patients undergoing LH were included. 16% of the total procedure time was spent 
on colpotomy (SD 7.8%). BMI was positively correlated with colpotomy time, even 
after correcting for longer operation time. No relation was found between colpotomy 
time and blood loss or uterine weight. The surgical colpotomy step in laparoscopic 
hysterectomy should be simplified as this study demonstrates that it is time consuming 
and is considered to be more difficult than in other hysterectomy procedures. A vaginal 
approach to the colpotomy is proposed to achieve this simplification. 
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Introduction
New surgical techniques and technical equipment have attempted to facilitate laparoscopic 
hysterectomy (LH), after shortcomings of LH in comparison with vaginal hysterectomy 
(VH) and abdominal hysterectomy (AH) were demonstrated.[1]  New alternatives for 
conventional suturing, such as bipolar coagulation, have improved hemostasis of the 
uterine and ovarian pedicles.[1] Furthermore, in a systematic review the superiority of 
vessel sealing devices with respect to blood loss and shorter operation time in some 
abdominal procedures was demonstrated compared to other electrothermical devices. 
[2] Finally, barbed sutures have been introduced for vaginal vault closing and this 
technique  appears to be equal compared to standard sutures with respect to time to 
cuff closing, cuff healing and sexual function.[3] Although some of these effects are 
debatable, for instance due to possible contributing factors such as learning curve, they 
do demonstrate the efforts to facilitate the LH. Certainly, notwithstanding the well-
known benefits of LH, VH remains the gold standard for the hysterectomy procedure 
[1,4],  even though in contrast with this statement recent studies have shown that LH 
was associated with shorter hospital stay, less blood loss and less postoperative pain 
compared to VH.[5,6] Yet, LH is still associated with a longer operating time.[4,7] 
Furthermore, previous studies have demonstrated that LH  is regarded as more difficult 
when compared to AH and VH.[8] Learning curve issues and implementation errors have 
contributed to these results. However, there still are technical opportunities to simplify 
the LH procedure. Our hypothesis is that the colpotomy should be addressed in this 
context. Colpotomy is part of the final surgical steps in the LH procedure, following the 
ligation of the uterine arteries, the skeletonizing of the cervix  and the dissection of 
the bladder from the cervix. These steps are relatively hazardous and time consuming 
in the procedure. It is in this anatomical area where most of the bleeding and ureter 
injuries occur.[9,10] Moreover, the delicacy of laparoscopic surgery in this anatomical 
area was demonstrated by the initial higher incidence of ureter injuries during LH, which 
only decreased after a certain learning curve was passed.[11] In this light, an alternative 
route for colpotomy has been investigated: analysis of the current colpotomy procedure 
demonstrated that the main difficulties of this surgical step are the limited visibility 
during colpotomy (due to the anterior view of the endoscope combined with the 
location of the cervix deep in the pelvis), and the need for a 360° circular cutting motion 
during colpotomy. To overcome these difficulties, a vaginal approach to the colpotomy 
was suggested. A first test with a prototype of a vaginal colpotomy device on an in vitro 
vaginal model demonstrated a significant reduction of colpotomy time. [12] 
The aim of this study was to substantiate our hypothesis and to further evaluate the 
possibilities of a vaginal approach to colpotomy. The experienced difficulty,  the duration 
of the surgical colpotomy step, and possible agents of change are evaluated. In addition, 
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the idea of a vaginal approach to colpotomy is shaped into a new surgical instrument that 
may simplify colpotomy. [13]
 
Materials & Methods
Firstly, to investigate the difficulty of the colpotomy procedure, a structured interview 
was performed among experts in minimally invasive gynecologic surgery working at 
different hospitals throughout the Netherlands. The interview assessed the participants 
perception regarding the surgical step of the colpotomy. Furthermore, they were 
asked about their opinion regarding several features of the proposed facilitation of the 
colpotomy. (Figure 1) Participants were asked to answer using a 5 point Likert scale: 1 
meaning ‘easy’ / ‘not important’ , to 5 meaning ‘complex’ / ‘important’.
Next, a prospective cohort study was performed at 2 hospitals specialized in minimally 
invasive gynecologic surgery. From June 2010 till May 2014, LH procedures were timed 
to assess the duration of colpotomy. The total operating time (TOT) was defined as the 
time from the insertion of the Veress needle to the final stitches used for closing last 
trocar incision site. Colpotomy time (CT) was defined as the time from the first incision 
in the vaginal fornix (after ligating the uterine arteries  and all uterine ligaments) until the 
 
 
1.  What is your estimation of the total procedure time of a total hysterectomy and what is the estimated 
time required for the separation of the uterus from the vagina (absolute time and relative to the total 
procedure time)?
2.  Can your estimate the complexity of separating the uterus from the vaginal wall for the dierent 
procedures?
3.  How important is it to maintain the possibility to manipulate the possibility to manipulate the uterus 
with a manipulator while dissecting the uterus?
4.  What is the importance of coagulation when separating the uterus from the vaginal wall with respect 
to the following items: Easy cutting, less bleeding, impaired wound healing, accurate dissection, less 
collateral tissue damage.
5.  How important is a visual position mark of the dissection device in a uterus extraction product such 
that the position of the instrument in the vagina can be seen through the laparoscopic endoscope?
6.  What eort will it take to adapt the surgical procedure in your hospital and implement the use of this 
instrument?
7.  All in all, do you think the envisioned instrument may provide a benet enabling a faster and/or 
easier uterus extraction?
Fig. 1 Structured interview
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complete separation of the cervix from the vaginal wall. An extrafascial technique was 
used to perform total laparoscopic hysterectomy. The vaginal wall was opened anteriorly 
at the vesicovaginal fold, after which the colpotomy was completed. All consecutive 
LH procedures were eligible for inclusion. This study was exempt from approval by the 
Medical Ethics Committee. Procedures were performed by 5 gynecologists who perform 
LH on a regular basis and have experience in well over 100 TLH procedures. The number of 
participating gynecologists was chosen to enhance the external validity of the outcome. 
Inter-surgeon variability was minimised by using similar surgical procedure protocols. 
Furthermore, all surgeons received their training at the Leiden Residency Program.  The 
Valtchev or Clermont Ferrand uterine manipulator were used. Bipolar and ultrasonic 
instruments were used for colpotomy. Basic patient characteristics were gathered. The 
uterine weight and the total amount of blood loss were measured in the operating room. 
Patients were excluded in case of missing colpotomy time. Complications were classified 
according to the severity of the complications on the basis of the framework set by the 
Dutch Society for Obstetrics and Gynecology (NVOG).[14] 
Statistical analysis 
Baseline characteristics were summarized by means and standard deviations and, when 
applicable, by numbers and percentages. For the structured interview, an independent 
sample t- test and a paired t-test were used to compare experts versus residents and 
the type of hysterectomy respectively. For the prospective study, t tests were used 
when applicable. A Pearson’s correlation coefficient and  Analysis of Variance (ANOVA) 
techniques were used to test any correlation between different variables and colpotomy. 
A generalized linear model was performed to assess the independent effect of certain 
parameters (such as uterine weight, Body Mass Index (BMI)) on the duration of 





Sixteen experts from 12 hospitals were interviewed. (Tables 1 and 2) On average, the 
experts performed 35 (SD 24) hysterectomy procedures annually, of which 59 % (SD 
24) LH procedures, 19% (SD 21) VH and 22% (SD 15) AH. The estimated TOT 114 
(SD 24) minutes, and they estimated to spent 18% (SD 11) the TOT on the colpotomy. 
The colpotomy in LH received highest scores for difficulty (2.8 ± 1.2), compared to 
AH and VH. Colpotomy in LH was estimated as more difficult than in AH (2.8 vs 1.4, 
p < .001). The same trend is seen for the difficulty of colpotomy in LH versus VH (2.8 
vs 2.0), however this difference was nog significant (p = .08). With respect to the vaginal
approach to simplify colpotomy, the following functions of the envisaged instrument 
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Table 1: Participants opinion regarding colpotomy (N=16 expert)
Mean (SD) p value
Number of hysterectomy procedures per year 35 (24)
Amount of TLH (%) 59 (24)
Amount of VH (%) 19 (21)
Amount of AH (%) 22 (15)
Estimated length of TLH procedure (minutes) 114 (24)
Estimated colpotomy time TLH (minutes) 20 (10)
Complexity of colpotomy TLH a 2.8 (1.2)
Complexity of colpotomy VH a 2.0 (1.3)
Complexity of colpotomy AH a 1,4 (.6)
Estimated colpotomy vs total OR time (%) 18 (11)
TLH vs VH 2.8 vs 2.0 .08
TLH vs AH 2.8 vs 1.4 < .001
VH vs AH 2.0 vs 1.4 .02
TLH: total laparoscopic hysterectomy, VH vaginal hysterectomy, AH abdominal hysterectomy vaginal 
hysterectomy
a1 easy–5 complex
Table 2: Preferred functions and adaptation of the new device (N=16)
Mean SD
Importance of a uterine manipulator 4.5 1.4 4.5 1.4
e Importance of coagulation instead of cutting when 
separating the uterus from the vagina
- Collateral tissue damage 2.3 1.6
- Easy cutting 3.5 2.0
- Wound healing 2.6 1.6
- Accurate dissection 3.1 2.2
- Bleeding 4.2 1.1
Importance of markings so that a vaginal instrument is visible 
during laparoscopy
4.6 0.7
Scale 1–5 = not–moderate–important
were regarded as moderately important to important by the participants: the ability to 
manipulate the uterus (4.5, SD 1.4), the presence of coagulation to stop bleeding during 
the colpotomy procedure (4.2, SD 1.1) and the existence of markings on the device to 
help visualize the device by the camera (4.6, SD .7). 
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Table 3: Patient characteristics and procedure data (N=107; 91 Leiden University Medical 
Center and 16 Bronovo hospital)
  Mean SD P value
Age (years)  49.4 10.6
BMI (kg/m²)  27.4 7.0
Parity a  2 1.4
Number (%)
Previous operations None 66 (62)  
One or more abdominal surgeries 41 (38)  
Indication for operation Abnormal bleeding and / or 
uterine leiomyoma
68 (64)  
(pre-)malignancy 37 (35)  
Other b 2 (2)  
Total operating time (min)  116.4 35.3
Colpotomy time (min)  17.9 7.8
TOT minus CT (min)  98.5 31.5
Uterine weight (g)  242.8 175.0
Estimated blood loss (ml)  142.5 194.7
Complications (total and %) Peri-operative lesions c 1 (1%)
Post-operative infection d 6 (6%)
Other e 9 (9%)  
Colpotomy-total OR time (%)  16  5
Colpotomy time No complications occurred (n=91) 18.0 8.1
A complication occurred (n=15) 17.9 6.0 1.0
Colpotomy time No previous abdominal surgery 17.6 7.3
.6
With previous abdominal surgery 18.4 8.6
BMI body mass index
a = median
b = 1 endometritis and salpingitis, 1 abdominal pain
c = 1 bladder injury
d = 5 urinary tract infections, 1 pneumonia
e =  1 ileus, 1 urinary retention, 1 re-admittance for unexplained fever, 1 lost needle during surgery resulting in 
enlargement of the trocar incision,1 patient with facial subcutaneous emphysema that required admittance 
at the intensive care unit,1 infected hematoma, 1 vaginal cuff dehiscence occurring 4 weeks after surgery, 
1 abdominal pain that led  to additional surgery 10 days after TLH resulting in a partial oophorectomy and 
1 repeat laparoscopy on the same day regarding a loss of blood exceeding 300ml.
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Table 4  Pearson correlation and generalized linear model (N=107; 91 LUMC and 16 Bronovo)
 Colpotomy time (min)
Pearson correlation Sig. N
BMI (kg/m²) .329 .001 104
Age (years) .278 .004 107
TOT minus CT (min) .380 .000 105
Uterine weight (g) .092 .349 105
Estimated blood loss (ml) .082 .399 107
Generalized linear model        Ba
BMI (kg/m2) .403 <.001
Uterine weight (g) -.002 .703
BMI body mass index
a B unstandardized regression coefficient
Colpotomy analysis
Out of 164 consecutive patients, 107 patients undergoing LH were included. 57 (35%) 
were excluded due to missing colpotomy time. Patient characteristics and procedure 
data are shown in Table 3. Most common indications for surgery were abnormal bleeding 
and/or uterine myoma. The mean total operating time was 116.4 minutes (SD 35.3 
min) and the mean colpotomy time was 17.9 minutes (SD 7.8 min). On average, 16% 
of the total procedure time was spent on colpotomy. BMI was positively correlated 
with colpotomy time (.320 and .311, both p=.001), and the generalized linear model 
confirmed the identified correlation and proved that it was independent from the other 
variables (Table 4). No statistically significant correlation was found between colpotomy 
time and uterine weight or blood loss.  
Discussion
This study demonstrates that the surgical colpotomy is a time consuming step in the LH 
procedure, that is preceded by the hazardous dissection of the uterine arteries, bladder 
and cervix, risking blood loss and ureter injuries. Colpotomy time comprises 16% of the 
total operation time, even reaching 45%. Albeit an extreme value, it does demonstrate 
the difficulty that can be experienced when performing this task. This is substantiated 
by our structured interview. In accordance with a previous study[8], our structured 
interview revealed that experts find colpotomy in LH significantly more difficult than 
in AH, and that the same trend is seen for colpotomy in LH compared to VH (although 
not significant). It is also demonstrated that a rise in BMI proved to be associated with a 
longer colpotomy time. The effect of BMI on the duration of surgery is in line with other 
18046 Lucas van den Haak.indd   24 03-10-18   20:01
25Simplifying colpotomy in laparoscopic hysterectomy |
studies.[15,16] However, in our study the effect of BMI on the colpotomy time remained 
even after correcting for total operation time.  Apparently, higher BMI apart from the 
additional procedure time, accounts for an additional complicating factor regarding the 
colpotomy step. These women especially may benefit from the simplification of this 
procedure. Moreover, as the incidence of obesity is increasing, higher BMI will become 
part of everyday work in laparoscopic surgery.[17] No other factors, such as the amount 
of blood loss, previous abdominal surgery or the presence of complications seemed to 
influence the duration of colpotomy. Surprisingly, also for uterine weight no correlation 
was found with colpotomy time. It is our opinion, that the colpotomy procedure can be 
regarded as independent from “uterine” factors, such as uterine weight.  Indeed, when 
performing the colpotomy after all uterine ligaments and arteries have been dissected, 
the obtained additional mobility of the uterus will compensate for restrictions due to 
uterine weight. However, although uteri weighing up to 930 grams were removed, the 
vast majority of uteri in our cohort weighed below 360 grams. Therefore we realize that, 
based on the results from our cohort, our statement may not fully apply to very large 
uteri. Yet support of our opinion can be found in literature, where the feasibility of LH in 
women with larger uteri has already been established.[18,19]  A limitation of our study 
is the high number of exclusions, especially given the prospective design of this study. 
However, the overall effect of the exclusions on the outcome of our study is limited. 
Missing data can be considered random and therefore effect cohort size rather than the 
results, although the introduction of bias cannot be fully excluded. Only one surgical 
protocol was used for our prospective study and this raises the question of external 
validity regarding other surgical protocols. However the relative colpotomy time that 
resulted from our prospective study matches the estimated relative colpotomy time 
from our interview (16% vs 18% respectively), in which gynecologists participated who 
use different protocols. This study did not focus on procedural steps of the LH other than 
colpotomy, which could be considered a flaw. For instance, dissection and sealing of the 
uterine artery would have been an interesting addition. On the other hand, this step has 
already been enhanced by new surgical techniques and technology. All other steps of the 
hysterectomy procedure are relatively straightforward and appear to be in no apparent 
need of improvement. Notwithstanding these shortcomings, our findings regarding 
colpotomy time are important. A recent study demonstrated that operative time was an 
independent predictor of postoperative morbidity and reoperation.[20] Furthermore, 
a cost analysis of different approaches to hysterectomy showed that patient operation 
room costs and total patient costs are higher for LH when compared to VH, and that 
longer operation time proved to be an important contributor to these higher costs. 
[21] In light of these studies, reducing CT and thereby the TOT may have beneficial 
effects on patient morbidity as well as on health care costs. This will become increasingly 
important, since there is an increase of laparoscopic hysterectomy procedures at the 
expense of the number of vaginal hysterectomies [22]
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Vaginal approach for colpotomy
A prototype for a vaginal colptomizer device has been assembled.[13] Although  several 
methods exist to perform the surgical colpotomy such as bipolar and harmonics, to 
our knowledge, the vaginal route to colpotomy has not yet been proposed. Figure 2 
demonstrates our prototype. 
Fig. 2: MobiSep prototype
The intrauterine part of the manipulator has mobility in all planes (i.e. anterior-posterior, 
lateral and rotation).  After introducing the manipulator into the uterus, a cap is positioned 
over the cervix. This cervical cap, which rotates, has several functions: it presents the 
vaginal cuff and helps to push the uterus cranially. Furthermore, it houses the knife 
that enables the vaginal colpotomy. The knife is deployed and operated by moving the 
knife driver and the handle of the manipulator. The exact location where the knife is 
introduced into the vaginal wall (and hence in the abdominal cavity) is identified by a 
light source in the manipulator. Figure 3 and 4 demonstrate the knife during colpotomy 
in a human cadaver test and in detail respectively. 
Fig. 3: Vaginal colpotomy with MobiSep prototype in human cadaver test
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Fig. 4: Detail of the knife action of the vaginal colpotomizer in relation to safety cap
Finally, after colpotomy is completed, the entire surgical specimen and the manipulator 
are removed. Certain questions remain to be answered. For instance, our interview tried 
to assess the preference for a coagulation based or “cold knife” based  cutting mechanism. 
Coagulation was preferred in case of bleeding and , to lesser extent, to facilitate the 
cutting action. However, some concerns were raised over the possible negative effects 
of coagulation with respect to wound healing. Several studies have reported a higher 
incidence of vaginal vault dehiscence after LH when compared to VH and AH. [23-25] It has 
been suggested that electrocoagulation may be the cause for this higher incidence, due to 
more extensive tissue damage and/or suboptimal tissue healing.[26,27] However, in large 
series no effect of electrocoagulation was demonstrated with respect to the occurrence 
of vaginal vault dehiscence. [28] Moreover, no effect of the power settings was observed.
[28] It was concluded that the current available scientific evidence does not support one 
technique over the other, and it is expected that this topic will continue to be a main point 
of interest for gynecological societies. However, in light of the feasibility of the device, a 
cold knife cutting mechanism was designed. The structured interview also demonstrated 
the need for a manipulator function integrated in the device.  The importance of a uterine 
manipulator during LH has been demonstrated in literature. A manipulator is considered to 
increase the distance between the ureter and uterine arteries, thereby creating more space 
for the dissection of the uterine arteries.[29] Furthermore, in a recent Delphi study, full 
agreement was  reached regarding the use of a uterine manipulator during LH to prevent 
ureter injuries during LH.[30] This resulted in the final design of the prototype: a uterine 
manipulator with an integrated vaginal colpotomizer. 
In all, the significance of the present study is the clinically driven approach to innovating 
the difficult surgical colpotomy step. Experiences in the past have shown the need 
for a careful introduction of new technology in daily practice.[31,32] Consequently, 
innovation should start with a thorough analysis of the problem at hand. The eVALuate 
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study has taught us that LH has certain disadvantages with respect to patient safety 
when compared to VH and AH.[1] Technical developments have already contributed to 
the enhanced safety of LH. However further simplifying the LH is necessary, since our 
study demonstrates that the surgical colpotomy step takes place in an anatomical area 
which is at risk for complications,  is regarded as difficult, and comprises a considerable 
amount of the total duration of the LH procedure. Therefore, much can be gained by 
simplifying this step .
 
Conclusions
Earlier studies have taught us that LH has certain disadvantages with respect to patient 
safety when compared to VH and AH.  Technical developments have already contributed 
to the enhanced safety of LH. However further simplifying the LH is necessary, since 
reducing the operation time of LH may reduce health care costs and complication rates.
[20,21]Our study demonstrates that the colpotomy step in LH should be simplified. Not 
only is this surgical step time consuming, it is also regarded as significantly more difficult 
when compared to AH.  A vaginal approach of the colpotomy step may solve these issues. 
A surgical instrument was designed as a uterine manipulator with an integrated vaginal 
colpotomizer. The device intends to address the shortcomings of the current colpotomy 
technique. Clinical studies will commence shortly to evaluate the efficacy and safety of 
the vaginal approach to colpotomy.
 
18046 Lucas van den Haak.indd   28 03-10-18   20:01
29Simplifying colpotomy in laparoscopic hysterectomy |
Reference List
1 Garry R, Fountain J, Brown J et al (2004) EVALUATE hysterectomy trial: a multicentre 
randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. 
Health Technol Assess 8:1-154
2 Janssen PF, Brolmann HA, Huirne JA (2012) Effectiveness of electrothermal bipolar vessel-
sealing devices versus other electrothermal and ultrasonic devices for abdominal surgical 
hemostasis: a systematic review. Surg Endosc 26:2892-2901
3 Einarsson JI, Cohen SL, Gobern JM et al (2013) Barbed versus standard suture: a randomized 
trial for laparoscopic vaginal cuff closure. J Minim Invasive Gynecol 20:492-498
4 Nieboer TE, Johnson N, Lethaby A et al (2009) Surgical approach to hysterectomy for benign 
gynaecological disease. Cochrane Database Syst Rev:CD003677
5 Candiani M, Izzo S (2010) Laparoscopic versus vaginal hysterectomy for benign pathology. 
Curr Opin Obstet Gynecol 22:304-308
6 Candiani M, Izzo S, Bulfoni A et al (2009) Laparoscopic vs vaginal hysterectomy for benign 
pathology. Am J Obstet Gynecol 200:368-7
7 Johnson N, Barlow D, Lethaby A et al (2005) Methods of hysterectomy: systematic review and 
meta-analysis of randomised controlled trials. BMJ 330:1478
8 Nieboer TE, Spaanderman ME, Bongers MY et al (2010) Gynaecologists estimate and 
experience laparoscopic hysterectomy as more difficult compared with abdominal 
hysterectomy. Gynecol Surg 7:359-363
9 Janssen PF, Brolmann HA, Huirne JA (2013) Causes and prevention of laparoscopic ureter 
injuries: an analysis of 31 cases during laparoscopic hysterectomy in the Netherlands. Surg 
Endosc 27:946-956
10 Elliott SP, McAninch JW (2006) Ureteral injuries: external and iatrogenic. Urol Clin North Am 
33:55-66, vi
11 Makinen J, Brummer T, Jalkanen J et al (2013) Ten years of progress--improved hysterectomy 
outcomes in Finland 1996-2006: a longitudinal observation study. BMJ Open 3:e003169
12 Gahler MM, van de Berg NN, Rhemrev J et al (2010) Vaginal Approach for Uterus Separation 
During Laparoscopic Hysterectomy. Journal of Medical Devices 4:027514
13 Jansen FW, Rhemrev J (2013) MobiSep: A New Approach to Colpotomy in TLH. Journal of 
Minimally Invasive Gynecology 20:S51
14 Twijnstra AR, Zeeman GG, Jansen FW (2010) A novel approach to registration of adverse 
outcomes in obstetrics and gynaecology: a feasibility study. Qual Saf Health Care 19:132-137
15 Bardens D, Solomayer E, Baum S et al (2014) The impact of the body mass index (BMI) on 
laparoscopic hysterectomy for benign disease. Arch Gynecol Obstet 289:803-807
16 Osler M, Daugbjerg S, Frederiksen BL et al (2011) Body mass and risk of complications after 
hysterectomy on benign indications. Hum Reprod 26:1512-1518
18046 Lucas van den Haak.indd   29 03-10-18   20:01
30 Chapter 2|
17 Wang Y, Beydoun MA (2007) The obesity epidemic in the United States--gender, age, 
socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-
regression analysis. Epidemiol Rev 29:6-28
18 O’Hanlan KA, McCutcheon SP, McCutcheon JG (2011) Laparoscopic hysterectomy: impact of 
uterine size. J Minim Invasive Gynecol 18:85-91
19 Uccella S, Cromi A, Serati M et al (2014) Laparoscopic hysterectomy in case of uteri weighing 
>/=1 kilogram: a series of 71 cases and review of the literature. J Minim Invasive Gynecol 
21:460-465
20 Hanwright PJ, Mioton LM, Thomassee MS et al (2013) Risk profiles and outcomes of total 
laparoscopic hysterectomy compared with laparoscopically assisted vaginal hysterectomy. 
Obstet Gynecol 121:781-787
21 Wright KN, Jonsdottir GM, Jorgensen S et al (2012) Costs and outcomes of abdominal, vaginal, 
laparoscopic and robotic hysterectomies. JSLS 16:519-524
22 Driessen SRC, Baden NLM, van Zwet EW, Twijnstra ARH, Jansen FW. Trends in the 
implementation of advanced minimally invasive gynecologic surgical procedures in the 
Netherlands. J of Minim Invasive Gynecol. In press.
23 Kho RM, Akl MN, Cornella JL et al (2009) Incidence and characteristics of patients with vaginal 
cuff dehiscence after robotic procedures. Obstet Gynecol 114:231-235
24 Hur HC, Donnellan N, Mansuria S et al (2011) Vaginal cuff dehiscence after different modes 
of hysterectomy. Obstet Gynecol 118:794-801
25 Croak AJ, Gebhart JB, Klingele CJ et al (2004) Characteristics of patients with vaginal rupture 
and evisceration. Obstet Gynecol 103:572-576
26 Klauschie J, Wen Y, Chen B et al (2014) Histologic characteristics of vaginal cuff tissue from 
patients with vaginal cuff dehiscence. J Minim Invasive Gynecol 21:442-446
27 Sowa DE, Masterson BJ, Nealon N et al (1985) Effects of thermal knives on wound healing. 
Obstet Gynecol 66:436-439
28 Uccella S, Ceccaroni M, Cromi A et al (2012) Vaginal cuff dehiscence in a series of 12,398 
hysterectomies: effect of different types of colpotomy and vaginal closure. Obstet Gynecol 
120:516-523
29 Koh CH (1998) A new technique and system for simplifying total laparoscopic hysterectomy. 
J Am Assoc Gynecol Laparosc 5:187-192
30 Janssen PF, Brolmann HA, Huirne JA (2011) Recommendations to prevent urinary tract 
injuries during laparoscopic hysterectomy: a systematic Delphi procedure among experts. J 
Minim Invasive Gynecol 18:314-321
31 Stefanidis D, Fanelli RD, Price R et al (2014) SAGES guidelines for the introduction of new 
technology and techniques. Surg Endosc 28:2257-2271
32 Strasberg SM, Ludbrook PA (2003) Who oversees innovative practice? Is there a structure 
that meets the monitoring needs of new techniques? J Am Coll Surg 196:938-948
18046 Lucas van den Haak.indd   30 03-10-18   20:01
18046 Lucas van den Haak.indd   31 03-10-18   20:01
18046 Lucas van den Haak.indd   32 03-10-18   20:01
3
Efficacy and Safety of Uterine Manipulators 
in Laparoscopic Surgery: a Review










Arch Gynecol Obstet. 2015 Nov;292(5): 1003-11
18046 Lucas van den Haak.indd   33 03-10-18   20:01
34 Chapter 3|
Abstract
Purpose: This review aims to objectively assess the efficacy and safety of uterine 
manipulators as reported in scientific literature. Furthermore it evaluates as to which 
manipulator best suits which surgical procedure.
Methods: PubMed, Embase, Web of Science, COCHRANE, CINAHL, Academic Search 
Premier, ScienceDirect and the MAUDE database were searched. Technical information 
was retrieved from the manufacturers.
Results: 25 articles covering 10 uterine manipulators were found. Studies regarding 
implementation and use of manipulators are scarce, only 2 surveys were found comparing 
different manipulators. Moreover, clinical evidence proving the efficacy of manipulators 
with respect to prevention of complications, inherent to laparoscopic surgery, does not 
exist.
Conclusion: the use of uterine manipulators is well established and it is clear that uterine 
manipulators offer the easiest way to handle the uterus during surgery.  However, detailed 
information regarding efficacy and safety is scarce. Clinical evidence substantiating 
the assumed mechanism of prevention of ureter injuries was not found. Our review 
did not find the optimal manipulator. Some are more versatile than others and not all 
instruments are appropriate for all types of surgery. Therefore, gynecologists should 
choose the manipulator that best suits the type of surgery that is performed.
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Introduction
Uterine manipulators are widely adapted surgical instruments that facilitate various 
surgical procedures. In gynecology, the importance of a uterine manipulator regarding 
the prevention of ureter injuries during laparoscopic hysterectomy (LH), has been 
highlighted.[1] This reduced risk with respect to ureter injury is reported in several 
studies.[1-6] According to these publications, this may be achieved in several ways. 
Firstly by lateralising the uterus, manipulators facilitate a perpendicular dissection of 
the uterine artery. Secondly they elevate the uterus exposing the cul-de-sac, especially 
important in case of endometriosis. Thirdly uterine manipulators provide delineation 
of the vaginal fornices, necessary for colpotomy and maintain the pneumoperitoneum 
after the vagina is incised. Finally manipulators increase the distance between the 
cervix and ureter by pushing the uterus cephalad, thus allowing safer dissection around 
the cervix. Meanwhile, it remains questionable if these advantages have been well 
researched. Although several surveys are available that offer an overview of different 
manipulators and their capabilities, they do not address the efficacy and patient safety of 
the different manipulators.[7,8] Since the indications for laparoscopy in gynecology are 
expanding, manipulators are likely to be found more often in the operation room and in 
different procedures. Without an objective overview, making an informed decision when 
introducing a uterine manipulator in daily surgical practice will be difficult. To obtain the 
necessary information, a literature review to gather all published data regarding existing 
manipulators and their mode of action was performed. These data were combined with 
an overview of reported adverse effects during the use of a uterine manipulator. With 
this review we aim to objectively assess the efficacy of uterine manipulators as reported 




A review of literature was performed, searching PubMed, Embase, Web of Science, 
COCHRANE, CINAHL, Academic Search Premier and ScienceDirect. Our search strategy 
was finalised by the research librarian of the medical library at the Leiden University 
Medical Centre (LUMC). The following terms were used: hysterectomy (MeSH), 
colpohysterectomy, (gyn(a)ecologic) surgical procedures (MeSH), uterus (MeSH), uteri, 
colon (MeSH), colectomy (MeSH), sigmoid (MeSH), sigmoidectomy, uterine diseases 
(MeSH), mobilizer, mobiliser, manipulator. This review focusses on all manipulators 
suitable for (total) laparoscopic hysterectomy ((T)LH), since these instruments are 
most versatile. Manipulators frequently used in clinical practice were added to the 
search strategy. Reports on the manipulators were also searched with “Google”. We 
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crosschecked the reference lists of retrieved articles for relevant studies. Articles were 
selected by LH and CA, with FWJ acting as third reviewer in case of disagreement. All full 
text articles, with uterine manipulators and their actions as main subject, were included. 
Articles not focussing on the actions of a manipulator were excluded. Articles describing 
manipulators and the possible spread of malignant cells were also excluded. Although this 
is a very important topic, it reaches beyond the bounds of what we intended to evaluate. 
When only an abstract was available we contacted the author for a complete copy of the 
article. We contacted the manufacturer for further details in case the company’s website 
provided insufficient information. Qualifications on manipulators as used by original 
authors were adapted in this review. 
Finally, the Manufacturer and User Facility Device Experience (MAUDE) database was 
checked for all reported complications over the last 10 years. This database is a passive 
surveillance system of the FDA for medical device safety. This study was exempt from 
approval by the  Medical Ethics Committee.
 
Results
299 references and 1 article from an online journal were found, of which 263 references 
were excluded based on title or content of the abstract and 6 due to missing full text 
versions (Figure 1).
Of the remaining 32 references LH and CA disagreed on the inclusion of 9 titles. Of 
these 9, 7 titles were excluded after assessment by FWJ. These articles did not sufficiently 
focus on uterine manipulators or its actions. Finally, a total of 26 references and the article 
from the online journal covering 10 manipulators suitable for (T)LH were evaluated 
in our review (Table 1).[1-26] The Hourcabie, a frequently mentioned manipulator, 
could not be assessed since no information regarding its manufacturer was found. 
The Koninckx manipulator, Donnez manipulator, McCarus Volker Fornisee System and 
Secufix Uterus Manipulator were also not described in this review since no scientific 
publications were available on these instruments. 
For purpose of accessibility, the literature is presented according to the manipulator. 
Table 2 offers an overview of the manipulators and their characteristics. It is largely 
based on the only 2 existing surveys that evaluated and compared different uterine 
manipulators.[7,8] Table 3 states all reports in the MAUDE database.
The Hohl manipulator is a reusable instrument. It has a 130˚ range of motion in the 
anterior-posterior plane. Lateral movement and elevation are given to be good and 
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Figure 1: Flow diagram of study selection
handling is reported to be easy. However, assembly is stated as difficult.[7] Most 
publications were found regarding this manipulator: three prospective studies, one 
retrospective study, a product survey and one case report.[4,7,12-16] One retrospective 
and one prospective cohort study were perfomed by Mueller et al., including 44 and 
567 patients respectively.[4,14] 1 ureter injury, 4 bladder injuries and 1 vagina injury 
occurred. In an additional prospective study, the Hohl manipulator was compared in 
women with BMI < 30 (219 patients) versus BMI >30 (38 patients).[13] 1 ureter injury, 
1 bladder and 1 vaginal injury were observed, all in the group with BMI < 30. However, 
there was a significant difference in uterine weight with smaller uteri in the group with 
BMI>30 (246 vs 185g). Another prospective cohort was published of 1432 patients 
undergoing total intrafascial laparoscopic hysterectomy (TAIL) using a Hohl manipulator, 
experiencing 1 ureter and 8 bladder injuries.[15] Finally, a case report exists describing a 
uterine perforation and bowel perforation in a patient were a Hohl manipulator was used.
[12] No reports on this manipulator were found in the MAUDE database. 
18046 Lucas van den Haak.indd   37 03-10-18   20:01
38 Chapter 3|
Table 1: Review of Literature




Hohl Mueller 2005 Retrospective 
cohort
TLH with Hohl 44 None
Mueller 2010 Prospective 
Controlled 
BMI <30 vs 
BMI>30
219 vs 38 1 ureter
1 bladder
1 vagina b
Mueller 2012 Prospective 
cohort
TLH with Hohl 567 1 ureter 
4 bladder
1 vagina
Hohl 2010 Prospective 
cohort






Janssen 2013 Retrospective 
case analysis
Ureter injuries
Akdemir 2014 Case report Complication 
Hohl
1 Uterine rupture and 
bowel penetration






Janssen 2013 Retrospective 
case analysis
Ureter injuries








25 vs 25 2x perforated uterus 
during dilation of the 
cervix




RUMI I + 
KOH 









435 Ureter 0.2 %
Bladder 0.2 %











Wu 2005 Case Report Complication 
RUMI
2 Uterine rupture
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Ellett 2013 Case Report Complication 
RUMI
1 KOH cup left behind













Janssen 2013 Retrospective 
case analysis
Ureter injuries







































Bernstein 1995 Product 
review
Valtchev
a TAIL: Total Intrafascial Laparoscopic Hysterectomy; AH: abdominal hysterectomy, VH: vaginal hysterectomy; 
TLH: total laparoscopic hysterectomy
b all injuries occurring in pts with BMI < 30. 
Table 1: Continued
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Table 3: Complications caused by uterine manipulators based on MAUDE database and 
literature
Manipulator Event Measures needed?
Hohl Uterine rupture and bowel penetration Laparotomy for bowel repair
Clearview Parts of the manipulator left behind in patient
Disintegration of manipulator while inside patient Removal with hysteroscopy
Uterine perforation due to cervical dilation
RUMI I Laceration of vaginal wall (multiple reports) Suturing. 
Excess haemorrhage from laceration Blood transfusion
Parts of the manipulator left behind in patient 
(multiple reports)
Disintegration when removing the manipulator
Spontaneous release of cup during colpotomy Prolonged operation time to 
check integrity of ureters
Retroperitoneal haematoma caused by uterine 
perforation after hyperination of the intra-uterine 
balloon
Laparotomy and uterine 
artery ligation
Vaginal mucosa stuck in RUMI
Vcare Disintegration when removing the manipulator
Parts of the manipulator left behind (multiple reports) 
Laceration of vaginal wall (multiple reports) Suturing
Perforation of vagina and cervix due to cup
Perforation of uterus with intra-uterine tip
Repetitive Strain Injury of the assistant 
Melting of the cup
 
The Clermont Ferrand manipulator is a reusable instrument and offers 140˚ range of 
motion in the anterior-posterior plane. Lateral motion and elevation are mentioned to 
be good and handling is easy.[7] No studies evaluated the efficacy of this instrument and 
no reports in the MAUDE database exist. 
The Clearview manipulator is a lightweight disposable instrument. With 210˚, it has the 
greatest range of motion in the anterior-posterior plane of all the manipulators. It was 
previously known as the Endopath uterine manipulator. It is reported to have excellent 
characteristics.[7] Unfortunately it does not offer delineation of the vaginal fornices and 
it cannot maintain the pneumoperitoneum, making it less suitable for total laparoscopic 
hysterectomy (TLH). It allows the manipulation of the uterus by the gynecologic surgeon, 
without the need of an assistant holding the manipulator. This manipulator is the only 
instrument to have been tested in a randomised trial.[17] In this trial, 50 patients were 
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randomly assigned to a Clearview manipulator or a Cohen cannula. Various laparoscopic 
procedures were performed except for (T)LH. The authors found a better range of 
motion (120˚ versus 84˚ p<0.0001 anterior, -20˚ vs -8˚ p<0.0001 posterior) in favour of 
the Clearview manipulator. However, the Clearview took longer to insert (116s vs 27s, 
p=.02). No significant differences were found in other parameters, such as ease of use. 
Two minor complications occurred in the group of the Clearview manipulator: in both 
cases a cervical perforation occurred during dilation because of cervical stenosis. Two 
reports were found in the MAUDE database, concerning one case where the manipulator 
disintegrated inside the patient and one case where parts of the manipulator came loose 
and remained inside a patient. 
The RUMI system consists of the RUMI manipulator, the Koh cervical cup and the Koh 
colpo-pneumo-occluder. It has a 140˚ range in the anterior-posterior plane. Along with 
the Hohl manipulator, most publications were found on this instrument:  two retrospective 
and one prospective studies, two case reports and several product reviews.[2,3,5-7,18,26] 
However, the two retrospective cohort studies, including 435 and 512 patients, describe 
the same patient population, with one containing more patients due to a longer inclusion 
period. [5,6] Injury rate in the largest cohort was 0.2% for ureter, 0.4% for bladder and 
1% for the vagina. The prospective study describes a cohort of 25 patients.[2] Two case 
reports exist: the first is a uterine rupture in 2 patients due to hyperinflation of the intra-
uterine balloon of the RUMI manipulator, and the second a KOH cup that remained inside 
a patient and was discovered 14 months after surgery. [18,26] Lastly, several reports were 
found in the MAUDE database on the disintegration of the instrument or on parts being 
left behind, in some cases leading to lacerations of the vaginal wall. The RUMI system has 
been updated, however no studies were found on the RUMI II system. 
The Vcare manipulator is a lightweight disposable instrument. It does not offer 
independent motion of the intra-uterine tip, rather it uses leverage to manipulate the 
uterus. The Vcare has a wide range of motion, it is said to offer good delineation and to 
maintain the pneumoperitoneum well. Also, handling is easy. However the lightweight 
design is reported to be less suitable to manipulate larger uteri.[7,8,19] Multiple reports 
were found in the MAUDE database on disintegration of the instrument or on parts being 
left behind. Also lacerations of the vaginal wall have been described. Lastly, the melting 
of the cervical cup was mentioned in one report, however without causing harm or 
damage to the patient. 
The Dr. Mangeshikar manipulator is the only instrument to offer indepent laevo- and 
dextrorotation of the intra-uterine tip. It offers a wide range of motion in all directions 
and assembly and handling are mentioned to be easy.[7] Unfortunately, no additional 
publications are available on this instrument. 
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The Vectec manipulator, like the Vcare, uses levarage to manipulate the uterus instead 
of a intra-uterine tip with independent movement. It is a disposable instrument. One 
study was found, demonstrating that the suction mechanism by which the manipulator 
secures itself, does not modify the endometrium and therefore should be safe to use. 
[20] The Vectec is also available with a screw mechanism. 
The Valtchev manipulator is one of the oldest instruments in our study. It is a reusable 
instrument and offers 135˚ movement in the anterior-posterior plane. It is reported 
to be easy to assemble and handle.[7,25] The McCartney tube was also included 
in this review. Strictly speaking it is not an intra-uterine manipulator as it does not 
have an intra-uterine section, therefore not allowing movement of the uterus in a 
frontal or horizontal plane. It does, however, offer delineation of the vaginal fornices 
and is able to maintain the pneumoperitoneum well. It also allows the introduction 
of materials through the vaginal tube instead of the transabdominal trocars. Since it 
provides excellent cephalad movement of the uterus, it has a place among the uterine 
manipulators as will be discussed later. Two retrospective cohorts (73 and 1500 
patients) describe the McCartney tube as manipulator.[21,22] Regrettably, no reports 




This review offers an overview of all scientific literature on manipulators. There is 
a paucity of well-designed studies that assess the different instruments. Only one 
randomised trial exists and it addressed the Clearview manipulator.[17] Based on 
our review, the Clermont Ferrand, Dr. Mangeshikar, Valtchev and RUMI System 
manipulators seem to be most versatile due to excellent capabilities, although the 
Clermont Ferrand and RUMI System are considered difficult to assemble. The Vcare, 
Clearview and Valtchev are very user friendly. However, the Vcare is considered 
too light to use in larger uteri. The Clearview manipulator lacks a cervical cup and 
cannot maintain the pneumoperitoneum, making it less suitable for TLH; however it 
may be a useful instrument for other gynecological procedures. The Dr. Mangeshikar 
manipulator is the only instrument in our review to provide independent laevo- and 
dextrorotation of the uterus, thereby presenting the uterine arteries without having 
to stretch the manipulator too far laterally. In theory, this may offer an advantage 
especially in case of vaginal atrophy or stenosis. The Clermont Ferrand and the 
Dr. Mangeshikar offer the best exposure of the cul-de-sac due to excellent uterine 
elevation. In case of endometrioses of the cul-de-sac, these 2 instruments may be the 
instrument of choice. 
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Surprisingly, little evidence exists regarding the efficacy and safety of uterine 
manipulators. Furthermore, although many authors feel that the cephalad motion of 
the uterus is extremely important for avoiding urinary tract injuries, since this increases 
the distance between ureter and cervix [3-5], no study exists demonstrating the actual 
mechanism of the increased distance between cervix and ureter by pushing the uterus 
cephalad. Only one study mentioned having visualised an increased distance between 
ureter and cervix when using the RUMI system by placing lighted ureteral stents. [3] 
However, the author did not explain how this was performed nor did he supply figures 
of his observations. The same author also states that distance between ureter and cervix 
actually decreased when using a cervical cup that is too large. If indeed true, this finding is 
worrisome, since it implies a reduction of patient safety when using an improper cervical 
cup. Moreover, no studies are available on this specific subject, making it impossible to 
predict the correct shape of the cervical cup, including cups of existing manipulators. 
In addition, several articles were found where this movement is provided by alternative 
methods. [9-11]  
Considering the low incidence of ureter injuries, it will be difficult to demonstrate the effect 
of a uterine manipulator as ultimate tool for the prevention of these injuries. Moreover, 
ureter injury rate depends on far more than just the use of a uterine manipulator, such 
as learning curve and experience of the gynecologist, and the presence of additional 
disease, e.g. endometriosis. Subsequently, although the earlier mentioned Delphi study 
by Janssen et al is the best evidence we have regarding the prevention of ureter injuries, 
it is important to realize that the recommendations on ureter injuries were established 
based on expert opinions rather than clinical evidence. [1] This is substantiated by  the 
analyses of 31 ureter injuries performed by the same author.[16] A uterine manipulator 
was used in the vast majority (83.9%) of cases of ureter injury. These results affirm that 
a uterine manipulator is not the ultimate tool to prevent ureter injuries. 
Unfortunately, statements regarding the safety of the reviewed manipulators cannot be 
made. Since there certainly is under-reporting of complications, accurately determining 
a rate of complications caused by a uterine manipulator is impossible. However, a trend 
is seen that (partly) disposable, relatively lightweight uterine manipulators that need 
assembly are at risk for adverse events due to disintegration of the instrument or to parts 
being left behind in patients. 
A cost analysis of the manipulators could not be performed, due to variable prices 
between countries, sometimes even between hospitals. Given this variability and since 
we compare (partly) disposable manipulators to reusable ones,  we feel a full cost analysis 
is unlikely to add significant data to our review.  
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Although our search did not include the possible effects of manipulators on uterine 
malignancies, this topic should be addressed since laparoscopy is increasingly 
implemented in gynecologic oncology. In both cervical and endometrial malignancies, 
clinic-pathological parameters such as infiltration depth and lymphovascular space 
invasion (LVSI) may be influenced when a manipulator is used [27-31] However, it is 
hypothesised that other factors such as artefacts and tissue handling contributed to 
these findings. More importantly,  no negative effects on the oncological outcome were 
found in these studies. In addition, larger studies including a prospective randomised 
trial did not find this influence on clinic-pathological parameters. [32-36] Based on these 
studies it can be concluded that the use of a uterine manipulator during gynecologic 
oncology procedures is unlikely to negatively affect a patients oncological outcome. 
However, in absence of definitive evidence, several authors suggest closing the fallopian 
tubes via cautery or clipping prior to the insertion of a manipulator to prevent spread of 
malignant cells into the abdomen.  
The shortcoming of our study is the limited number of unbiased papers and randomised 
trials available on this subject. Since the aim of our study was an objective evaluation 
of the existing literature, we did not test the instruments ourselves. This makes an 
extensive evaluation of the manipulators more difficult. As a result, all characteristics 
of the manipulators are based mostly on the 2 available surveys. Furthermore, strong 
conclusions with respect to complications during the use of certain manipulators cannot 
be made due to earlier mentioned reasons. 
However, to our knowledge, this review is the first review to independently assess 
manipulators based on available studies and on safety reports. In contrast with some 
studies we’ve found, our study is not commercially driven. Therefore, it offers valuable 
additional information to existing literature.  Furthermore, our finding that statements 
with respect to the prevention of ureter injuries are not substantiated by clinical evidence 
has important implications. Given the possible adverse effects, our study demonstrates 
that a uterine manipulator should not be introduced without fair consideration. Ideally, 
for every procedure, the most appropriate manipulator should be considered. 
 
Conclusion
Uterine manipulators are very useful instruments that help expose the anatomy during 
surgical procedures. However, evidence regarding their efficacy and safety is scarce. 
Although uterine manipulators are probably the easiest way to handle the uterus during 
laparoscopy, alternatives without manipulators have been published. More importantly, 
evidence proving how manipulators prevent ureter injuries is absent. The findings of 
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1 study, mentioning a decrease in distance between  cervix and ureter when using too 
large cervical cups, are worrisome and in need of further investigation.[3] Subsequently 
it is unclear if uterine manipulators are the ultimate tool to prevent ureter injuries.  
Conclusions with respect to reported complications caused by uterine manipulators 
cannot be made, due to underreporting. However, it appears that lightweight disposable 
manipulators in need of assembly seem to be at risk to cause specific adverse effects. 
Therefore they should be used with extra care.   
Our literature review did not provide the ultimate uterine manipulator.  The Clermont 
Ferrand and Dr. Mangeshikar manipulator seem to be the most versatile, and the latter 
is the only manipulator in our review to offer independent laevo- and dextrorotation. 
However, no publications such as cohort studies or randomised trials exist on these 
instruments. In all, gynecologists should choose the uterine manipulator that best meets 
the requirements for the type of surgery to be performed. 
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Abstract
Background: New technology should be extensively tested before it is tried on patients. 
Unfortunately representative models are lacking. In theory, fresh frozen human cadavers 
are excellent models. 
Objective: To identify strengths and weaknesses of fresh frozen human cadavers as 
research models for new technology prior to implementation in gynecological surgery.
Methods: During pre-clinical validation studies regarding the MobiSep uterine 
manipulator, test procedures were performed on fresh frozen cadavers. Both the 
experimental setup as the performance of the prototype were assessed.
Results: Five tests including six human cadavers were performed. Major changes were 
made to the MobiSep prototype design. The cadavers of two tests closely resembled 
surgical experiences as found in live patients. The anatomy of 4 of the 6 cadavers was not 
fully representative due to atrophy of the internal genitalia caused by age and due to the 
presence of pathology such extensive tumorous tissue. 
Conclusion: The cadaver tests provided vital information regarding design and 
functionality, that failed to emerge during the in-vitro testing. However, experiments 
are subject to anatomical uncertainties or restrictions. Consequently, the suitability of a 
cadaver should be carefully assessed before it is used for testing new technology.
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Introduction
Innovations in surgical instruments and techniques (hereafter called ‘technology’) are 
important tools to enhance patient safety in minimally invasive surgery (MIS). They 
facilitate technically challenging procedures, which constitute MIS. At the same time, 
experiences in the past have demonstrated the risks that accompany the implementation 
of such innovations. For instance, the introduction of laparoscopic cholecystectomy 
resulted in a significant increase of the number of bile duct injuries. In gynecology, 
prolapse repair surgery using vaginal meshes, Essure sterilization and the use of power 
morcellators in laparoscopic hysterectomy or myomectomy, are examples of widely used 
technology that have recently come under scrutiny due to unforeseen adverse effects. 
[1-4] To reduce the risk of these adverse effects, pre-market approval for new technology 
by a Conformité Européenne (CE) mark or review by the U.S. Food and Drug Administration 
(FDA) is required in Europe and the USA respectively.[5] However approval or clearance 
does not guarantee safety, and even minor changes or additions to an existing technology, 
which undergo less extensive evaluation, may be hazardous.[6] At present, there are 5 
stages in the implementation of new technology  into early daily practice [7]: innovation 
(stage 0), testing of proof of concept and safety (stage 1), development and exploration 
(stage 2a-b), assessment (stage 3) and long term implementation and monitoring 
(stage 4). As soon as stage 1, testing is performed on live humans. It is only in stage 
0 that the pre-human tests take place. Evidently, compared to the introduction of new 
pharmaceuticals, which is bound by vigorous protocols, new technology is subject to 
less strict implementation criteria. This has recently been recognised by the European 
Parliament (EP). In May 2016, the EP reached a provisional agreement on more strict 
rules for new technology. In addition, the importance of pre-human stage 0 testing has 
been incorporated in recent guidelines regarding the introduction of new technology, 
created by clinicians.[8] These guidelines strongly advise the surgeon to familiarize him- 
or herself with the new technology by practicing on appropriate training models, before 
it is implemented in daily practice.[8] However, finding a proper model is difficult. For 
instance in gynecology, animal models are generally not representative due to different 
anatomy of the internal genitalia. In addition, virtual reality tools have difficulty depicting 
real life conditions including tactile feedback.  
In theory, human cadavers could be of value in establishing the feasibility and safety of 
a new product. They are widely used in universities to demonstrate anatomy to medical 
students. Furthermore, human cadavers have been proposed for the laparoscopic 
training of residents.[9,10] However, no evidence is available on the use of human 
cadavers for testing new technology. The aim of our study is to evaluate the strengths 
and shortcomings of human cadavers as a model for testing new technology in minimally 
invasive surgery, during the pre-clinical stage of development.
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Materials & Methods
Fresh frozen cadavers were used to maximally approach conditions as found in live patients, 
such as tissue resistance and tissue colour. On arrival at the anatomy department, the 
cadaver is cooled at -40°Celsius, after which it is stored at -20°C. Before use, the cadaver 
is defrosted and after use it is stored again at -20°C. It is possible to use the cadaver up 
to 3 times with this protocol. 
To assess the feasibility of fresh frozen cadavers as a model during preclinical testing, 
the mode of action of a new instrument, the MobiSep uterus manipulator and separator, 
was tested during a total laparoscopic hysterectomy (TLH) as part of the pre-clinical 
development stage. The MobiSep instrument consists of a uterine manipulator and 
a vaginal blade that allows a vaginal approach to colpotomy during hysterectomy 
(figure 1) .[11-13]  
All procedures were performed according to a strict study protocol. The following 
parameters were rated poor, moderate, sufficient or excellent: accessibility of the vagina, 
visualisation of the cervix, ease of cervical dilatation, insertion of the manipulator into 
the cervix, insertion of the intra-uterine tip into the uterus, the ease of manipulation 
of the uterus and of colpotomy. Furthermore, adverse tissue effects were registered. 
Standard instruments for MIS were used. The degree of possible manipulation of the 
uterus was verified by using an existing uterine manipulator (model Vectec®), before 
the MobiSep instrument was tested. 
Experiments were performed at the anatomical laboratories of the University Medical 
Centre of Utrecht and the Radboud University Medical Centre, Nijmegen. FWJ, JPR and 




Five tests including 6 fresh frozen human cadavers were performed, the results are 
presented in table 1.
The first hysterectomy was performed abdominally to familiarize the research team with 
the MobiSep instrument, all other procedures were performed via standard multiport 
abdominal laparoscopy. The first test was performed using the original MobiSep 
prototype (figure 1). This device comprises an intra-uterine tip and cervical cup which 
are attached to a rotational mechanism responsible for uterine manipulation. The 
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blade to perform colpotomy is located inside the cervical cup. Manipulation up to 90° 
anteriorly and laterally was demonstrated with MobiSep. However, the extreme range of 
motion combined with the size of the rotational unit, caused extensive tissue damage, 
to the point of tearing the uterus from the vaginal wall. Furthermore, due to the design, 
manipulation posteriorly was not possible. 
Based on these results, the prototype was adapted for the second test. The maximum 
anterior motion was reduced to 60°, and posterior manipulation was added. Furthermore 
the cogwheel of the rotational unit was encased to prevent tissue damage. Manipulation 
to the maximum ability of the instrument was feasible.  Unfortunately, extensive tissue 
damage occurred again, this time due to the fixated cervical cup which did not allow 
adapting to the present anatomy. It was concluded that to avoid tissue damage, the 
cervical cup and rotational unit should operate separate from each other. However due 
to the nature of the design, this functionality could not be incorporated into the device. 
Therefore, the MobiSep instrument was redesigned. The rotational unit was replaced by a 
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multi-directional intra-uterine tip based on the DEAM mechanism.[14]  This mechanism 
consists of an easy steerable tip and was inspired by the tentacles of a squid. In addition, 
the new prototype enables independent movement of the cervical cup encasing the 
colpotomy blade. (figure 2) This blade was first evaluated in test 3. Two issues were found. 
Firstly, it proved difficult to bring the tissue under sufficient tension with the cervical cup, 
and to perform the colpotomy in the desired tissue plane and direction. Additional handling 
of the tissue by the surgeon or the assistant via laparoscopy was needed. Secondly, it was 
concluded that a thermal or ultrasonic cutting device is preferred over a cold-knife.  Due to 
the complexity of such a system, it was decided to develop a uterine manipulator without 
separator based on the DEAM system and, parallel to this process, to evaluate the feasibility 
of a thermal or ultrasonic blade. Test 4 was scheduled to assess the strength of the DEAM 
system, as originally, this system was developed for endovascular procedures. Although 2 
cadavers were available, unfortunately test 4 could not be performed due to anatomical 
abnormalities of the cadavers. Therefore, a 5th test was organized. Manipulation before 
the main ligaments of the uterus were dissected proved difficult due to lack of strength of 
the DEAM system. However, after dissection and before colpotomy, uterine manipulation 
was excellent in any direction without restrictions. It was the conclusion that the DEAM 
mechanism has excellent potential as a uterine manipulator, however the strength of this 
mechanism needs to be further enhanced. 
 
Discussion
The present study describes our experiences with human cadavers as a model for testing 
the feasibility and safety of new technology in a pre-clinical stage of development. 
Several strengths of the model were found. The mode of action of the MobiSep device 
was extensively tested on in-vitro models, where the functionality of all features was 
established including the rotational mechanism and the vaginal colpotomy blade. 
Nevertheless,  the cadaver tests provided vital information regarding design and 
functionality of the MobiSep prototype, that failed to emerge during the in-vitro testing. 
This resulted in a substantial alteration of the MobiSep design and function. The rotational 
device was removed and replaced by an alternative mechanism, the cervical cup was 
redesigned to move independently, and the colpotomy blade is further developed before 
additional testing.  Apparently, there is a big gap between results obtained from  in-vitro 
situations versus real life ones. Therefore, it can be concluded that human cadavers as a 
model offer a valuable contribution in the pre-clinical stage of the development of new 
technology. 
These findings are in agreement with multiple studies demonstrating the benefits of 
using human cadavers for surgical training purposes. [15-17] Moreover, cadavers as a 
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laparoscopic training model were preferred over high-fidelity virtual reality simulators.
[18] Fresh frozen cadavers were favoured in most studies, although other preservation 
methods may closely mimic tissue appearance and handling of fresh frozen specimens.
[17,19] Interestingly, studies on the value of human cadavers in the developmental 
stages of new technology were not found. 
Our tests also revealed several limitations of the human cadaver model.  Only 2 cadavers 
were regarded as an optimal model (test 3 and 5). The cervix and uterus of the cadavers 
used in test 1 and 2 were severely atrophied. Cervical dilatation and insertion of the 
instrument was difficult, even with the standard manipulator. This could have negatively 
influenced tissue handling and manipulation, which complicates the interpretation of the 
test results. Test 4 could not be performed altogether, even though 2 cadavers were 
available. In the first cadaver, a cervix and uterus could hardly be identified, possibly due 
to a congenital abnormality. The second cadaver apparently suffered from a malignant 
process spreading throughout the small pelvis. As a result, the bladder, uterus and 
intestines were incorporated in this process and fixed to the pelvic wall. Therefore, 
identification of the pelvic organs was not possible and manipulation could not be 
evaluated.  
These limitations could possibly be overcome if more information on the cadaver is 
available. Privacy legislation however, prohibits the disclosure of the cadavers’ full 
medical history. In addition, the actual anatomy can only be assessed after the cadaver 
has already been prepared for the test.  Finally, not all institutes may have sufficient 
suitable fresh frozen specimens at their disposal, making it difficult to implement this 
model on a wider scale.  
In addition to this limitations, a critical evaluation is fair from an ethical point of view, 
regarding the necessity of using human cadavers for testing new technology. In our 
opinion, the acquired knowledge regarding the mechanism of vaginal colpotomy by the 
device could only have come from the human cadaver model due to its specific anatomy. 
Moreover, testing high risk, new technology on cadavers before it is introduced in live 
patients can easily be justified. However, the results from our study show that a thorough 
preparation is necessary to select a suitable cadaver for the intended test. Furthermore, 
considerations in the early stage of development regarding basic design and mode of 
action, such as instrument dimensions in our case, should ideally be evaluated in proper 
non-human models. In this light, the ongoing developments in 3D printing are of interest. 
Recent papers have studied the value of 3D models for training purposes, and the 
feasibility of creating representative models of human anatomy has been demonstrated.
[20-22]  These models of human anatomy may prove valuable in the future. 
18046 Lucas van den Haak.indd   60 03-10-18   20:02
61Human cadavers to evaluate new instrument prototypes |
Finally it is important to realise that a cadaver test is one component of the developmental 
and implementation stage of new technology. In order to minimize the chance of direct 
or long-term adverse events occurring, several other measurements should be taken. For 
instance, a prospective risk inventory (PRI) may be attempted, to identify and correct 
all possible adverse effects before new technology is introduced. [23] In addition, post-
market surveillance to register all complications should be centralised and be mandatory.
In all, human cadavers provide important insights of new technology during the pre-
clinical developmental stage, before the new technology is tested in live patients for the 
first time. A thorough preparation to select a suitable cadaver to match the intended test 
is necessary.  This will prevent the improper use of human remains and will ensure that 




We are indebted to the people who donated their remains to science, and to their 
families. We would like to thank the employees of both participating Departments of 
Anatomy for their cooperation. 
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Abstract
Study Objective: To assess the basic morcellation process in laparoscopic supracervical 
hysterectomy (LSH). Proper understanding of this process may help enhance future 
efficacy of morcellation regarding prevention of tissue scatter.   
Design: Time Action Analysis was performed based on video imaging of the procedures 
(Canadian Task Force classification II-2)
Setting: Procedures were performed at Leiden University Medical Centre (LUMC) and 
St. Lucas Andreas Hospital (SLAZ), Amsterdam.    
Patients: Women undergoing LSH for benign conditions. 
Interventions: Power morcellation of uterine tissue.
Measurements and Main Results: The morcellation process was divided into 4 stages: 
tissue manipulation, tissue cutting, tissue depositing and cleaning. Stages were timed and 
perioperative data were gathered. Data were analysed as a whole, and after subdivision 
into three groups according to uterine weight: <350g, 350-750g, >750g.  A cut-off point 
was found at uterine weight of 350g, after which an increase in uterine weight did not 
affect the cleaning stage. Tissue strip cutting time was used as a measure for tissue 
strip length. With progression of the morcellation process, the tissue strip cutting time 
decreases. The majority of cutting time is of short duration, 60% of the cutting lasts 5 
seconds or less, and these occur later on in the morcellation process. 
Conclusion: With the current power morcellators, the amount of tissue spread peaks and 
is independent of uterine weight after a certain cut-off point (in this study 350g). There 
is a relative inefficiency in the rotational mechanism because mostly small tissue strips are 
created. These small tissue strips occur increasingly later on in the procedure. Because 
small tissue strips are inherently more prone to scatter by the rotational mechanism 
of the morcellator, the risk of tissue spread is highest at the end of the morcellation 
procedure. This means that LSH and laparoscopic myomectomy procedures may be at 
higher risk for tissue scatter than TLH. Finally, engineers should evaluate how to create 
only large tissue strips or assess alternatives to the rotational mechanism. 
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Introduction
Morcellation has allowed laparoscopic surgeons to remove large uteri and myoma, 
thereby offering more women the benefits of a minimally invasive approach to their 
surgery. Yet the United States Food and Drug Administration (FDA) has recently 
discouraged the use of uterine power morcellation in laparoscopic hysterectomy 
and myomectomy because of serious safety concerns after the accidental use of this 
technique in women with occult uterine sarcoma (e.g. leiomyosarcoma). Patient 
outcome with respect to morbidity and mortality may be negatively influenced due 
to morcellation. [1,2] Unfortunately, the diagnosis of uterine sarcoma is complex 
since methods to rule out this condition with certainty do not exist.  Furthermore, 
although considered difficult due to a paucity of studies with large series of patients, 
it was estimated by the FDA that 1 in 350 women undergoing hysterectomy or 
myomectomy for fibroids will have an unsuspected uterine sarcoma.[3] To prevent 
the unintentional morcellation of a uterine malignancy, it is proposed to stop using a 
power morcellator and return to traditional methods such as abdominal laparotomy 
or vaginal incision to remove the uterus or myoma. Methods to avoid tissue spread 
such as in-bag morcellation are under investigation. [4-8] In theory contact between 
tissue and abdominal wall and cavity is avoided, however studies in Urology and 
Gastroenterology have, in fact, demonstrated port-site metastases after contained 
morcellation. [9-12] Although these occurrences have been rare and additional risk 
factors other than morcellation have been proposed, they stress the importance of 
larger studies to confirm the efficacy of in-bag morcellation in gynaecology. Moreover, 
before any alternative can be proposed, it is essential to understand the actual problem 
at hand. Without solid knowledge of the process of morcellation, tissue spread and 
tumour seeding, it is unlikely that a sustainable solution will be discovered. The aim of 
our study was to assess the occurrence and amount of tissue spread in the morcellation 
procedure, and to identify any factors that influence the tissue spread. This study 
intends to contribute to the development  of a more effective morcellation technique. 
Understanding the pattern of tissue spread may help us find a solution to a serious 
problem, so that in the future the benefits of minimally invasive surgery will not be lost 
for women with larger uteri. 
 
Methods & Materials
A prospective observational  study was performed from January 2011 till May 2013 
at the Leiden University Medical Centre (LUMC) and the St Lucas Andreas Hospital 
(SLAZ) in Amsterdam.  The morcellation procedure in Total Laparoscopic Hysterectomy 
(TLH) procedures and Laparoscopic Supracervical Hysterectomy (LSH) procedures 
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were timed and basic procedure and patient characteristics were gathered. Seperately, 
LSH procedures were recorded for a Time Action Analysis (TAA). All procedures were 
performed by 4 experts in minimally invasive gynaecologic surgery, except for the 
procedures in the TAA which were performed by 1 expert. The Gynecare Morcellex 
(Ethicon, Inc., Somerville, NJ) and LiNA Xcise (LiNA medical, Glostrup, Denmark) 
were used during the procedures. No distinction was made in the data between the 
type of used morcellator since the Morcellex and LiNA Xcise rely on the same ‘motor 
peeling’ working principle, have by approximation a similar instrument diameter, blade 
rotation speed, weight, and are disposable.[13] Intra-operative data and basic patient 
characteristics were gathered. To accurately analyse the morcellation procedure, 
this procedure was divided into 4 stages: Stage 1 or Tissue manipulation: grasping 
and manipulation of the uterine tissue toward the cutting blade of the morcellator. 
Stage 2 or Tissue cutting: morcellation instrument actively cutting tissue, and tissue 
being pulled through the morcellation tube. Stage 3 or Tissue depositing: morcellation 
instrument inactive, tissue strip being deposited in a retainer outside the patient, and 
reinsertion of the grasper through the morcellator. Stage 1 to 3 were used to calculate 
the total morcellation time. Stage 4 or Cleaning stage: inspection of the abdomen to 
detect and remove residual uterine tissue pieces, and irrigation of the abdominal area. 
Tissue spread is determined by counting the number of visually detectable tissue pieces 
removed during stage 4 through grasping, suction and rinsing. In addition, the duration 
of stage 4 was used as to further estimate the amount of tissue spread. Morcellation 
rate is calculated in grams per minute as the weight of the excised tissue divided by 
the morcellation time. Statistical analysis using the 2-tailed t test under assumption of 
homogeneity of variance was performed for the LSH and TLH groups separately with 
respect to the TAA group. For the TAA group, procedures were divided into 3 groups 
according to uterine weight (A: <350g, B: 350-750g, C: >750g). A 2-tailed t test was 
used for identifying significant differences between groups. Standard linear regression 
analysis was performed to assess the interdependence between recorded variables. 
A p-value of .05 was considered statistically significant. All patients consented to 
participate in this study. 
 
Results
A combined total of 52 TLH and LSH procedures were analysed, of which 23 LSH 
procedures were analysed by TAA. Table 1 shows that no statistical differences were 
observed in patient characteristics and morcellation related parameters between the 
procedures that were timed and the procedures that were analysed through TAA. The 
average operation time was 152 min and 158 min respectively and the morcellation 
procedure comprises 13% and 15% respectively of total operation time. 
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Table 1: Patient characteristics and morcellation procedure parameters; comparison between 
Time Action Analysis Group and remaining group. Data provided as mean (Standard deviation; 
range)
TAA group (n=23) TLH & LSH without TAA (n=29) p
Age 47 (6,5; 36-68) 45,8 (5,9; 31-57) .5
Parity 1,1 (1,1; 0-3) 1,6 (1,4; 0-4) .2
BMI* 24,5 (3,0; 21-32) 27,3 (5,7; 18-40) .1
Indication for surgery
- Uterine myoma 18 (78,3 %) 24 (82,8 %)
- menorrhagia 4 (17,4 %) 4 (13,8 %)
- dysmenorrhea - 1 (3,4 %)
- unavailable 1 (4,3 %) -
Total operation time [min] 158 (47; 78-245) 152 (45; 90-332) .7
Uterine weight [g] 425 (341; 29,5-1260) 377 (237; 75-1265) .5
Morcellation stage time [min] 24 (19; 3,4-245) 20 (15; 3-74) .4
Morcellated weight [g] 421 (337; 29,5-1260) 302 (237; 75-1265) .1
Morcellation rate [g/min] 17,8 (8,0; 8,1-33,9) 17,8 (9,7; 4,5-46,7) 1
Number of excised tissue strips 48,5 (40,7; 2-131) 37.7 (29,8; 9-146) .3
Average weight per strip 9,7 (4,0; 5,1-19,8) 8.8 (3,5; 4,2-19,3) .4
Bloodloss [ml] 200 (186; 0-800) 270 (328; 0-1600) .4
* Data missing from 6 patients in TAA group and 3 in remaining group.
The results from the TAA are provided in table 2. Morcellation conditions were similar 
in all 3 groups because no significant differences were found in morcellation rate 
and weight per removed tissue strip. Figure 1 is a graphic representation of the time 
division of the separate morcellation stages. It shows the stage percentages (stages 
1-3) and total morcellation time as compared with the cleaning stage time (stage 4). 
A large proportion of time is spent on manipulating tissue and depositing tissue, and 
only a limited amount on cutting the tissue. With increasing uterine weight, the total 
morcellation time also increased. Analysis of the different stages of total morcellation 
time showed similar increase for stages 1, 2 and 3, but not for stage 4 (i.e. the cleaning 
stage). No significant difference was found in the cleaning stage between weight group 
B (350g-750g) and group C (>750g). No significant difference was found in the number 
of scattered tissue pieces between groups B and C. 
To further analyse the cutting process, the tissue cutting time throughout the 
morcellation procedure was analysed. The length of every single removed tissue strip 
was approximated by the time spent cutting that tissue strip in the TAA, thereby 



































Figure 1: Chart providing the division of morcellation stages in percentages and the morcellation 
stage and cleaning stage time of groups A, B and C. Note that the presented percentages do not 
exactly add up to 100% because the percentages are calculated for every separate procedure and 
the mean is calculated afterwards over the population size.
allowing an evaluation of the change in length of the removed tissue strip during the 
morcellation process. This resulted in Figure 2, which shows the mean tissue cutting time 
per tissue strip for all patients combined, as a function of morcellation completion (in 
percentage). The morcellation completion percentage was calculated as 100 times the 
n-th tissue strip cutting action divided by the total number of cutting actions required 
to remove the full mass. The mean tissue cutting time over all patients was calculated 
for every 2% of morcellation completion. Linear regression analysis through the mean 
data shows a negative Pearson’s correlation coefficient of r = -.,81 (p<.001). This means 
that the length of tissue strips appears to decrease with progression of the morcellation 
completion. 
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raw data of all patients combined
mean strip removal time per 2%
linear regression line
Figure 2: Linear regression analysis for tissue strip cutting time as function of the percentage 
of removed tissue during morcellation. The percentage of tissue removed is approximated as 
100 times the nth tissue cutting action divided by the total number of cutting actions required to 
remove the tissue mass. Raw data from all patients is used to obtain a mean strip removal time for 
every 2%. Linear regression analysis is performed on the mean data.
Discussion & Conclusion
This study was performed to provide insight into the ‘physiology’ of the morcellation 
process. The complete morcellation process has 4 stages. Overall morcellation time 
amounts to 15% of the total procedure time on average, showing that morcellation 
does not account for a large extension of the total operation time. Manipulation of 
tissue (stage 1) comprises 50% of the morcellation procedure, whereas only 25% of 
the time is spent on the actual cutting of tissue (stage 2). As expected, the duration 
of tissue handling, tissue cutting and tissue depositing (stages 1 to 3) increases with 
larger uteri. In contrast, duration of the cleaning stage (stage 4) did not demonstrate 
the same linearity. Compared to uteri <350g, more time was spent on cleaning in cases 
with uteri weighing between 350g-750g. Interestingly, no further increase of stage 4 
was noticed when uteri over 750g were compared to uteri weighing 350-750g. The 
same can be said for the number of scattered tissue pieces during stage 4. Apparently, 
there seems to be a cut-off point. If the amount of tissue scatter is estimated by the 
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duration of the cleaning stage (meaning that a longer cleaning stage indicates more 
tissue scatter), then it implies that tissue scatter increases significantly after this 
cut-off point, and furthermore that after this point tissue scatter remains constant 
regardless of uterine weight. It can be cautiously concluded that the amount of tissue 
scatter is not related to uterine weight, but correlates with a certain cut-off point. To 
limit the amount of tissue spread with the current technology, power morcellation may 
only be used until a certain uterine weight. In this study, the cut-off point was found 
at 350g. 
Linear regression analysis of the mean  tissue cutting time per tissue strip showed that 
cutting time decreases as the morcellation process progresses. Using the tissue cutting 
time to estimate the length of the tissue strips, it can be concluded that at the start of 
the morcellation process the tissue strips are larger and tissue strips become shorter 
with progression of the morcellation process. Furthermore, although the range of the 
raw data is large, 82%, of the tissue cutting action has a duration of less than 10 seconds, 
and  60% under 5 seconds, both occurring more frequently later on in the procedure. 
This implies a certain inefficiency in the morcellation procedure, because apparently 
large pieces of tissue strips are only created at the very beginning of the cutting process. 
In this light, the rotational mechanism of the current power morcellators should be 
reconsidered, given that smaller tissue strips are inherently more prone to scatter by the 
rotating blade of the power morcellator. This rotational mechanism may be an important 
focus for enhancing the efficacy of the morcellation process regarding tissue spread. A 
solution may be to enhance the creation of large tissue strips or to assess an alternative 
for the rotational mechanism. One alternative for this mechanism already exists. The 
PKS PlasmaSORD (Solid Organ Removal Device) is manufactured by Olympus and it uses 
bipolar cutting instead of a rotating blade. Unfortunately, it causes smoke and it has 
been hypothesised that other mechanisms such as the CO
2
 pneumoperitoneum, raised 
abdominal pressure and smoke may contribute to tissue spread.[9] Another important 
finding of our study is the moment of the morcellation process which is at greatest risk 
of tissue spread. As stated, over 60% of morcellation time is under 5 seconds, meaning 
that these tissue strips are small, therefore possibly at risk for spreading. In addition, 
our study demonstrated these small tissue strips occur increasingly towards the end of 
the morcellation process, meaning that the risk of tissue spread is highest at the end 
of the morcellation process. From this it may be concluded that LSH and laparoscopic 
myomectomy  procedures, that do not have a vaginal access, are more prone to tissue 
scatter since all tissue needs morcellation, compared to TLH procedures in which only 
part of the uterus is morcellated to the point where the uterine remnant fits through 
the vagina. A solution to this problem in LSH en LM procedures could be to only use 
morcellation to the point where the uterine corpus or myoma can be removed vaginally 
after performing a colpotomy. 
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Although several studies have been published regarding power morcellators, relatively 
few comparative or clinical studies exist and some morcellators have been introduced in 
clinical practice without any (published) studies altogether. [13,14] The main focus of 
these studies appear to have been technical characteristics such as morcellation rate. It 
is questionable if upon introduction of power morcellators tissue spread was considered 
to be a severe side effect of the morcellation process. Gradually reports were published 
on the iatrogenic spread of benign uterine tissue. It is only afterwards, that information 
regarding the unintentional morcellation of malignant tissue became available. Naturally 
power morcellators were never intended for use in case of a malignancy and moreover, 
any fragmentation of malignant tissue is usually contraindicated in the principles of 
oncologic surgery. 
The weakness of our study is that tissue spread was not evaluated on a cellular level. 
Instead, the number of macroscopically detectable scattered tissue pieces and the and 
duration of the cleaning stage were used to determine the amount of tissue spread. 
Although the complete abdominal cavity and peritoneum were carefully and meticulously 
searched for tissue spread, it is possible that small tissue fragments were overlooked. 
Furthermore, the tissue strip cutting time was considered to be representative for  the 
length of the tissue strips. Therefore, any conclusion regarding tissue scatter and tissue 
strip length should be interpreted with relativism. It was attempted to define the cut-
off point of the uterine weight more precisely. A cut-off point calculated on raw data 
(instead of by comparing the 3 groups according to uterine weight) could not be found 
due to relatively limited sample size of 23 patients. For the same reason, a confidence 
interval in which the cut-off point lies could not be calculated. Lastly, the outcome of our 
study may not be applicable to power morcellators with other technical specifications 
such as a difference in diameter. 
To solve these shortcomings, a TAA of the morcellation process in a larger population 
is needed to verify the results of this study. Microscopic evaluation of tissue spread 
and the pattern of tissue spread may be an interesting addition to future studies. 
Notwithstanding these limitations, this study offers valuable knowledge regarding the 
basic ‘physiology’ of the morcellation procedure and tissue spread. Based on the results, 
the current rotational mechanism of the power morcellators should be reconsidered 
due to their relative inefficiency with respect to tissue scatter. Furthermore, the partial 
morcellation of uterine tissue seems less at risk to cause tissue spread compared to 
complete morcellation. For LSH and LH procedures this means that only part of the 
uterine tissue should be morcellated after which the remnant tissue can be removed 
vaginally through colpotomy. In TLH this is already standard procedure.  
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Finally, solutions that allow morcellation without spread are being investigated and focus 
mainly on in-bag morcellation. Although in-bag morcellation may be a proper solution 
for now, it treats a “symptom” rather than the underlying condition. To come to a 
sustainable solution to the current problem of tissue spread, it is most important that 
the underlying mechanism is addressed. This study suggests the rotational mechanism 
as an important factor. It is time for the engineer to further evaluate and enhance the 
technology of power morcellators.  
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Abstract
Study Objective: To assess features of power morcellators (blade diameter, circular 
versus oscillating cutting, blade rotation speed, experience level) regarding their effect 
on the amount of tissue spill. In addition, the amount of tissue spill after the initial two-
thirds and final one-third of the morcellated specimen was evaluated.
Design: An in-vitro study (Canadian Task Force classification II-2).
Setting: Laparoscopic skills lab of an academic hospital
Patients: Not applicable
Intervention: Power morcellation of beef tongue specimens 
Measurements and main results: Twenty-four trials were performed. Morcellation 
was performed in 2 phases (phase 1: initial two-thirds of the total tissue, phase 2: last 
one-third of the tissue). With larger blade diameter a decline was observed in both the 
weight of the spilled particles (phase 1) and the number of spilled particles (phases 1, 2 
and both combined) (weight phase 1=  6.5g vs 6.3gr vs 2.2gr for 12.5mm vs 15mm vs 
20mm respectively, p=.04; number particles:  Phase 1= 10.2 vs 7.2 vs 2.7 p = .01,  Phase 
2=  22.9 vs 19.0 vs 8.9 p= .02, Total= 34.7 vs 26.2 vs 11.6 p=.01). Also, spinning of the 
tissue mass due to torque being applied by the rotating blade occurred later when blade 
size increased, and the size of the spilled particles was larger (weight of morcellated 
tissue at onset of torque: 136g vs 198g vs 222g p=.07 and Size: .6g vs .9g vs .8g p=.1). 
In the oscillation mode, there was less total spill (6.8g/100g versus 21.3g/100g, p=.01, 
for oscillation and circular cutting respectively)
Conclusion: The present study demonstrates that less spill is created by power 
morcellators with an oscillating blade and / or a large diameter (≥20mm). Furthermore, 
when using a large diameter blade the spilled particles are larger and less morcellation 
repetitions are needed. By combining these features with currently introduced contained 
morcellation, the safety of the morcellation process with respect to tissue spill can be 
further improved.
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Introduction
The safety of power morcellators for the laparoscopic removal of large uteri and myoma 
is seriously questioned after reports of the accidental morcellation of occult uterine 
malignancies. The occurrence of tissue spread, caused by morcellation, is strongly 
believed to result in an upstage of the disease.[1] As a result, the U.S. Food and Drug 
Administration (FDA) decided in 2014 to advise against the further use of these 
instruments in almost all cases.[2] This poses a challenge for the future of minimally 
invasive gynecologic surgery, since the FDA statement effectively implies a return to 
laparotomy for numerous hysterectomy and myomectomy procedures.  However, it 
is questionable if this return to laparotomy is sustainable. In fact, it has been argued 
that a return to this approach in all cases of hysterectomy and myomectomy will lead 
to higher morbidity, mortality and costs when compared to laparoscopy, even when 
including the accidental morcellation of uterine malignancies.[3,4] Based on these 
studies, the morcellation technique should not be swiftly abandoned. However, it is 
clear that the safety of power morcellation should be enhanced. Currently, research on 
this topic focusses mainly on contained morcellation techniques, because in theory this 
should prevent complications due to tissue spread and may also help to prevent direct 
organ damage by the morcellation blade. Although the feasibility of in-bag morcellation 
has been demonstrated in several studies [5-7], long term outcomes do not exist and 
containment bags are even used off-label. Moreover, contained morcellation does not 
address the shortcomings of current power morcellators. A recent study, demonstrated 
that tissue spill increases significantly after a certain weight was morcellated and, in 
addition, that the efficiency of the current instruments may be improved.[8] The goal 
of this study is to further explore the technical features of power morcellators and their 
effect on tissue spill during the morcellation process. By clarifying the details of this 
process we hope to contribute to the development of more efficient and safe instruments 
and of surgical techniques with respect to tissue spill.
 
Methods
The following features and their effect on tissue spill were examined in an in vitro setting 
(table 1): 
First, the effect of different blade diameters was assessed. Diameters of 12.5mm, 15mm 
and 20mm were used. Speed was set at 400 rotations per minute (rpm) combined with 
standard circular cutting of the blade; Second, oscillation instead of circular cutting was 
assessed. In the oscillation mode, the morcellation blade rotates alternately 4 times 
clockwise and 4 times counter-clockwise; Third, the effect of rotation speed of the 
morcellation blade was evaluated. For this purpose, the speed was set at 800 rpm and 
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compared to 400 rpm; Fourth, the effect of experience level was studied, by comparing 
the results of the expert with a novice (LH, a resident in obstetrics and gynecology), 
Finally, the point in time (defined as the weight of tissue already morcellated) was 
evaluated where the tissue cutting action unintentionally shifts to torque being applied 
to the tissue mass due to friction, and as a result, the tissue mass starts rotating 
uncontrollably with the blade. 
Table 1: experiment design
12.5 mm 15 mm 20 mm
Diameter a 4 trials 4 trials 4 trials
Oscillation b 4 trials
Speed c 4 trials
Novice d 4 trials
Total 24 trials
a  Standard setting: speed 400 rpm, circular cutting
b Oscillation mode: 4 rotations clockwise alternated by 4 counter-clockwise.  Speed 400 rpm. 
c 800 rpm was compared to 400 rpm. 
d Novice: 2nd level according to the ESGE Standard Laparoscopy
All trials were performed by an expert in minimally invasive gynecologic surgery (FWJ), 
except for the novice trials. In agreement with other in vitro studies, beef tongue was 
used to simulate uterine tissue. [5,9,10] Pieces of 400-500 grams were morcellated. To 
collect all tissue spill, the morcellation specimen was placed in a clear plastic bag in an 
open laparoscopic box trainer (fig 1). 
Figure 1: The test setting in an open laparoscopic box trainer.
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The Blue Endo MOREsolution Tissue Morcellation System (Benetec Advanced Medical 
Systems, Retie, Belgium) power morcellator was used to perform all tests.[11] The 
system allows the use of 3 different diameters with the same instrument and power 
settings, thereby ensuring that measured differences can be attributed to diameter alone 
and not to instrument-specific features. Moreover, the MOREsolution provides circular 
cutting as well as oscillation, and adjustable blade rotating speed. 
All trials consisted of 2 phases. First, the intitial two-thirds of the beef tongue specimen 
was morcellated. The weight of the morcellated tissue was subtracted of the total 
specimen weight to determine the cut-off point. Next, the remaining one-third of the 
tissue (minus the spilled particles) was transferred to a new, clean bag and morcellation 
continued until all tissue was morcellated. The 2 bags were then inspected for 
macroscopic tissue spill. Spill was defined as any remaining tissue that could be extracted 
via the morcellator tube without activation of the morcellator. All tissue spill particles 
were counted and weighed. 
The primary outcomes are number and weight of spilled particles (phase 1, phase 2 and 
both combined), duration of the morcellation procedure, the morcellated tissue weight 
at the onset of torque, the number of morcellation repetitions (meaning the number 
of tissue strips removed by the morcellator) and the size per spilled particle (weight 
per particle). All results (except for time and torque) are standardised for comparison, 
by calculating the outcome per 100 gram of morcellated tissue. Non-parametric tests 
(the Mann-Whitney U and Wilcoxon signed-rank test) were used to analyse all data. 
The Jonckheere-Terpstra test was used to evaluate the presence of trends in the studied 
diameters. All results are shown as median values, unless otherwise specified. P ≤ .05 was 
considered significant. 
Results
Twenty-three trials and 1 test trial devided over 6 groeps were performed (table 1). 
For all groups combined, the mean weight of beef tongue was 431 grams (380-504g). 
During phase 1 and 2, 63% and 30% of the total weight was morcellated respectively. 
Mean weight and percentage of weight morcellated during phase 1 and 2, did not differ 
between groups. (table2) 
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Fig 2  outcome of Jonckheere-Terpstra test. Diameter (mm), weight (g/100g), particles (n/100g), 
time (min), torque (grams morcellated weight)
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With a larger diameter, both the weight of the spilled particles (phase 1) and the number 
of spilled particles (phase 1, 2 and in total) declined (weight phase 1= 6.5g vs 6.3g vs 2.2g 
for 12.5mm vs 15mm vs 20mm respectively, p=.04; number particles: Phase 1= 10.2 vs 7.2 
vs 2.7 p = .01, Phase 2= 22.9 vs 19.0 vs 8.9 p= .02, Total= 34.7 vs 26.2 vs 11.6 p=.01).  Also 
with a larger diameter, morcellation was quicker and less morcellation repetitions were 
needed (time for total procedure: 18min vs 11min vs 6min p<.001 and repetitions: 13.7 vs 
10.2 vs 4.3 p=.02). Finally, the onset of torque applied to the tissue mass occured later and 
the spilled particles were larger (Torque: 136g vs 198g vs 222g p=.07 and Size: .6g vs .9g 
vs .8g p=.1). (fig 2), although these differences were not statistically significant. 
In the oscillation mode, there was less total spill per 100g (6.8g/100g versus 21.3g/ 
100g, U=.000, p=.01, for oscillation and circular cutting respectively) and spilled particles 
were smaller (.3g/particle vs .9g/particle, U=.000, p=.01). 
The novice created smaller spilled particles (.6g/particle vs .9 g/particle, U=.000, p=.02, 
for novice and expert respectively) and the onset of torque applied on the tissue mass 
occurred sooner (after 142g vs 198g, U=.000, p=.02). Also, morcellation by the novice 
was significantly slower (18min vs 11min p=.02).
No significant differences or trends were observed between rotation speed of 800 rpm 
and 400 rpm. 
Finally, comparing phase 1 and 2 of all diameters of the expert trials with circular cutting, 
more spillage (particles and weight) occurred in phase 2 (6.0 particles/100g vs 19.0 
particles/100g, T=120 p= .001 and 4.3g/100g vs 13.9g/100g, T=120 p=.001 for phase 
1 and 2 respectively; data not shown). 
 
Discussion
Technical features of power morcellators and the morcellation process are assessed 
in this study. When a larger diameter morcellation blade was used, tissue spill was 
significantly reduced, less morcellation repetitions were needed, and the procedure was 
faster when compared to smaller diameters. Next, our study confirmed  our previous 
finding that more tissue is spilled later in the morcellation process. [8] Additionally, it 
is strongly suggested that the onset of torque applied to the tissue mass occurs later. 
This implies that this onset of torque may be prevented when a large diameter blade is 
used combined with partial instead of complete morcellation. Finally, the spilled tissue 
particles are larger. This may be advantageous since larger spilled particles are easier to 
detect and remove and are less likely to escape from containment bags. 
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Interestingly in the oscillation mode, although no effect was found on the onset of 
torque to the tissue, less total spill was observed when compared to circular cutting.  It 
appears that less spill is an inherent quality of the oscillation mode. It is questionable if 
the oscillation mode is optimal in the used morcellator: a cycle of 4 turns clockwise is 
alternated by the same cycle counterclockwise, still allowing the blade to apply torque 
on the tissue. In theory, it is expected that reducing the cycle to a 1x1 movement  may 
further delay or even prevent torque being applied to the tissue, however this has to be 
confirmed in future studies. 
The differences in the onset of torque and size of spilled particles as observed in the 
novices trials underline the technical skills that are needed to morcellate tissue. More 
“coring” and less “peeling” of tissue occurred in the trials of the novice.  Although this study 
was not powered to evaluate a learning curve, a sharp reduction in the morcellation time 
was found in the 4 trials of the novice (26min to 13 min). When teaching morcellation 
to a novice, the “peeling” motion should be emphasized and spillage should be carefully 
monitored. 
In all, the results from our study appear to be in contrast with new developments in 
minimally invasive surgery with respect to minimizing the size and number of key holes 
during laparoscopic procedures in vivo. Our results suggest that power morcellators with 
oscillating blades and a large diameter, of 20mm or perhaps more, are advantageous 
with respect to the amount of tissue spill. Furthermore, less spill is produced when tissue 
is only partially morcellated. In case of total laparoscopic hysterectomy (TLH) , larger 
instruments can be readily used by morcellating vaginally. In addition, removal of the 
larger remnant after partial morcellation should not be difficult via the vagina.  However, 
in case of laparoscopic myomectomy (LMM) or laparoscopic supracervical hysterectomy 
(LSH), an enlargement of the port-site may be necessary to accommodate larger 
instruments and to extract the remaining tissue. This can be achieved abdominally, or 
vaginally by culdotomy. 
The current developments in contained morcellation may appear to obviate the need for 
more efficient power morcellators. However, evidence questions the protective value 
of contained morcellation in high stage/grade tumors.[12,13] Therefore additional 
measures should be considered given the often high grade, aggressive characteristics of 
uterine sarcoma. Furthermore, it has been established that the integrity of morcellation 
bags can be impaired after use, even when the bags appear intact on gross examination.
[14,15] Larger particles are less likely to pass through small puncture holes in the bags, 
and in case of abdominal spillage, are more easily detected. Finally, less morcellation 
repetitions decreases the risk of puncture by the device. 
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Because our experiment was not performed by classical laparoscopy, it may be questioned 
if our results are clinically applicable and this may be considered a weakness of our study. 
Our study was intended to examine the technical features of the morcellation instrument 
and process. By using a box trainer, our results are not affected by laparoscopic skills or 
the limitations of minimally invasive surgery as such. Furthermore, the use of beef tongue 
specimens instead of (human) uterine tissue and/or fibroids may be questionable in this 
context. Although beef tongue has been favorably used in other in vitro studies [5,9,10], 
its structure may not be completely similar to human fibroid tissue. Fibroids often are 
inhomogeneous due to calcifications or necrosis, and because of this, the pattern of 
tissue spread could be different than what we observed. However in our opinion, the 
inhomogeneity of fibroids may actually cause more tissue spread than the ideal model of 
beef tongue. Our definition of tissue spill in phase 1 and 2 could be considered artificial. 
After phase 1, all remaining large tissue particles were transferred to phase 2 and then 
morcellated. Of course during surgery, morcellation is a continuous process. Moreover, 
by using the same morcellator for all experiments, the difference in technical features of 
morcellator was excluded as an influence on the results. As a consequence, however, the 
outcome from our study may not apply to other commercially available morcellators. 
Nevertheless, our results are in agreement with previous observations in a clinical 
setting in which different morcellators were used.[8] Finally, we are aware of the limited 
sample size of this study. However, large differences were found that were statistically 
significant even in this sample. Furthermore, it was calculated that, based on our results, 
only 10-15 trials are necessary to make the trends in torque and particle size significant. 
Notwithstanding these shortcomings, the results of our study are highly relevant as 
they finally allow specific recommendations on the morcellator features. Moreover, our 
recommendations are easy to implement in daily practice and may contribute to safer a 
morcellation process regarding tissue spill in the very near future. In addition, our study 
can be used by the health care industry to improve and extend the range of existing 
power morcellators with oscillating blades and large diameter. 
In conclusion, the results from our study demonstrate that tissue spill can be further 
decreased by using power morcellators with favorable features. Contained morcellation 
alone has yet to be proven effective, and its shortcomings have been demonstrated. The 
combined use of in-bag morcellation and more effective power morcellators may well 
lead to the enhanced safety of this procedure.
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Abstract
Laparoscopic hysterectomy is a procedure that involves the removal of the uterus 
through an abdominal keyhole incision. Morcellators have been specifically designed for 
this task, but their use has been discouraged by the Food and Drug Administration since 
November 2014 because of risks of cancerous tissue spread. The use of laparoscopic 
bags to catch and contain tissue debris has been suggested, but this does not solve the 
root cause of tissue spread. The fundamental problem lies in the tendency of the tissue 
mass outside the morcellation tube to rotate along with the cutting blade, causing tissue 
to be spread through the abdomen. This paper presents a bio-inspired concept that 
constrains the tissue mass in the advent of its rotation in order to improve the overall 
morcellation efficacy and reduce tissue spread. A design of gripping teeth integrated 
into the inner diameter of the morcellation tube is proposed. Various tooth geometries 
were developed and evaluated through an iterative process in order to maximize the 
gripping forces of these teeth. The maximum gripping force was determined through 
the measurement of force-displacement curves during the gripping of gelatin and bovine 
tissue samples. The results indicate that a tooth ring with a diameter of 15 mm can 
provide a torque resistance of 1.9 Ncm. Finally, a full morcellation instrument concept 
design is provided.
Keywords: laparoscopic devices, minimally invasive surgery, morcellation, tissue spread, 
tissue constraining
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Introduction
In laparoscopic hysterectomy and myomectomy, tissue needs to be removed without 
compromising the integrity of the minimally invasive procedure. The power morcellator 
is an instrument designed for this purpose, having a fast rotating cylindrical blade that 
allows for the division and removal of tissue. 
The Food and Drug Administration (FDA) issued a press release in November 2014, 
discouraging the use of power morcellators because of their risk of spreading cancerous 
tissue within the abdomen and pelvis in women with unsuspected uterine sarcoma [1]. 
It has been estimated by the FDA that 1 in 350 women undergoing hysterectomy or 
myomectomy for myomas will have unsuspected uterine sarcoma [1,2]. Although this 
statement has been refuted and is believed to be closer to 1 in 1,550 [3], these FDA 
statements nonetheless led to the restriction of morcellation, thereby limiting many 
women with symptomatic leiomyomas to total abdominal hysterectomies. Over the 
eight months following the FDA safety communication, a decrease of laparoscopic 
hysterectomies was observed together with an increase in abdominal and vaginal 
hysterectomies, as well as an increase in major surgical complications and hospital 
readmissions [3,4]. Concerns have been raised with respect to potentially higher 
patient morbidity and the long-term outcome of surgical techniques that are adopted 
as alternatives to standard power morcellation, such as the use of containment bags, 
vaginal incisions, and intraoperative biopsies [5]. Although complications of morcellation 
are rare, both the development of parasitic fibroids and the spread of sarcoma cells in the 
abdominal cavity have been reported [6-8]. Clearly, the issue of tissue spread caused by 
current power morcellators is one that requires solving.
Cause of Tissue Spread
Tissue spread is the result of a fundamental problem in morcellators that rely on the 
‘motor peeling’ mechanism [9]. The morcellation process constitutes the repetitive 
grasping, cutting, and disposing of tissue strips sliced from the main tissue mass. Initially 
relatively long tissue strips are created. With progression of the morcellation process, 
that is, after the first few tissue strips have been cut and removed, the created tissue 
strips become shorter [10]. An explanation for this phenomenon is that the tissue mass 
decreases in size and weight and becomes increasingly distorted in shape. Consequently, 
the tissue mass itself becomes prone to being dragged along with the fast rotating 
cutting blade because of friction between the two. Eventually the entire tissue mass 
may start rotating along with the cutting blade, thereby scattering tissue fragments 
throughout the intraperitoneal area.
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In Figure 1, the tissue spread problem is depicted in detail in three separate instances 
from left to right: 1) initiation of tissue morcellation, 2) during morcellation, and 
3) morcellation failure. When initiating a morcellation action (Fig. 1, left), the tissue 
mass is grabbed and pulled into the morcellation tube. In the beginning, the length of 
the tissue strip sliced thus far (through application of force F
pull
) is short and unable 
to twist significantly. Accordingly, the surgeon has proper control through force F
pull
. 
However, as the slicing of the tissue strip continues, the length of the strip increases 
and friction between the cutting blade and the main tissue mass outside the tube can 
induce spinning of the mass (through force F
T
), with twisting of the tissue strip as a 
result (Fig. 1, middle). Spinning of the main tissue mass is especially prominent when the 
cutting blade has dulled during its use, for example, due to having morcellated calcified 
myomas or unintentional grasper-blade contact. Literature shows that a high force level 
is required to achieve steady-state cutting when the blade sharpness is low [11-16]. 
Thus, when morcellating with a dulled cutting blade, a high force F
pull
 is required to cut 
the tissue. A low F
pull
 will maintain tissue-blade contact but not initiate cutting, resulting 
in the tissue mass rotating along with the blade.
Figure 1: Representation of the tissue mass spinning problem underlying power morcellators. 
(a) Initiation of morcellation where tissue is pulled into the morcellation tube (F
pull
) and a tissue 
strip is being cut properly. (b) Midway through morcellating a tissue strip, where the strip has come 
to be of such length that twisting of the strip inside the tube occurs. This results in a (possible) 
torque (F
T
) of the tissue mass, induced by the rotating cutting blade, spinning the tissue. (c) 
Morcellation failure due to rupturing of the (twisted) tissue strip inside the tube. The tissue mass 
is free to follow the torque F
T
 as well as disconnect from the morcellation tube (F
z
), resulting in a 
combined force vector F
c
, indicating the direction to where the tissue mass falls or is flung. Note: 
force-vectors not to scale.
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The shape of the mass, which is initially roughly spherical, is deformed due to the 
excision of tissue strips, increasing the likelihood of tissue scatter during tissue mass 
spinning. Rotation of the mass may lead to rupturing of the tissue strip (Fig. 1, right), 
after which the tissue mass is free to rotate with the cutting blade (F
T
) and disconnect 
from the distal end of the morcellation tube (e.g., through gravitational force F
z
). The 
combination of forces results in a force vector Fc, in which direction the tissue mass 
either falls (at low F
T




In order to provide a brief overview of the state-of-the-art with respect to morcellators, 
a patent search was performed in the Espacenet database using the search terms morce* 
AND (instr* OR tool* OR device*), providing 84 results. Filtering these results on title and 
abstract on relevance with respect to laparoscopic uterine tissue morcellation (excluding 
intra-uterine shavers), and removing duplicate patents from the same applicants that 
describe different or updated facets of the same instrument design, yielded a list of 45 
relevant patents. Note that this patent search is not all-inclusive as morcellator patents 
may exist that do not contain the string morce*.
Standard morcellators that rely on the ‘motor peeling’ working principle are abundant, 
where the differences between patents mostly relate to aspects such as reusability versus 
disposability, instrument dimensions, and cutting blade drive mechanisms [17-25]. Patents 
of existing morcellators include the LiNA Xcise (LiNA Medical, Glostrup, Denmark) [23], 
Gynecare Morcellex (Ethicon, Inc., Somerville, NJ, USA) [17, 21], and Storz Rotocut G1 
(Karl Storz GmbH & Co, Tuttlingen, Germany) [26]. For a full list of current morcellators 
used in clinical practice, one may refer to Driessen et al. [9]. Alternative cutting 
mechanisms include oscillating or vibrating cutting blades [27,28], electrosurgical cutting 
[29-36], waterjet cutting [37], grinding [38], or the use of a wire mesh to slice tissue [39-
41]. Each of these alternative cutting methods have their own strengths and weaknesses. 
An instrument having an oscillating cutting blade is the MOREsolution Tissue Morcellator 
(AxtroCare/BlueEndo, Lenexa, KS), which alternately turns four times clockwise and four 
times counterclockwise. Although this instrument has shown to provide less tissue spread 
when in oscillation mode as compared to rotation mode [42], the oscillating mode still uses 
full blade rotations. Electrosurgical cutting speed is dependent on power settings [43], and 
smoke may obscure the surgeon’s vision [44] and contain carcinogenic agents [45]. Using 
waterjet cutting as a morcellation method macerates the tissue, potentially creating tissue 
spill in the process, and making histological evaluation no longer possible [46]. Lastly, wire 
mesh cutting is a method that encapsulates the tissue mass and subdivides it into multiple 
smaller pieces by drawing the wire mesh through the tissue [39-41]. This method may be 
time-consuming, as the time required to manipulate a tissue mass into the encapsulating 
bag has been reported to range from 1 to 13 minutes [47, 48].
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To catch and contain tissue spread, a number of laparoscopic tissue entrapment 
bags have been proposed, each with their own material properties with respect to 
robustness against perforations and number of openings [49-58]. Following the FDA 
safety communication, several studies have been performed to evaluate the safety 
and applicability of such bags in combination with current morcellators [47, 59-61]. 
Alternatively, several patents describe the bag as inherent parts of the morcellation 
mechanism [29,32,62-65]. 
Lastly, the transport of tissue through the morcellation tube can either be done 
manually, as is current standard practice using a laparoscopic grasper, or automatically, 
either through suction [29,32,64,66], an internal auger [38], or screw thread [67]. The 
method of tissue transport strongly relates to the way the surgeon is able to control the 
uterine tissue mass. The standard morcellator with a laparoscopic grasper may cause 
tissue scatter problems as described above, whereas automated transport mechanisms 
usually have some additional way of constraining the tissue. Three patents specifically 
describe mechanisms that provide improved tissue control [68-70]. The first patent 
describes an additional instrument that constrains the tissue mass and allows it to be 
presented to the morcellator in the best way possible [68] (Fig. 2a). The remaining 
patents describe a morcellator with grasping jaws at their distal end to confine the tissue 
at the time of cutting (Figs 2b and 2c). The use of such components is beneficial to close 
the force loop near the cutting mechanism.
Figure 2: Patent morcellator designs that engage and constrain the main tissue mass during 
morcellation. (a) patent US20150073224A1. (b) patent US20130090642A1. (c) EP0706781A2. 
Images cropped and component numbers removed from original patents.
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Proposed solution
Solutions identified in the literature to solve the issue of tissue spread are to introduce 
an alternative cutting method, to encapsulate the specimen being morcellated, or to 
enhance the efficacy of the rotational cutting mechanism itself. The use of an alternative 
cutting method has already been explored extensively, but the rotating cutting blade 
method has remained the standard. The use of a bag is feasible but does not address the 
source of the problem that causes tissue spread. Furthermore, studies have shown that 
up to 30% of bags used to contain morcellation spillage may exhibit leakage [71-73], 
and contained morcellation may not prevent metastasis of high-grade tumors, despite 
having used a bag [74, 75]. The current research focuses on enhancing the efficacy of 
the current ‘motor peeling’ principle to reduce tissue scatter, an approach that may be 
complementary to the use of bags. Our approach locally confines the tissue mass during 
morcellation, such as shown in the patents presented in Figures 2b and 2c, thereby 
preventing the tissue mass from spinning with the rotating blade. Our design differs 
from those shown in Figure 2 in that the method of tissue confinement is integrated 
in the standard morcellation instrument, rather than using an external fixation method 
such as the jaws shown in Figures 2b and 2c. Moreover, our design does not require a 
change in the standard tissue cutting method. 
 
Concept Design
Many animals can be found that make clever use of tooth geometries and configurations. 
For example, a method seen in nature for holding and swallowing (slippery or struggling) 
prey are the large and backward facing pointed papillae that cover the tongue and roof 
of the mouth of the penguin for eating arrow squids [76], or the upper and lower jaws 
of the leatherback sea turtle to aid in the consumption of jellyfish [77,78]. Examples of 
animals that prey on fish or mammals larger than themselves are the cookie cutter shark 
(Isistius brasiliensis) and the lamprey (Petromyzontiformes, Fig. 3a), which both behave 
much like a morcellator. Using a mouth and saw teeth that are adapted for sucking, 
the small shark maintains an attachment to its prey, and is able to slice and scoop out 
chunks of tissue by using its lower band of saw teeth while rotating its entire body [79, 
80]. Similarly, using suction and a vast array of teeth arranged in whorls around the 
mouth opening, the lamprey attaches itself to other fish. The tongue, also having teeth, 
is subsequently used to rasp away flesh from the host.
Taking cues from nature, a viable solution to improving the efficacy of morcellators may 
be through the integration of teeth to provide grip on the tissue mass. In specific, these 
teeth should compensate for forces FT and FZ. An example of a morcellator design we 
have created with this principle in mind is provided in Figure 3b, where teeth have been 
18046 Lucas van den Haak.indd   97 03-10-18   20:02
98 Chapter 7|
integrated into the instrument tip. In order to investigate the potential of this solution, 
a proof-of-principle design has been made of a single ring of teeth. These teeth are 
required to generate a reaction force close to the location where force FT is generated 
by the blade, thereby locally closing the force-loop in the event of spinning of the tissue 
mass. The teeth should engage the tissue mass only when it starts to rotate with the 
blade, and not hinder the normal tissue debulking process of the morcellator. 
The design of the ring of teeth (Fig. 3c) is such that it can be placed coaxially on the 
inside of the circular rotating blade, at the distal end of a standard morcellation tube. The 
geometry and orientation of the teeth ensure that they hook into the tissue mass when 
it starts to rotate with the blade. The teeth are angled inwards, into the morcellation 
tube, freely allowing the tissue to be pulled up the tube, but blocking it from sliding back 
into the peritoneal area. 
This paper presents research into the dimensions and number of teeth to achieve an 
optimal gripping force on the tissue mass, whilst still allowing the pulling of the debulked 
tissue strip through the morcellation tube. Test-bench trials have moreover been 
performed to assess the grip strength of the teeth on animal muscle tissue.
Figure 3: (a). Lamprey. Image edited to only show the mouth [93]. (b) Lamprey inspired 
morcellation instrument tip, having integrated teeth for tissue traction. (c) Design of a single 
teeth ring. Dimensions are in millimetres.
Method
The measurements and validation of the proposed design was performed in two 
stages together comprising six measurement sessions. Firstly, through porcine gelatin 
tests (measurement sessions 1–4) teeth of various dimensions were assessed in order 
to motivate the design choices made in prototyping a single teeth ring. The second 
stage of tests (measurement sessions 5 & 6) provided the quantification of this ring in 
terms of gripping strength when using bovine muscle tissue. For all measurements, a 
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force-displacement curve was obtained by drawing a sample of gelatin or animal tissue 
past the teeth. The sequence in which the six measurements sessions were performed is 
shown in Figure 4. The selection process of tooth geometries based on measured forces 
is described in the subsequent Methods sections (see also Fig. 4, ‘selection’ boxes); the 
actual force values are provided in the Results section. 
Figure 4: Flowchart of the sequence of measurements performed, where at each measurement 
a force-displacement curve was generated. In measurement sessions 1–4, porcine gelatin 






 (Fig. 1), using the test 





, in contact with the teeth ring, using the test setup shown in Figure 7.
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Teeth optimization for tissue grip – Gelatin tests
To study the tooth geometry and measure their maximum gripping force, a test setup 
was created as shown in Figure 5. A 1.0 mm thick metal plate, containing sets of teeth, 
could be placed under an angle of 30°, 45° or 60° with respect to the smooth horizontal 
surface (see annotation in Fig. 5b), so that only the teeth were protruding upwards. 
A spring-loaded mechanism under the metal plate was used to center the plate parallel 
and flush with respect to the surface. Two metal plates of various sets of teeth were 
created (Fig. 6). The three angles with respect to the horizontal surface were chosen to 
span a range that is likely to show an influence on the measured forces. Only three angles 
were assessed to keep the number of measurements to a manageable size. Assessing the 
fine-grained influence of the gripping angle is left for future research.
Measurements involved placing a set of teeth in the middle of the surface, and a gelatin 
sample in front of them. The gelatin sample consisted of 15% gelatin and 85% water. 
A pulling wire (fishing thread, 0.2 mm diameter) ran from a load cell (Futek LSB200, 
10lb), having a force measurement range of 0 to 45 N and resolution of 0.038 N, to 
the gelatin block and back. The wire was placed around the sample with a small plate 
at the back, allowing the pulling force to be distributed equally over the back surface 
of the sample. The load cell was attached to a linear stage having a movement step 
size of 1 µm and speed of 1.25 mm/s. By generating a force-displacement curve while 
drawing samples past the teeth, the peak gripping force (i.e., the highest measured 
force, F
max






, Fig. 5). For 
each sample, the front-facing surface contacting the teeth had dimensions 24 x 17mm. 
A roof plate was placed closely above, but initially not contacting, the gelatin samples 
(not shown in Fig. 5), vertically constraining them from (upwards) escaping the grasp 
of the teeth. The friction forces resulting from contact between the sample and both the 
horizontal surface and the roof plate were measured separately and subtracted from the 
Figure 5: (a) 3D view of the gelatin and teeth test setup. (b) Side view of the setup. (c) Example 
of the teeth that have been evaluated. A gelatin sample (small blue block) was placed near the 
teeth, which were placed under an angle. Pulling the sample in the force directions FZ, FT and FC, 
(as also shown in Fig. 1) evaluated the gripping force the teeth had on the sample in that specific 
direction. Force-displacement measurements were performed with a tensile tester.
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results. Not all teeth were measured in all force directions and under all combinations 
of conditions in order to keep the amount of measurements to a manageable number. 
A total of 194 measurements were performed in measurement sessions 1 through 4, 
with each measurement taking about 4 minutes.
Measurement Session 1) Gripping force at teeth of different geometry. With the goal of 
finding a well-performing tooth geometry, various teeth were assessed (Fig. 6, top). 
These teeth had a constant height of 1.0 mm, and were varied in wedge angle (range 20° 
and 60°, see teeth A, B, C, & I), curvature (linear or radius of 1.0 or 2.0 mm, see teeth E, F, 
& H), combinations of teeth (D & F) and blunt teeth (G). For this measurement session, 
the teeth were kept under a 45° angle with respect to the horizontal surface (Fig. 5b). 
This angle was the mid-range value around which a high gripping force was expected 
to be measured. Force direction F
Z
 was assessed. The total number of measurements 
performed was 54 (9 different tooth geometries * 6 measurements per geometry).
Measurement Session 2) Gripping force at teeth of different width and height. The 
results of measurement session 1 showed that tooth geometry D (Fig. 6, top), having 
a combination of two differently sized teeth, generated the highest maximum gripping 
force (for full results see Section 4.1). These teeth were redesigned to function in force 
direction FT by curving them in a 45° angle sideways (Fig. 6, bottom), and were varied 
in height (1.0, 1.5, & 2.0 mm). The teeth also varied in width by equally distributing 
their number (range 4 to 8) over a length of 10 mm. Both ‘combined teeth’ (e.g., Fig. 6, 
bottom, tooth geometry B) and ‘singular teeth’ (e.g., Fig. 6, bottom, tooth geometry A) 
were designed. Measurements were performed in force direction FC, while again keeping 
the teeth under a 45° angle with respect to the horizontal surface. Total number of 
measurements performed was 80 (10 types of tooth geometries * 8 measurements per 
geometry). Figure 6 (bottom) provides an overview of the 10 teeth that were tested in 
measurement session 2.
Measurement Session 3) Gripping force in all force directions. From measurement session 
2, teeth F and J (Fig. 6, bottom) were found to have the highest mean maximum gripping 
force (F
max
) in force direction F
C
 (for full results see Section 4.1). These teeth were further 




, whilst still keeping their angle with respect to the 
horizontal surface at 45°. Total number of measurement performed was 24 (2 types of 
tooth geometries * 6 measurements per geometry * 2 force directions).
Measurement Session 4) Gripping force for different teeth angles with respect to the 
horizontal surface. Following measurement session 3, tooth geometry J (Fig. 6, bottom) 
was found to provide the highest gripping force (F
max
). Having already quantified the 
teeth in all force directions at a 45° angle with respect to the horizontal surface (Fig. 5b), 
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this angle was varied to 30°, 45° and 60°. The maximum gripping force was measured in 
force directions FC and the inverse direction of FZ (i.e., –FZ). –FZ was used to quantify 
the force required to draw a gelatin sample over the teeth in their non-gripping direction, 
which is equivalent to drawing tissue into the morcellator tube in a clinical scenario. Total 
number of measurement performed was 36 (6 measurements * 2 force directions * 3 
angles with respect to the horizontal surface).
Figure 6: First (top) and second (bottom) range of teeth evaluated in measurement session 1 
and sessions 2-4, respectively.
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Teeth ring assessment for tissue grip – Bovine tissue tests
Through the design-oriented measurement sessions 1–4, tooth geometry J (teeth 
of 2.0 mm height and 1.4 mm width, 0.3 mm spacing between teeth, and a 45° angle 
with respect to the horizontal surface) was selected to be developed into a teeth ring 





 respectively, using the test setup shown in Figure 8 and the same linear stage as 
used in sessions 1–4. Here, the teeth ring was attached to the end of a tube with outer 
diameter 12.5 mm and inner diameter 11.0 mm, which is approximately equal to the size 
of most current morcellation instruments. Bovine muscle tissue strips were collected 
from three larger tissue samples. The strips, each with size 10 x 10 x 40 mm, were cut 
in four different directions, assuring an equal distribution of muscle striations among all 
tissue samples. Each sample was clamped in the test setup by pulling it for a set distance 
into the fixation tube and placing a pin all the way through the tissue sample. The tissue 
strip was drawn into the morcellation tube and a 5 mm distance was kept between the 
fixation and morcellation tube.
Figure 7: Prototyped steel teeth ring, using tooth geometry J (Fig. 10, bottom), 2.0 mm height, 
1.4 mm width, 0.3 mm spacing between teeth, and 45° inward angle. The ring has 21 teeth.
 
Measurement Session 5) Gripping force at tissue translation. Tissue placed inside the 
morcellation tube was pulled out of the tube by translating the fixation tube backwards 
over a distance of 12 mm. First, 9 measurements (i.e., 3 tissue strips, each used 3 times) 
were used to measure the friction resistance of the morcellation tube in the absence 
of gripping teeth. Next, 45 measurements (15 tissue strips, each used 3 times) were 
performed, measuring the maximum gripping force (Fmax) of the ring of teeth.
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Measurement Session 6) Gripping force at tissue rotation. Lastly, tissue placed inside 
the morcellation tube was rotated by rotating the fixation tube by approximately 2.7 
turns (by translating the linear stage over a distance of 107 mm). As in measurement 
session 5, first 9 measurements were performed without involving the gripping teeth to 
ascertain the friction resistance of the morcellation tube itself. Next, 60 measurements 
were performed, divided over 15 tissue strips, where each strip was measured 4 times. At 
each strip, the first three measurements involved rotating the tissue against the pointing 
direction of the teeth. During the fourth measurement, the tissue was rotated along 
with the pointing direction of the teeth, to measure the force required to rotate tissue 
free from the gripping teeth.
Differences between the tooth geometries were assessed using a one-way analysis of 
variance (ANOVA) with the Tukey-Kramer method and a significance level α of 0.05.
Figure 8: (a) 3D view of the bovine tissue and teeth test setup. (b) Close-up of tissue sample 
clamped and subjected to forces FZ or FT while in contact with the teeth ring. (c) Top view of 
the setup. A tissue sample (blue) is placed in contact with the teeth, which is mounted at the 




, as also 
shown in Figure 1, evaluates the grip the teeth have on the sample in that specific direction. Force-
displacement measurements were performed with a tensile tester.
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Results
Teeth optimization for tissue grip – Gelatin tests
An example of a force-displacement curve of a measurement where a block of gelatin 
was drawn into teeth D of teeth range 1 is shown in Figure 9a. At a displacement of 0 
mm, the gelatin sample was right up against the teeth but not yet drawn into them. At 
continued displacement, the teeth dug into the sample and elastic deformation of the 
sample occurred while the measured force sharply rose. At the force peak (F
max
), the 
sample material started to rupture. As a result, the teeth lost grip and the measured 
force dropped sharply. At continued displacement, the sample was drawn over and 
through the teeth, where the second rise and drop in grip force can be attributed to the 
teeth regaining their grip on the gelatin sample.
Measurement Session 1) Gripping force at teeth of different geometry. Means and standard 
deviations of F
max
 at all teeth of the first teeth range (Fig. 8, top), measured in force 
direction F
Z
, are presented in Figure 9b. The ANOVA revealed a significant difference 
between tooth geometries, (F(8,45) = 3.56, p = .003). Teeth type D provided the 
highest mean F
max
. This difference is statistically significant compared to teeth types A, 
B, G, H, and I (p
A-D
 = .043, p
B-D
 = .022, p
G-D
 = .007, p
H-D
 = .001, p
I-D
 = .015). A possible 
explanation why teeth type D outperforms the other teeth types may be that it uses a 
combination of two different teeth types (A and C). The depth of the teeth alternate 
among each other, which may have an effect on the location from where the gelatin 
sample starts to rupture.
Measurement Session 2) Gripping force at teeth of different width and height. Means 
and standard deviations of F
max
 for all teeth of the second teeth range (Fig. 8, bottom), 
measured in force direction F
C
, are presented in Figure 9c. According to the ANOVA, 
the tooth geometries were significantly different from each other (F(9,70) = 2.30, p = 
.025). The two teeth types with the highest mean F
max
 were F and J, with 0.92 N (SD = 
0.13 N) and 0.97 N (SD = 0.11 N) respectively. Only teeth J was statistically significantly 
different from teeth D (p
D-J
 = .021).
As the teeth height was varied between h = 1.0 mm, 1.5 mm and 2.0 mm, grouping 
those respective gripping forces together gave 0.70 N (SD = 0.31 N), 0.82 (SD = 0.23 
N), and 0.91 N (SD = 0.12 N), respectively. According to the ANOVA, these three means 
were significantly different from each other, F(2,77) = 5.19, p = .008). The mean force 
for teeth with a height of 2.0 mm was statistically significantly higher compared to the 
mean force of teeth 1.0 mm in height (p = .006). No statistically significant difference 
was found for the teeth having a height of 1.5 mm as compared to the other teeth. The 
teeth providing the highest mean gripping force of both the 1.5 mm and 2.0 mm teeth 
height groups, being teeth F and J, were selected to be further investigated.
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Measurement Session 3) Gripping force in all force directions. Measuring the gripping 
force of teeth types F and J in all force directions yielded the results as shown in Figure 
9d. Teeth type J outperformed F in all measurements, although this difference is only 
statistically significant in direction F
T
 (F(1,10) = 13.33, p = .004).
Figure 9: (a) Characteristic sample measurement (teeth range 1, teeth type D, measurement 
session 1). The maximum grip force on the gelatin sample is indicated by Fmax. (b–e) Results 
of measurement sessions 1 through 4. All results are presented as mean ± SD gripping force. (b) 
Measurement session 1. Force generated by various tooth geometries in force direction FZ. (c) 
Measurement session 2. Force generated by various geometry and size teeth in force direction 
FC. (d) Measurement session 3. Force generated by teeth types F and J in force directions FZ, 
FT and FC. (e) Measurement session 4. Force generated by tooth geometry J in force directions 
FC and inverse of FZ (i.e.,  FZ), each for three different angles of the teeth with respect to the 
horizontal surface. 
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Measurement Session 4) Gripping force for different teeth angles with respect to the 
horizontal surface. Measuring teeth type J (Fig. 9, bottom) while varying their angle 
with respect to the horizontal surface (Fig. 5b) resulted in Figure 9e. Force directions 
F
C




) had been assessed. In the direction of –F
Z
, the force 
should have been as low as possible, as this represents the resistance of the sample when 
drawing it along with the facing direction of the teeth, rather than opposing them. No 
statistically significant differences were observed. For the design of the teeth ring, the 
aim was to generate a gripping force in the direction of FC as high as possible. Accordingly, 
the choice for teeth type J under an angle of 45° was made.
Teeth ring assessment for tissue grip – Bovine tissue tests
Measurement Sessions 5&6) Gripping force at tissue translation and rotation. 





, by respectively translating and rotating tissue while in contact with 
Figure 10: Results of measurement sessions 5 and 6. (a) Mean ± SD maximum teeth gripping 
force in force directions FZ and FC (translations and rotations plot respectively). Three 
measurement trials were performed per tissue strip, and results are group per trial number. 
(b) Results of measurement sessions 5 and 6. Mean ± SD of the maximum teeth gripping force 
pulled along with and against the pointing direction of the teeth, respectively.
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the teeth ring. The teeth ring was designed using teeth type J (see Fig. 6) under an 
inward angulation of 45° with respect to the morcellation tube. All tissue strips had 
been measured three times. Separating the measurements into groups based on their 
trial number yielded the results shown in Figure 10a. No significant differences were 
observed in the F
Z
 force direction. However, the ANOVA showed a significant difference 
between trials in the F
T
 force direction (F(2,42) = 8.01, p = .001) (see Fig. 10b). The 









 = .001), potentially a result of tissue damage caused by 
the teeth. In the force direction F
Z
, all the data was therefore grouped. However, in the 
direction F
T
 the first time a tissue strip was measured was considered separately from 
subsequent trials. 
The results for both force directions, measured both against and along with the teeth, 
are shown in Figure 10b.
 
Instrument design
The tests performed in measurement sessions 5 and 6 with the teeth ring yielded a 
maximum gripping force of 1.67 N (SD = 0.93 N) in the FZ direction, and 2.32 N (SD 
= 1.00 N) and 1.44 N (SD = 0.53 N) in the FT direction for the first and subsequent 
trials, respectively. Because existing morcellators vary in diameter, it is interesting to 
extrapolate these results [9]. Considering that the teeth ring had 21 teeth that were 
equally distributed along its inner diameter (øinner = 11.5 mm), a teeth ring integrated 
into a morcellator with an outer diameter of 15 mm and wall thickness 0.5 mm (leading 
to øinner = 14 mm) would have 25 teeth. Such a teeth ring would provide 2.76 N of 
gripping force in the FT force direction the first time that grip is generated (assuming that 
all teeth grip the tissue equally). Assuming that the gripping force is a linear function of 
the number of teeth, scaling up the diameter of the morcellation tube to 20 and 30 mm 
(thereby matching for example the 20 mm diameter of the Morce Power Plus (Richard 
Wolf, Germany)[81] and the 30 mm diameter of a proposed transvaginal morcellation 
design [82]) would provide 3.76 N and 5.74 N of grip force, respectively. The function 
that relates torque to radius (=rF) shows that for a tube of 15 mm diameter, a single 
teeth ring can counteract a torque up to 1.93 Ncm (=0.7 cm * 2.76 N). For diameters of 
20 and 30 mm this would be 3.57 Ncm and 8.32 Ncm per teeth ring, respectively.
Torques of cutting blades reported in literature range from 80 Ncm (TCM3000BL 
Morcellator, Nouvag [83]) to 1.5 Nm (MoreSolution, Axtrocare [84]), whereas the RPM 
of morcellators ranges from 50 to 2,000 RPM (TCM3000BL Morcellator: 50 to 1000, 
MorseSolution: 100 to 800). Torque is inversely related to RPM, and thus morcellators 
18046 Lucas van den Haak.indd   108 03-10-18   20:03
109A redesign of the laparoscopic power morcellator |
that allow for higher RPM have a lower maximum torque. The optimal torque-RPM 
setting likely depends on the tissue type, the diameter of the morcellation tube, and 
the pulling force (F
pull
) with which the tissue is presented to the blade. Extrapolating 
the measured torque resistance for a single teeth ring to a series of stacked rings yields 
an estimated torque resistance of 38 Ncm, assuming 20 stacked rings over a length of 
30 mm and a tube diameter of 15 mm (Fig. 3b). This torque resistance accounts for 
approximately half of the possible maximum torque generated by for example for the 
TCM3000BL Morcellator [83]. The gripping force generated by 20 stacked rings in the 
direction along with the teeth is estimated to be 4.7 N (0.2N * (25 teeth / 21 teeth) * 20 
rings); hence the required pulling force (F
pull
) to be supplied by the surgeon to the tissue 
mass only increases slightly. Although this is an approximate calculation, it does show 
that it is theoretically possible to use teeth to compensate for force F
T
. A full concept 
design of a morcellator is provided in Figure 11. Future research should be conducted to 
experimentally validate the estimated torque resistances, and to integrate the stacked 
rings into an existing morcellation instrument.
Figure 11: Concept design of a generic morcellator combined with an add-on module providing 
a passive inner morcellation tube with teeth rings that hook into the tissue strip at the 
occurrence of tissue mass spinning. (a) The add-on module connects to the morcellator through 
a clamping mechanism at the back-end. a) 3D zoom-in on instrument tip; (b) full 3D model (c) 
back view of model (d) front view and side view with cross-section of instrument tip.
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Discussion
This paper presented the iterative design and evaluation of gripping teeth for the purpose 
of constraining tissue mass in the advent of its rotation along with the morcellation 
cutting blade. The measurements suggest that a series of stacked teeth rings can 
provide an adequate torque resistance for this purpose. Several measurement and design 
limitation have to be considered, however.
Measurement limitations
Measurement sessions 1 through 4 used porcine gelatin samples to evaluate the 
gripping strength of teeth of varying geometry, and empirically determine which 
geometry performed the best. The use of gelatin was advantageous as it allowed for 
a large number of measurements within a short time frame, was readily available, and 
had an elasticity modulus comparable to that of actual tissue. Gelatin is frequently 
used for needle-tissue interaction investigations and its force-position curve is linear. 
In contrast, bovine tissue is nonlinear and has a rupture toughness that differs from 
gelatin [85]. Therefore, the results from measurement sessions 1 through 4 have to 
be assessed relative to each other and should not be compared with sessions 5 and 6 
in absolute terms. 
Bovine muscle tissue is striated by nature, whereas the female uterus consists of 
smooth muscle tissue. Human uterine tissue or smooth muscle tissue that resembles 
the human uterus, are not readily available for testing. For this reason, measured 
gripping force levels may be different from a true clinical scenario. In our research, 
the tissue strips were cut in various directions to obtain a roughly equal distribution in 
striation directions, thereby compensating for the influence of striations. An additional 
limitation of the measurements was that the tissue strips were precut. Therefore, the 
shape of morcellated tissue strips created during clinical procedures was not a factor 
that influenced our results. Lastly, the measurement results represent a quasi-static 
scenario, because the tissue was slowly drawn through the teeth. The speed of tissue 
translation or rotation was not varied.
Not all observed differences in teeth gripping forces were statistically significant at 
each individual measurement session. However, through the successive design process 
(Fig. 4), this research iterated towards a single teeth design. This process was an efficient 
alternative to testing all teeth across all possible variations, angles, and force directions. 
The current design, however, may represent a local optimum in the design solution 
space, and further refinements may be possible. 
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Teeth design
The measurement results in this research were used to come to a teeth design that 
provided the largest gripping force in specific force directions. These teeth were 
subsequently integrated into a proof-of-principle design for future validation and 
quantification. 
The measurements were not intended to provide a deep understanding of the relation 
between tooth parameters (e.g., geometry and sharpness), tissue properties (e.g., 
elasticity and viscosity), or crack formation. Although the ability to grasp tissues (e.g., 
the gall bladder or colon) with laparoscopic graspers without causing tissue damage is 
important for clinical practice [86], the amount of published research into the design 
of gripping teeth with respect to pinching force, tissue damage, and tissue slippage is 
limited [86-91]. One factor of importance is the curvature of individual teeth, where an 
increase of radius results in reduced tissue damage at the expense of gripping strength 
[87-90]. During morcellation the degree of tissue damage is not important; hence 
in this research only aggressive teeth were assessed. In the literature, both 1.0 mm 
and 2.0 mm sized teeth have been tested, resulting in no clear differences in gripping 
forces between these two designs [88, 89]. This is in agreement with the present 
results (Fig. 9c). However, the results in the literature have been obtained for 
straight symmetrical teeth, comparable to the teeth tested in measurement session 1 
(Fig. 10, top). To the best of our knowledge, no results are available in the literature 
with respect to angled teeth such as those used in measurement sessions 2, 3 and 4 
(Fig. 8, bottom).
An interesting finding was that the best-performing tooth geometry consisted of two 
different sized teeth (teeth D, Fig. 8, top). Compared to a single teeth design (e.g., teeth 
A, Fig. 8, top), there may be a difference in crack formation and propagation, because 
the depths with which the tissue can sink in between the teeth alternate between 0.85 
mm and 0.65 mm. However, teeth F (Fig. 8, top) also consisted of two differently sized 
teeth, yet did not exhibit the same performance as teeth D. The underlying mechanism 
behind the effects of alternating teeth requires further investigation.





directions and the obstruction force -F
Z
. These forces are a function of teeth size, tooth 
geometry, number of teeth, and their angle with respect to the horizontal surface. 
When stacking multiple teeth rings in a row, the relative spacing between the rings 
will be another factor that determines the amount of tissue grip generated. One can 
make a comparison in this regards to fenestrations (i.e., openings) in laparoscopic 
graspers, where it has been theorized that fenestrations allow the tissue to bulge into 
them, thereby achieving a form-fit between tissue and grasper. Literature provides 
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contradicting evidence regarding the effects of fenestrations for creating tissue grip 
[89,91], thus providing no indication regarding the distance that teeth need be apart. 
Lastly, the structural integrity of the tissue strip is of importance for the level of gripping 
force that can be obtained with the teeth. This is evidenced by the difference that was 
observed in the F
T
 force direction between the first and subsequent trials. This finding 
suggests that the initial gripping force generated on tissue mass at the onset of tissue 
mass rotation should directly be of adequate level to prevent the mass from spinning.
Instrument design and optimization
In essence, by using teeth to prevent the tissue mass from spinning, one is removing the 
surgeon from the ‘force loop’ near the cutting blade. In the standard morcellator design, 
the influence of the surgeon is limited to applying a pulling force F
pull
, whereas in order 
to prevent the tissue mass from spinning, the surgeon should also be able to rotationally 
constrain the tissue mass. It is possible, but impractical, to leave this to an assisting 
surgeon who makes use of a laparoscopic grasper disposed through a different trocar. 
By integrating gripping teeth designed to compensate for force F
T
 whilst not hindering 
tissue strip cutting and transport, the tissue mass is controlled without actually having 
to change the standard morcellation process. Moreover, by preventing the tissue mass 
from spinning, the amount of tissue spread generated should be reduced. The degree 
in which tissue spread decreases as well as potential influences of this method on the 
human-machine interaction (e.g., the influence of increased pull force) are subjects for 
future research.
Integrating the teeth into an existing morcellator introduces certain design 
complexities considering that stacked teeth rings need to be integrated into the 
morcellation tube (Fig. 3b). A potentially simple fabrication method is to punch press 
the teeth into a single piece of sheet metal and bend this sheet metal into a tube 
shape. To be considered is that the addition of a teeth-bearing tube placed into an 
existing morcellation tube reduces that instrument’s inner diameter. Preferably, the 
cutting tube should flare open to a larger diameter, allowing for the insertion of a tube 
with an inner diameter equal to the effective cutting blade diameter. The LiNA Xcise 
for example has this feature [92].
The presented instrument design (Fig. 11) may be extended to further improve tissue 
mass control. Going back to both the cookie cutter shark and the lamprey, their use 
of a suctorial mouth may inspire continued morcellator development. As suggested 
in several patents [29,32,64], the use of suction to draw tissue into contact with the 
morcellation instrument, combined with a fluid environment, may be an effective 
strategy. In light of the recent implementation of laparoscopic containment bags that 
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catch the tissue spread [47,59-61], adding integrated teeth and suction may be a 
complementary solution to improve morcellation efficacy and safety. 
 
Conclusions
Through an iterative design and measurement process, a teeth ring was designed, 
prototyped, and evaluated with respect to its potential gripping strength on tissue. The 
evaluation showed that the teeth ring generated grip in the advent of tissue translation 
and rotation. Stacked teeth rings over a length of 30 mm and having an inner tube 
diameter of 15 mm provide a theoretical 38 Ncm of torque resistance to prevent the 
tissue mass from rotating along with the morcellation cutting blade. Future research 
may implement the proposed design into an already existing morcellator and assess it 
through an in-vitro benchtop evaluation.
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Abstract
Objective: To estimate the risk of uterine leiomyosarcoma in patients undergoing 
gynecological surgery. Also, to identify groups at risk for unrecognized uterine 
leiomyosarcoma 
Methods: A national cohort study was performed evaluating all uterine leiomyosarcoma 
(ULMS) diagnosed in the Netherlands between January 2000 and September 2015. 
Cases were identified and supplied by the nationwide network and registry of histo- 
and cytopathology in the Netherlands (PALGA). Unexpected and expected ULMS were 
compared. Approval for this study was granted by the Medical Ethics Committee of all 
participating hospitals and by the review board of PALGA.
Results: 262 original cases were included. The overall incidence of ULMS in our study 
was 0.25% or 1:400 patients. The incidence of unexpected ULMS was 0.12% or 1:865 
patients. Preoperatively, a malignancy was unexpected in 46% of the cases and expected 
in 54%. Abnormal uterine bleeding constituted most of the symptoms. 90% of women 
underwent abdominal hysterectomy and/or bilateral salpingo-oophorectomy . 
Conclusions: Leiomyosarcoma are rare. Woman aged 40-50 years with abnormal 
uterine bleeding are most at risk for unexpected ULMS. In contrast this risk is low in 
postmenopausal women. ULMS were highly uncommon in women aged under 40 years. 
Keywords
Hysterectomy; laparoscopy; leiomyosarcoma;  morcellation. 
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Introduction
The number of laparoscopic procedures has decreased in favor of laparotomy, since the 
Food and Drug Administrations (FDA) decided to discourage power morcellation [1-
5] This decision was based on the occurrence of unexpected uterine (leiomyo)sarcoma 
during hysterectomy or myomectomy for presumed benign fibroids. It was calculated 
by the FDA that this risk is as high as 1 in 498 for uterine leiomyosarcoma (ULMS).[6] 
However, the evidence that formed the basis for this calculation has been criticized for 
its weakness and potential bias. For instance, mainly single center studies were used 
and pre-operatively diagnosed malignancies were included. [7,8] Recently the FDA has 
updated this risk of occult ULMS to 1 in 495 to 1 in 1100 women undergoing surgery, using 
data from more recent studies.[9]  Applying this notable range to a decision analysis for 
perioperative risk estimations regarding laparoscopic hysterectomy versus laparotomy, 
scenarios can be found in favor for both approaches.[10] To improve the accuracy of 
such models and thus better inform patients, more data on the actual incidence of 
(unexpected) ULMS is needed. The primary aim of our study was to expand the current 
data by calculating the risk of unexpected ULMS during gynecological procedures in The 
Netherlands. Secondly, we attempted to identify groups at relatively high or low risk for 




Approval for this study was granted by the Medical Ethics Committee of all participating 
hospitals and by the review board of PALGA. 
A national cohort study was performed evaluating all patients diagnosed with ULMS 
in the Netherlands between January 2000 and September 2015. Cases were identified 
and supplied by the nationwide network and registry of histo- and cytopathology in 
the Netherlands (PALGA).[11]  Women with a histo-pathologically confirmed ULMS 
diagnosis after surgical treatment (abdominal, vaginal and laparoscopic hysterectomy; 
hysteroscopic, laparoscopic and abdominal myomectomy; staging laparotomy and 
debulking surgery) were included. Only the initial procedure identifying the ULMS 
was considered, to avoid multiple registration of the same case. This naturally implies 
that second opinions of these cases, although registrered in the PALGA database, were 
excluded. Basic patient characteristics, relevant medical history, clinical presentation 
and the preoperative diagnostics were retrieved from medical charts. All abnormal 
bleeding patterns (including excessive , irregulair or postmenopausal) were defined as 
abnormal uterine bleeding. Size of myoma was measured in centimeters or compared to 
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weeks of gestation. Rapid growth of myoma was considered present if this was explicitly 
stated in the medical charts. Cases were classified as unexpected ULMS if (any type of) 
malignancy was not considered preoperatively, was not stated as indication for surgery, 
or if surgical techniques were used that were not in accordance with ULMS treatment 
guidelines (meaning abdominal hysterectomy, with or without salpingo-oophorectomy) 
. Preoperative ultrasound (US), computed tomography (CT), magnetic resonance 
imaging (MRI), hysteroscopy and endometrial sampling/curettage was considered 
suspicious if (any type of) malignancy was considered by the examining gynecologist, 
radiologist or pathologist. To calculate the risk of ULMS in surgical specimens in our 
cohort, the number of all types of benign tumors of the myometrium was used during 
the same inclusion period. This number was also derived from the PALGA database 
and consisted of leiomyoma (epithelioid, myxoid, cellular, bizar, angioleiomyoma, 
angiomyoleiomoma), angiomyofibroblastoma and inflammatory pseudotumors. An 
independent student-t test, a Pearson Chi square test and Fisher exact test were used 
where applicable. Differences with a p-value <.05 were considered statistically significant. 
SPSS 20 was used to analyze all data. 
To compare our data, a literature search was performed using the PubMed, Web of 
Science, Embase and Cochrane databases. Search terms consisted of ‘hysterectomy’, 
‘myomectomy ‘, ‘uterine (leiomyo)sarcoma’, ‘risk’, ‘prevalence’ and ‘incidence’. Only 
original cohorts from multicenter studies evaluating ULMS were included, to match our 
cohort as well as possible. 
 
Results
From January 2000 until September 2015, 752 ULMS were registered in The Netherlands 
by the PALGA database, originating from 67 hospitals. 43 hospitals (63%) were willing 
to participate in this study, comprising of 6 academic referral centers (of 8 in total), 
2 additional tertiary referral centers (of 2), and 35 general hospitals (of 57). These 
hospitals reflect 514 cases (72%). 252 cases were excluded because they were not 
original cases (mainly second opinion referrals to specialised pathology centres to 
confirm the diagnosis) or due to not meeting the inclusion criteria.(figure 1) In all, 262 
original cases were eligible for inclusion. Of these, the medical records were missing 
from 26 cases and only the original pathology report could be found. These cases were 
therefore only used to calculate the risk of ULMS and not for patient characteristics. 
Basic characteristics are shown in table 1. Of the cases of ULMS, 54% were suspected 
of having a malignancy and 46% were unexpected. The mean age in the expected 
group was 62 (range 20-91) and it was 52 (range 31-81) in the unexpected group. 
ULMS was most often found in women aged 50-60 years as is demonstrated by the 
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age distribution in figure 2. Sixty-seven percent of the unexpected cases concerned pre-
menopausal women and 17% of the expected cases were pre-menopausal. Abnormal 
uterine bleeding (AUB) constituted most of the symptoms: 43% overall and 52% versus 
33% in the unexpected and expected group. 
Figure 1: Inclusion flowchart. 25 hospitals did not participate, in the majority of instances 
without reason.Second opinions consisted of double registrations in the PALGA system. Only the 
first original case was included in this study. Not meeting inclusion criteria: 14 stromal tumors 
of unknown significance (STUMP), 5 endometrial stromal sarcoma (ESS), 4 carcinosarcoma, 2 
adenosarcoma, 1 malignant mixed müllarian tumor, 1 undifferentiated endometrial carcinoma, 2 
cellular leiomyoma, 43 other reasons (non-gynecological sarcomatoid tumors or recurrences of 
primary tumors not eligible for inclusion), and from 15 cases no chart could be found. 
The pre-operative average uterine size was in accordance with 20 weeks of gestation 
(based on 82 cases) and pre-operative average myoma size was 10cm (based on 139 
cases). Uterus and myoma were larger in the expected ULMS group: 19 weeks versus 22 
weeks, p .01 and 9cm vs 12cm, p .003. For the majority of cases (64%) the myoma was 
solitary (based on 137 cases). In cases with multiple myoma, a malignancy was less often 
expected: 34%, p < .06. Rapid myoma growth was reported in 67% of cases (based on 42 
cases). No differences were found regarding growth and menopausal status or expected 
versus unexpected ULMS. 
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Table 1: Basic characteristics
Cohort Unexpected Expected
N 236 109 (46%) 127 (54%)
Age 58 (12, 20-91) 52 (9, 31-81)* 62 (12, 20-91)*
Menopause Pre 40 67* 17*
Post 60 33* 83*
Symptoms Pain 15 14 16
AUB 43 52 33
AUB + pain 12 12 12
Mass eect 21 20 22
Weight loss 8 0 15
None 2 2 2
Type of Surgery AH 25 46 5
AH+BSO 46 30 65
LH 4 7 2
VH 1 3 0
MM 2 4 0
TCRM 4 7 1
Debulking 13 1 26
Other 5 3 1
No of Myoma One 64 57 72
> one 36 43 28
Uterine Sizea 20 19* 22*
Myoma Sizeb 10 9* 12*
Rapid myoma growth No 33 44 18
Yes 67 56 82
Age: mean (standard deviation, range); Expected/Symptoms/Type of Surgery: percentages. AUB: abnormal 
uterine bleeding; AH: abdominal hysterectomy; BSO: bilateral salpingo-oophorectomy; LH: laparoscopic 
hysterectomy; VH: vaginal hysterectomy; MM: myomectomy; TCRM: transcervical resection of myoma. 
Uterine size based on 82 cases, Myoma size based on 139 cases. Rapid myoma growth based on 42 cases. *: 
significant at p ≤ .05
 














Fig 2: age distribution of ou  cohort (%)
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Next, the pre-operative workup and treatment is presented. Nearly all patients (99%) 
received an US. CT and MRI were performed in 29% and 7% of cases respectively, 
hysteroscopy in 16% and sampling of the endometrium in 38%. For US, CT, MRI, 
hysteroscopy and sampling respectively, 37%, 75%, 56%, 32% and 45% of the findings 
were indicative of a malignancy. (table 2) US and sampling were more often suspicious 
in postmenopausal patients than in premenopausal patients (51% versus 20%, p < .001 
and 58% versus 17%, p <.001 respectively). 
Table 2: Pre-operative diagnostic workup.  
Cohort (N=236) Premenopausal Postmenopausal
Ultrasound Total 99 98 99
Suspicious 37 20* 51*
CT Total 29 19 36
Suspicious 75 71 76
MRI Total 7 7 7
Suspicious 56 43 67
Hysteroscopy Total 16 13 29
Suspicious 32 18 39
Endometrial Sampling Total 38 32 44
Suspicious 45 17* 57*
Numbers are percentages of the cohort. *: significant at p ≤ .05
Most women (69%) were treated by abdominal hysterectomy with or without bilateral 
salpingo-oophorectomy (AH±BSO). An additional 15% of women received staging 
laparotomy or debulking surgery. Laparoscopic hysterectomy (LH) was used in only in 
4% of all women. In the unexpected group, power morcellation was used in 2 cases. In 
addition, manual morcellation was performed in 2 other cases: to accommodate vaginal 
extraction of the uterus after LH, and during conversion of vaginal hysterectomy (VH) 
to AH.
During the same inclusion period as our cohort, 144.431 benign tumors of the 
myometrium were registered by PALGA. Consequently, the overall incidence of ULMS in 
our study was .25% or 1:400 patients. The risk of unexpected ULMS was .12% or 1:865 
patients. The risk of receiving other treatment for ULMS than AH±BSO or staging/
debulking in the unexpected group was .04% or 1:2500 patients.
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Discussion
This nationwide cohort study evaluated all ULMS cases in the Netherlands from January 
2000 – September 2015. The risk of encountering an unexpected ULMS was 0.12% or 
1:865 patients. Moreover the risk for patients with ULMS to undergo surgical treatment 
other than AH± BSO, staging or debulking was .04% or 1:2500 patients. These numbers 
are in concurrence with the studies found in our literature search. In total, 7 multicenter 
cohorts were found, with incidences ranging from 2.3% or 1:44 to .07% or 1:1465 cases 
[12-18] (table 3) Unfortunately, a meta-analysis of the data from these studies could 
not be performed due to heterogeneity of the included study population. 
Based on our evaluation, certain groups are at higher risk for preoperatively unrecognized 
ULMS than others. First, women aged 40 years and younger constituted only 4% of 
our cohort. Therefore minimally invasive and/or fertility sparing treatments such as a 
laparoscopic myomectomy could be considered for these women. The highest risk for 
preoperatively unrecognized ULMS was found in women aged 40-50. In this age group 
a malignancy was suspected in only 15% of the women as opposed to 53% and 63% in 
women aged 50-60 and 60-70 respectively. In women over 70 years of age, a malignancy 
was suspected in over 80%. Furthermore, symptoms and preoperative workup were not 
distinctive for this high-risk group. In our cohort most premenopausal women complained 
of AUB and, in contrast to post-menopausal women, this usually does not indicate a 
malignancy. Furthermore, as AUB and fibroids are the main indication for hysterectomy 
in benign conditions these women are likely to undergo surgery.[19] 
Next, a significant difference was found between uterus size and myoma size in 
unexpected and expected cases. Yet, these differences were small and size was overall 
large in both groups. Furthermore, these results should be interpreted with caution 
because possibly only distinctive cases were well registered. 
Finally, it was found that preoperative diagnostics were less likely to diagnose a 
malignancy in our cohort of premenopausal women. For instance, endometrial sampling 
demonstrated a malignancy in 57% of postmenopausal women compared to only in 17% 
of premenopausal women. Although US is often a readily available diagnostic test, the 
diagnostic value in our cohort was low. Interestingly an evaluation of tumor vascularity 
and Doppler measurements were not performed but in a few cases, although this 
could be due to suboptimal reporting and due to the time-span of the cohort. These 
measurements should not be overlooked as meanwhile favorable numbers regarding 
sensitivity, specificity and positive predictive value for ULMS have been described.[20] 
The vast majority of CT imaging (89%) was reserved for women over 50 years of age. 
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Naturally, in this group malignancies were more often suspected and CT was used to 
confirm the suspicion raised by a patients history, or to aid in staging of the disease. 
However, in light of the aforementioned risk group it is interesting to notice that in 
women aged 40-50, a CT and MRI was performed in a minority of cases. One explanation 
may be that these women were previously not considered at risk for ULMS. An increased 
awareness may thus aid in reducing the number of unexpected ULMS in this group. 
Our study has some potential weaknesses. Not all institutes were willing to participate, 
therefore not all cases could be verified. Next, due to the retrospective design, missing 
data occurred. A surprisingly low number of patients were treated by minimally invasive 
surgical treatments, explaining the very low risk for patients with unexpected ULMS to 
undergo non-standard oncological treatments. Therefore, this risk (1:2500) may have 
limited external validity. The strength of our study is the nationwide cohort. Almost 
all tertiary care academic centers as well as the majority of general care hospitals in 
the Netherlands participated in this study. In our literature search, only 1 other study 
encompasses true nationwide data.[12] This study consisted of women undergoing 
laparoscopy for abnormal uterine bleeding or leiomyoma. Our study evaluated all ULMS 
cases, eliminating selection bias due to treatment groups. Therefore notwithstanding 
the shortcomings, our data are a valuable addition to the already existing evidence. 
Furthermore our study identified high and low risk groups, thereby offering an 
additional means in clinical practice to decide a treatment strategy together with 
the patient. Future studies include a matched case-control study using this cohort, 
to further define risk factors for ULMS, although it will take some time to find proper 
matched cases. Also, given the increase in laparoscopic procedures in the past decade it 
will be of interest to analyse a more recent cohort to compare the number of expected 




The risk of ULMS is overall low and the majority of cases were expected. Woman aged 
40-50 years with AUB are most at risk for unexpected malignancies. ULMS were highly 
uncommon in women aged under 40 years. 
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Abstract
Objective: Uncontained morcellation of leiomyomas during laparoscopic surgery has 
recently been discouraged, as undetected malignant tumours, namely leiomyosarcomas, 
could be fragmented which may result in upstaged disease. However, enucleating 
leiomyomas per se may be inappropriate from an oncological perspective because 
complete, radical resection of malignant tumours to prevent further tumour growth or 
recurrence is not achieved. Thus, the aim of this study was to determine whether spillage 
of leiomyoma cells occurs during laparotomic myomectomy.
Design: Observational study
Setting: Tertiary academic centre in the Netherlands.
Population: Women undergoing laparotomic myomectomy were included in the study.
Methods: Peritoneal abdominal washings were obtained on two occasions during the 
myomectomy procedure; the first one immediately after opening the abdomen and the 
second one after resection of the leiomyoma(s). Cytological evaluation of the fluids was 
performed.
Main outcome measures: The presence of leiomyoma cells in any of the washings.
Results: Five patients were included in this pilot study. All first washings were negative 
for leiomyoma cells. However, cytology positive for the presence of leiomyoma cells was 
found in three of the five second, post-myomectomy washings.
Conclusion: Tissue spillage from leiomyoma(s) occurs during conventional open 
myomectomy. The clinical relevance of tissue dissemination after myomectomy is unclear 
but it cannot be excluded that this may negatively affect the patient’s outcome if there 
is malignant change within the enucleated leiomyoma(s). Therefore, it is questionable 
whether morcellation in specially designed containment bags after laparoscopic 
myomectomy, guarantees any additional oncological safety.
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Introduction
The introduction of power morcellation in the field of gynaecology has contributed 
to the wider implementation of minimally invasive surgery by enabling laparoscopic 
extraction of large specimens. Although warnings regarding its oncological safety 
were published more than a decade ago[1,2], it was only in 2014 that the Food and 
Drug Administration (FDA) issued a press release discouraging the use of morcellation 
during laparoscopic gynaecologic surgery, namely hysterectomy and myomectomy, in 
the presence of leiomyomas.[3] This FDA statement was issued in response to reports 
of cases of morcellation of presumed benign tumours that subsequently turned out to 
be leiomyosarcoma(s). This in turn led to concerns that tissue dissemination of occult 
malignancy after morcellation could lead to an upstage of the disease.[4] Furthermore, 
preoperative prediction of malignant change within leiomyomas is unreliable in the 
absence of prognostic patient characteristics or discriminatory diagnostic tests.
One of the basic principles of surgical oncology is that malignant tumours should 
always be resected radically and in toto to prevent further tumour growth and/or 
recurrence. If all malignant tissue spillage is considered potentially harmful, as many 
authors advocate,[4-6] it can be questioned whether, from an oncological point of 
view, myomectomy for presumed leiomyomas is safe altogether. Indeed, the cleavage 
plane is almost never radical during myomectomy, regardless of the type of approach. 
Furthermore, leiomyosarcomas are heterogeneous tumours, meaning that malignant 
cells could be located anywhere inside the growth.
In light of these considerations we hypothesised that dissemination of leiomyomatous 
tissue occurs during resection of leiomyomas and not just as a result of subsequent 
morcellation of extracted tissue. Therefore the aim of the current study was to detect 




During the study period, all patients undergoing abdominal myomectomy at the 
Leiden University Medical Centre (Leiden, the Netherlands) were asked to participate. 
The study was exempted from Institutional Review Board approval, but patients were 
informed about the study procedure and gave oral consent. Inclusion criteria were 
women of 18 years or older, diagnosed with symptomatic leiomyomas and eligible to 
undergo abdominal myomectomy as per the judgment of the surgeon. Exclusion criteria 
were suspected malignancy and inability to give consent.
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The abdominal myomectomy procedure was performed according to standard 
techniques. As part of the study, the entire abdomen was washed two times with 500 
ml of normal saline during the procedure: the first washing was performed as a control, 
immediately after opening the abdomen, and the second washing after resection of the 
leiomyoma(s). After every washing the abdominal fluid was completely aspirated and 
collected in two separate bags for cytological evaluation. The main outcome of the study 
was to evaluate the presence of leiomyoma cells in any of the washings.
Before embedding the cells collected from the washings in paraffin, an erythrocyte lysis 
buffer (155 mM NH4Cl, 10 mM KHCO3, 1 mM EDTA, pH 7.4) was used to limit the 
amount of red blood cells which would impair visualisation during analyses. For each 
patient, two sets of formalin-fixed paraffin-embedded samples were obtained from the 
first and second washing. These samples were then cut at different levels and the tissue 
was stained with haematoxylin and eosin (HE stain). Next, the specimen slides were 
reviewed by an experienced pathologist (T.B.) to detect the presence of leiomyoma 
cells. In case of doubt, an additional staining with desmin was performed.
Data from the medical record of the patients were also abstracted and included: patient 
age and body mass index (BMI), indications for myomectomy, the number and weight 
of removed fibroids, and surgical outcomes such as operative time, intra-operative blood 
loss and complications. Complications were defined based on the classification of the 
Dutch Society of Obstetrics and Gynaecology.7
 
Results
Five patients were recruited to the study between April and October 2015. Patients were 
on average 34.6 years old (29– 40), with a BMI of 27.7 (22–34.1). Reasons for the 
surgery were heavy bleeding (n = 2) and/or infertility problems (n = 3) and/or pelvic 
pressure and pain (n = 2). On average, 3.8 fibroids (3–6) were removed and the removed 
specimens weighed 599.4 g (256–1040). All procedures were successfully completed, 
with an operative time of 108 min (91–134) and intra-operative blood loss of 685 ml 
(275–1300). Two patients experienced intraoperative haemorrhage of more than 1000 
ml. One of them received two packages of red blood cells postoperatively. No other 
complications occurred and the postoperative course was otherwise uneventful in all 
cases (Table 1). All peritoneal washings obtained directly after opening the abdomen 
were negative, whereas three of the five peritoneal washings acquired after resection 
of the leiomyomas were positive for leiomyoma cells (Table 1, Figure 1). In one case the 
presence of leiomyoma cells was confirmed after performing an additional staining with 
desmin.
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Figure 1: Leiomyoma cells (arrow) in the second peritoneal washing of patient 4 (HE stain).
Discussion
Main findings
There is evidence of micro-spillage of leiomyoma cells after conventional, open 
myomectomy but it is unclear whether these positive cytology results hold any clinical 
relevance if malignant change within the enucleated leiomyoma(s) is subsequently 
diagnosed following histological analysis.
Strengths and limitations
One limitation of our study could be the restriction of analysis to a conventional open 
abdominal myomectomy. However, the process of mechanically enucleating fibroids 
is similar during laparoscopic surgery and so one would expect the likelihood of tissue 
dissemination during myomectomy to be the same. The finding that tissue dissemination 
was not consistent following myomectomy, as no leiomyoma cells were detected in two 
of the five study cases, could be explained by the known limitations of the peritoneal 
washings technique[8] and so does not completely exclude their presence. In any case, 
even one positive cytology result would have been sufficient to support our hypothesis 
that dissemination of leiomyomatous tissue can occur during resection of leiomyomas. 
Our study analysed tumour dissemination of benign leiomyoma cells and not of 
leiomyosarcomas. Dissemination of leiomyosarcomas might also depend on whether small 
foci of sarcoma are at the edges of the excised specimen and/or breaches were made on 
the surface. Of note, in this study we focused only on myomectomy and so our conclusion 
can not be extrapolated to hysterectomy in the presence of uterine leiomyomas.
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Interpretation
The present study sheds new light on the current morcellation debate. In reaction to 
the FDA report warning of the use of power morcellation in the presence of uterine 
leiomyomas, gynaecologists throughout the world have sought to develop techniques 
to reduce the risk of potential spread, while conserving the less invasive laparoscopic 
approach. In addition to reducing surgical morbidity, preservation of the laparoscopic 
route of surgery seems reasonable given the low prevalence of leiomyosarcoma 
compared with that of leiomyoma.[9]
One of the suggested surgical options is ‘contained power morcellation’: after resection of 
the uterus or fibroid, a bag is inserted into the abdomen and the specimen is morcellated 
in the bag and removed.[10,11] In many clinics, contained power morcellation has been 
rapidly adopted and the first studies have shown that, despite a prolonged operative time 
of approximately 20–30 minutes, the technique is feasible.[12-14] Even though this 
technique is in its early phase of development, it can be questioned whether containment 
after extensive resection without a bag will ever provide any additional safety during 
myomectomy, as our study showed that during leiomyoma resection, tissue dissemination 
already occurs. Furthermore, studies evaluating the leakage during contained tissue 
extraction with power morcellation noted spillage of tissue from the bag in 9.2–33% of 
cases.[15,16] However, in all those cases the containment bags were visually intact.
In light of this, it is important to evaluate the impact of intra-abdominal malignant 
tissue dissemination on patient outcomes. Several studies have suggested that spread of 
uterine sarcomas leads to an upstaging of the disease and dramatically worsens the five-
year survival rate when compared with surgery where no morcellation was performed.
[4-6] Although the assumption that malignant tissue dissemination is associated with 
poorer outcomes seems instinctively plausible, we should be careful with the concept 
of upstaging used in the studies. Indeed, it implies that during initial surgery all 
leiomyosarcomas were stage I and that staging was based on a proper inspection of the 
abdomen, which seems unlikely when a benign tumour is expected.[17] Other studies 
have found no differences in survival rates between the morcellated and non-morcellated 
group, or have stated a lack of reliable evidence regarding the clinically relevance of the 
spread, especially as generally speaking the overall prognosis of a leiomyosarcoma is 
poor.[17,18] Furthermore, it is unknown whether a relation exists between the amount 
of tissue dissemination and the recurrence and/or survival rate, especially as advanced 
research demonstrated already detectable circulating tumour cells in the blood of 
patients with early-stage localised tumours.[19]
The influence of non-radical procedures on the recurrence and survival rate has also 
been investigated in other malignant tumours. For endometrial carcinoma, similar 
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washing studies have been performed, showing an increased percentage of positive 
cytology after dissemination of tissue from the endometrial cavity into the peritoneal 
cavity[20] but with inconsistent results regarding the prognosis and recurrence of the 
disease.[8, 20] Also for ovarian carcinoma, controversy exists regarding the magnitude 
of harm of tumour leakage.[21] In a meta-analysis on early-stage ovarian cancer, 
pre-operative ruptures were associated with poorer outcomes compared with 
intra-operative ruptures,[22] probably due to the duration and the amount of leakage in 
the abdomen.[21-23]
From a benign perspective, a condition called parasitic leiomyomas has been reported 
and although the exact aetiology remains unclear, it is believed to be caused by retained 
intra-abdominal tissue fragments.[24] The overall risk of parasitic leiomyomas after 
uncontained morcellation has recently been reported as between 0.12 and 0.95%.
[24] It would be interesting to know whether the prevalence changes with contained 
morcellation. Assuming that containment keeps macro-spread to a minimum during 
surgery, it cannot be excluded that micro-spread contributes to this rare condition. One 
recent published report recommended extensive washings after surgery to minimise the 
risk of retained tissue.[18]
Thus it is apparent that the impact of tissue dissemination on clinical outcomes is 
unclear, as is the protective value of contained extraction. Therefore, we believe that 
the gynaecological community should be cautious in widely adopting the peri-operative 
use of containment bags, which are most likely used off-label and without a proper 
systematic evaluation prior to implementation. Otherwise, there is a risk of offering a 
false sense of security. Furthermore, containment extraction should not distract us from 
seeking improved diagnosis of leiomyosarcomas and a better understanding of tumour 
biology including the impact of tissue dissemination on clinical outcomes.[25]
 
Conclusion
During open myomectomy, spillage of leiomyoma cells occurs. Although the clinical 
relevance of tissue dissemination after myomectomy is unclear, it cannot be excluded that 
it does negatively affect the patient’s outcome, especially in the presence of malignancy. 
As a result, it can be questioned whether contained morcellation, as currently performed 
after laparoscopic myomectomy, guarantees any additional oncological safety.
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Abstract
Background: To assess potential risks of new surgical procedures and devices before their 
introduction into daily practice a prospective risk inventory (PRI) is a required step. This 
study assesses the applicability of the Health Failure Mode and Effects Analysis (HFMEA) 
as part of a PRI of new technology in minimally invasive gynecologic surgery.
Methods: A reference case was defined of a patient with presumed benign leiomyoma 
undergoing a laparoscopic hysterectomy or myomectomy including in-bag power 
morcellation; however pathology defined a stage I uterine leiomyosarcoma. Using in-bag 
morcellation as a template, a HFMEA was performed. All steps of the in-bag morcellation 
technique were identified. Next, the possible hazards of these steps were explored and 
possible measures to eliminate these hazards were discussed. 
Results: Five main steps of the morcellation process were identified. For retrieval bags 
without openings to accommodate instruments inside the bag, 120 risks were identified. 
Of these risks, 67 should be eliminated. For containment bags with openings 131 risks 
were identified of which 68 should be eliminated. Of the 10 causes most at risk to cause 
spillage, two can be eliminated by using appropriate bag materials. Myomectomy appears 
to be more at risk for residual tissue spillage compared to total hysterectomy. 
Conclusion: The HFMEA has provided important new insights regarding potential 
weaknesses of the in-bag morcellation technique, particularly with respect to hazardous 
steps in the morcellation process as well as requirements that bags should meet. As such, 
this study has shown HFMEA to be a valuable method that identifies and quantifies 
potential hazards of new technology. 
Keywords: Hysterectomy; laparoscopy; morcellation; myomectomy; sarcoma
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Introduction
A prospective risk inventory (PRI) assesses potential hazards of new surgical procedures 
and devices (henceforth called technology) before their introduction in daily practice.
[1] However, prospectively assessing potential hazards of new and therefore unknown 
technology is challenging and methods are needed to aid this assessment.   
The Failure Mode and Effects Analysis (FMEA) is a step-by-step method, performed by 
a group of people involved in the process, aiming to identify failure modes and their 
effects before new technology is introduced in daily practice. Failure modes are manners 
in which a process may fail, and the effects analysis examines the consequences of these 
failures. The HFMEA was developed in 1949 to prospectively evaluate problems that 
might occur due to malfunctioning of new military systems.[2]. Due to its prospective 
nature, the conclusions are based on inductive reasoning. Nowadays, an FMEA is an 
important tool in safety and reliability engineering of consumer products, such as the 
car industry. The FMEA was adapted to also suit healthcare requirements: the Health 
Failure Mode and Effects Analysis (HFMEA). However, experience with this method as 
part of a PRI is limited. [3,4] 
The goal of our study was to assess the applicability of the HFMEA for new technology in 
gynecology. We used the efficacy of in-bag morcellation, with respect to the prevention of 
tissue spillage during morcellation, as a template for this method. Currently in minimally 
invasive gynecologic surgery (MIGS), in-bag morcellation is nearly regarded as the new 
gold standard for morcellation procedures to overcome the past safety issues regarding 
the spread of potential malignant tissue. The results of in vitro tests regarding the efficacy 
of containing tissue are favourable and the clinical feasibility has been demonstrated. 
[5-8] However, the oncological safety has yet to be proven. Furthermore, comparative 
trials are no longer ethically feasible, and prospective clinical data will only become 
available in several years. In theory, the HFMEA procedure overcomes these shortcomings 
of standard research methodology and provides necessary safety information of the 




The HFMEA was performed according to the instructions of the prospective risk analysis 
system developed by the Department of Veterans Affairs, National Center for Patient 
Safety.[3]  
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The analysis consisted of 5 steps: choosing a subject, assembling a team for the analysis, 
describing the complete process of the subject of interest, performing a hazard analysis 
of the entire process and finally resolving all serious hazards. 
 
Step 1: choosing the subject 
To maintain a workable analysis of the subject of interest, it should be defined as precise 
as possible. This allows the number of actions and potential hazards to be limited to the 
ones that are most essential to the subject. For our study, a fictional case was defined of 
a patient with undiagnosed stage I uterine leiomyosarcoma, undergoing a laparoscopic 
hysterectomy (LH) or myomectomy (LM) including in-bag power morcellation for 
presumed benign leiomyoma. This scenario was chosen as in theory these patients are 
most likely harmed by the occurrence of spillage of malignant cells due to an immediate 
upstaging of the disease, resulting in a significantly worse prognosis. Our focus being 
on spillage, risks considered inherent to all (laparoscopic) surgical procedures were 
excluded from the scope of the present study.
Step 2: assembling the team
A team is assembled representing most of the health care workers who are involved with 
the subject of interesting. An expert in the subject and a team leader are appointed. The 
expert helps explaining the process, and the team leader chairs the meetings. Novices 
to the process are also part of the team to promote an unbiased critical view of current 
practice. 
Step 3: describing the in-bag morcellation process 
Next, the studied subject is graphically described in a flow diagram. The main steps 
are defined and then for each main step the sub-steps are identified. Two types of 
morcellation bags were assessed: regular specimen retrieval bags without openings 
to accommodate instruments thus consequently in need of iatrogenic breach of bag 
integrity, and containment bags equipped with openings to accommodate a camera or 
instrument. Furthermore, morcellation after LH and after LM was evaluated.
Step 4: hazard analysis 
For the complete process as determined in step 3, all possible hazards (so called failure 
modes, meaning how and why a process might fail) are identified. To rank these hazards 
from most to least serious, these failure modes are scored for their impact on patient 
health or safety (‘severity’) and their chance of occurring (‘probability’). By multiplying 
the scores for severity and probability, a hazard score is calculated: high scores correspond 
with serious hazards. Severity was classified according to the following 4 categories: 
recovery without intervention (1 point), intervention needed for recovery (2 points), 
permanent damage or loss of function (3 points), death (4 points).(9) (Table 1). 
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> 1/10 16 12 8 4 
1/10 – 1/100 12 9 6 3 
1/100 – 
1/1000 8 6 4 2 
< 1/1000 4 3 2 1 
 
To maximize results of our analysis, any kind or amount of tissue spread or leakage was 
considered potentially lethal. ‘Probability’ was defined as occurring: in less than 1000 
procedures (1 point), between 1 in 100 and 1000 procedures (2 points), between 1 in 
10 and 100 procedures (3 points), 1 in 10 or more (4 points). A mean hazard score was 
calculated based on the individual scores provided by all participants. All participants 
calculated the hazard scores individually. Next, the scores were compared during the 
meetings and, in case of disagreement, discussed and adjusted to reach full agreement 
upon the final hazard score. 
Step 5: resolving serious hazards
The HFMEA decision tree is used to identify the failure modes that may cause safety 
issues and should therefore be eliminated. [3] In short this decision tree identifies 
all hazards with a hazard score ≥ 8 as a potential threat that needs to be addressed 
(colour red in table 1). Readily apparent hazards and hazards that are already known and 
controlled can be exempted. In addition, the decision tree identifies all critical steps in 
the process (so-called single point of weaknesses, meaning that the technique would fail 
if this single step fails) even with a hazard score <8. 
After identifying these hazards, recommendations were formulated in our final meeting 
to eliminate the most hazardous steps of the in-bag morcellation procedure . 
 
Results
A total of 7 participants were selected for the HFMEA: 1 gynecologist-oncologist, 1 
gynecologist specialised in MIGS, 1 urologist specialised in minimally invasive surgery, 
1 operating room (OR) nurse, 2 residents in gynecology and 1 researcher in MIGS. 
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The senior author acted as the expert on the in-bag morcellation process. An expert in 
surgical instrument safety with experience in HFMEA procedures (ACE) was appointed 
as team leader. To complete the five steps, six sessions of 2 h (in total 12 hours) were 
needed, followed by additional discussion via email. During the first two sessions, five 
main steps of the morcellation process were identified. The first step is inserting the 
bag in the abdomen. This involves unwrapping the bag, handing it to the OR nurse and 
then to the surgeon, until the bag is correctly placed inside the abdomen. In step 2, the 
tissue is placed in the bag, meaning that the tissue is grabbed by surgical graspers and is 
manipulated inside the bag. In step 3, the bag is positioned for morcellation and inflated 
with CO
2
 gas. For specimen retrieval bags without extra openings, this also involves the 
iatrogenic puncture of the bag to accommodate surgical instruments and inflation of the 
bag. In step 4, the tissue is morcellated and extracted until all tissue has been removed. 
Finally in step 5, the bag is retrieved from the abdomen and the abdomen is inspected 
for tissue residue. Figure 1 demonstrates these steps, as well as the number of sub-steps 
that were found for each main step. As an example, the sub-steps of main step number 4 

































Figure 1: All main steps of the morcellation process. *number of sub-steps for each main 
step: (retrieval bag without sleeves / containment bag with sleeves). Arrow (bottom): 
sub-steps of main step 4 ‘tissue morcellation and extraction’.
For regular retrieval bags without openings, 37 sub-steps and 120 failure modes were 
identified. Of these failure modes, 67 could be eliminated. For containment bags with 
openings, 41 sub-steps and 131 failure modes were identified. Of these, 68 were 
identified as possible hazards that could be eliminated. 
In Table 2, for both bags the moments of the in-bag morcellation procedure most at 
risk for tissue spillage (meaning with the highest hazard scores of 16) are supplied. 
These moments consist mainly of steps where tissue fragments may spread throughout 
18046 Lucas van den Haak.indd   152 03-10-18   20:04













































































































































































































































































































































































































































































































































































































































































































































































































18046 Lucas van den Haak.indd   153 03-10-18   20:04
154 Chapter 10|
the abdomen by instruments that have come in contact with the morcellated tissue. 
Possible measures to control these risks are also proposed in table 2. Hazards specific for 
myomectomy and additional hazards of retrieval bags without openings are highlighted 
in the same table. Four out of 10 causes most at risk to cause spillage, are specific for 
myomectomy and do not occur during hysterectomy. Two more causes can be eliminated 
by avoiding the iatrogenic puncture of retrieval bags without openings to accommodate 
the camera or morcellation instrument. 
 
Discussion
Using in-bag morcellation as a template, our study assessed the applicability of the 
HFMEA method as part of a PRI for new technology. Although the in-bag morcellation 
technique is already widely used in daily clinical practice, the HFMEA revealed several 
possible weaknesses that should be addressed to further enhance the safety of this 
procedure.  
All instruments (camera, graspers, portals) used inside the bag are a possible source 
for tissue spillage. In theory, when these instruments are later re-introduced into the 
abdominal cavity they may unintentionally insert tissue remnants that were initially 
contained in the bag. Also, handling these instruments and placing them on the 
instrument table may contaminate the surgical team itself and other instruments. 
However, in case of sarcoma the oncological effect of minimal amounts of spread or 
leakage, henceforth called micro-spillage, into the abdominal cavity is unclear. For 
instance, in endometrial carcinoma the spread of malignant cells in the abdominal cavity 
via the fallopian tubes during hysteroscopy, does not appear to negatively influence 
clinical outcome.[10-12] The same might apply to our findings. Nonetheless, in theory 
it seems appropriate to thoroughly clean or even change all instruments and surgical 
gloves after morcellation. In the same light, it became clear that myomectomy is at 
higher risk regarding tissue spread compared to hysterectomy. Tissue spillage during 
myomectomy has been demonstrated even without morcellation.[13,14]. Therefore in 
myomectomy, tissue may have spread both during and after the excision of the myoma, 
even before morcellation is performed. This does not occur after (total) hysterectomy, 
assuming that the integrity of the leiomyosarcomas is preserved. It follows that four out 
of 10 causes most at risk for spillage, can be eliminated when comparing hysterectomy 
to myomectomy.(table 2) It should be stressed however, that the meaning of micro-
spillage is unclear and this study does not propose to abandon the minimally invasive 
removal of fibroids. Yet in this light, the possible consequences of micro-spillage should 
be further studied to reach a complete understanding of the risks of morcellation. 
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The second main hazard for contamination is failure of bag integrity due to sharp 
instruments handled in or around the bag. Yet, this can be easily eliminated. Only 
materials should be used that can withstand forces applied during power morcellation, 
including instrument and tissue manipulation, as well as pressure and airflow caused by 
insufflation of the bag. In addition, bags should remain impermeable to tissue cells under 
these conditions. Furthermore, gynecologists should be aware of bag integrity failures 
when using their instruments near the bag.[5,15] Finally, the design of containment bags 
should be able to accommodate the camera, morcellator and possibly a third instrument 
in the bag. The intentional puncture of retrieval bags has already been shown as possible 
cause for tissue leakage during in-bag morcellation.[7] By avoiding this puncture, 2 of the 
10 (LM) and 2 of 6 (LH) main causes for spillage can be eliminated. (Table 2) To our 
knowledge, of the currently available morcellation bags only one claims to meet the above 
mentioned requirements. This bag was recently permitted to market by the FDA.[16] 
There are some considerations when interpreting the results from our study. Firstly, the 
consequence of micro-spillage is unclear as discussed. Nevertheless, there is increasing 
evidence that disease outcome is negatively influenced after (all types of) morcellation. 
[17-20] Next, there are limitations regarding the HFMEA. 
This method was considered too time consuming in some studies and concerns were 
raised regarding the external validity of the prioritizing of hazards in the HFMEA.[21,22]. 
The severity and probability of a potential hazard may not always be known and must 
therefore be estimated by the team. In addition, hazards may be overlooked altogether. 
On the other hand, the identification of all (sub)steps and hazards of a procedure was 
reliable and reproducible.[22] In our opinion, this is the most important component 
of the HFMEA as the identification of such hazards, regardless of prioritization, allows 
adjustments and improvements of the assessed technology. Finally, although the HFMEA 
was time consuming, the time we spent is insignificant in relation to the time needed 
to repair adverse events that could have been prevented with a thorough prospective 
evaluation. Indeed it can be questioned if a thorough risk analysis of power morcellation 
would have resulted in early warnings regarding the spill of malignant tissue being taken 
more seriously.[23-27] 
In conclusion, this study has demonstrated that the HFMEA is a valuable part of a 
prospective risk inventory of new surgical technology. Using in-bag morcellation as 
a template, the HFMEA has provided important new insights regarding potential 
weaknesses of this technique that were previously not recognized, even though 
in-bag morcellation is proposed as the new standard for morcellation. In addition, the 
recommendations that resulted from the HFMEA could be easily implemented in daily 
clinical practice. 
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Discussion
Approximately 500.000 types of medical instruments are used in daily clinical practice, 
ranging from blood pressure meters to advanced surgical robots.[1] Although 
regulating bodies exist that oversee the introduction of new instruments, a grey area 
exists whether a new technology is merely an improvement of an already existing and 
approved instrument or implies such significant changes that would justify generating 
a new safety protocol. Furthermore, the prudence with which new technology is 
introduced may often depend on the sense of responsibility of the medical specialist.
[2] A growing awareness exists, however,  that new instruments inherently have the 
potential to negatively influence patient safety due to unforeseen side effects. In the 
past serious short- and long-term adverse events have been described, some of which 
are discussed in the introduction.[3-7] Several reports were published proposing 
alternatives to better safeguard patient safety during the implementation of new 
medical devices.[1,2,5,6] In general, emphasis is placed on proper studies performed 
in human subjects. As such, randomised controlled trials are considered as highest level 
of evidence to demonstrate the superiority of an innovation compared to standard 
techniques. However, we hypothesized that much can be gained regarding patient 
safety by enhancing the pre-clinical course during the development of a new instrument. 
In the leidraad nieuwe interventies in de klinische praktijk the importance of this course 
is acknowledged.[2]
In this thesis we focussed on the earliest phase of the development of new surgical 
instruments, also known as stage 0. It assessed various pre-clinical evaluation methods 
for new instruments. 
Clinically driven approach
Firstly, the concept of a clinically driven approach to the development of a new surgical 
instrument was explored. In general, three approaches exist when trying to enhance 
daily medical practice. When new technology is devised by the medical industry or by 
engineers, the approach is called commercially driven or technically driven respectively.
[8,9] Although these approaches can lead to medical devices that are state-of-the-
art technically speaking, they may not always meet the demands of clinicians possibly 
rendering them useless.[9] The clinically driven approach starts with identifying a 
medical or surgical difficulty experienced by the users (i.e. physicians), which is then 
used as a starting point to create a solution. Usually this implies a close cooperation with 
technicians and or the medical industry.[10,11] 
In our research, the laparoscopic hysterectomy (LH) was chosen as the starting point for 
exploring the clinically driven approach. The LH is a frequently performed gynaecological 
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procedure worldwide, but is also considered as technically challenging. Two major topics 
were addressed.  
In Chapter 2, we demonstrated that the colpotomy step during LH (meaning the 
separation of the vagina from the cervix, generally the penultimate step of LH before 
suturing the vaginal vault) is regarded by gynecologists as difficult and time-consuming. 
This was substantiated by the measurements of total operation time and colpotomy time. 
Furthermore, we found that BMI was positively related to colpotomy time, independent 
from total operation time. As BMI in the general population is rising, colpotomy may 
increasingly be the limiting step during LH.[12] Subsequently, in cooperation with 
technicians from the University of Technology in Delft, The Netherlands, an alternative 
to the current colpotomy procedure was searched. It was proposed that a vaginal 
approach to colpotomy could possibly overcome present issues with this step in the LH 
procedure. This resulted in a prototype, called MobiSep, which combines the function of 
a uterine manipulator and a cutting function to seperate the vagina from the cervix.[13] 
A uterine manipulator is an important instrument used during laparoscopic procedures 
in gynecology as it allows movement and steering of the uterus during surgery. It is 
proposed that the use of a uterine manipulator should be mandatory because it is said 
to prevent against ureteric injuries during LH by displacing the ureters from the uterine 
arteries.[14] In chapter 3 a literature review was performed as a method to explore the 
required characteristics that the envisaged prototype should meet. The shortcomings 
of existing manipulators were used to improve the prototype. It was found that few 
manipulators offer lateral movement of the uterus, whereas at the same time this 
movement is regarded as important during ligation of the uterine arteries. Surprisingly, 
little evidence was found regarding the efficacy of uterine manipulators. For instance, only 
one observation existed in literature that reported an increase in distance between the 
ureter and uterine artery due to a uterine manipulator, however methods and materials 
were not supplied.[15] It is worrying that in the same article it was also observed that 
the distance can actually decrease due to a mismatch between the size of the cervical 
cup of the manipulator and the cervix. This would imply that in some cases, there is 
even more risk of ureteric injuries. Based on the results from our literature review, a 
study was performed evaluating the relationship between the ureter and uterine artery 
with and without a manipulator. In one case an increase was observed between the two 
structures.[16]  However, this could not be replicated in the second case. [oral, Lieng] In 
conclusion, important insights were gained, not only regarding the characteristics of the 
prototype, but also regarding the workings of uterine manipulators in general. 
The next step in our clinically driven approach was to assess the prototypes performance 
and to evaluate if changes should be made before the instrument is ready for a clinical 
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trial. However, an ideal model in which the new prototype had to be tested could not 
be found. Animal models are generally not  representative due to different anatomy 
of the internal genitalia. In addition, currently available virtual reality tools bear little 
resemblance to  real life conditions such as tactile feedback.  For training purposes, 
human cadavers have been shown to be a valuable method to improve surgical skills. 
[17-19] Furthermore, human cadavers were preferred over virtual reality simulators. 
[20] Based on these findings, in chapter 4 we decided to assess human cadavers as a 
model for testing new surgical instruments. Fresh frozen cadavers were chosen as they 
were favoured in training purposes with respect to tissue appearance and handling. 
[19,21] The results from the cadaver tests demanded that extensive modifications were 
applied to the prototype. Although the MobiSep was extensively tested in an in-vitro 
model, serious anatomical shortcomings of the design were encountered that were not 
revealed by the in-vitro model. As such, the cadaver tests added essential information to 
the developmental phase of MobiSep. However, significant limitations were encountered 
of cadavers as models. Only two of six human cadavers resembled normal anatomy 
of the internal genitalia. Other cadavers could not be used due to restrictions caused 
by age-induced atrophy, congenital abnormalities and a malignancy occupying the 
complete small pelvis. Unfortunately, the medical  history of a cadaver is not disclosed 
due to privacy legislation. Given the low efficiency, it is questionable if human cadavers 
should be used on a larger scale during the pre-clinical assessment of new technology. 
In this light, the ongoing developments in 3D printing are of interest. Recent papers 
have studied the value of 3D printed models for training purposes, and the feasibility 
of creating representative models of human anatomy has been demonstrated.[22-24]. 
Several applications already exist in clinical practice. For instance in orthopaedic surgery, 
3D printing is already used to preoperatively adept surgical plates and screws to a 
patient’s anatomy.[25] However, currently the main shortcoming of 3D printed models 
is the lack of resemblance to the natural compliance of human tissue.[26] When this issue 
is resolved 3D printing will ensure a major improvement of stage 0 of surgical innovation. 
The second topic that we addressed concerns power morcellation in laparoscopic 
hysterectomy and myomectomy. It was observed that during morcellation, small tissue 
particles are dispersed throughout the abdomen (called tissue spill or spillage). In case 
of uterine malignancies, it is believed that this tissue spill causes upstaging of the disease 
and can therefore negatively affect a patient’s prognosis.[27,28] 
We attempted to address this issue by improving the power morcellation instrument. 
To this end, we first examined the onset and characteristics of tissue spillage during 
morcellation in chapter 5. Next, in chapter 6 instrument characteristics that could 
influence the onset of tissue spillage were assessed. Important inefficiencies were 
demonstrated of the power morcellator mechanism available at that time. The onset of 
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torque (also called moment of force) was found to be the cause of tissue spillage. Torque 
is a rotational force applied to an object. Ideally the rotational blade of a morcellator only 
slices tissue without applying force to the tissue. However, due to torque, the sliced tissue 
starts to rotate uncontrollably resulting in tissue particles being dispersed through the 
abdomen. It was observed that only at the very beginning of the morcellation procedure 
large tissue segments were created by the instrument. During the majority of the 
procedure (60%) only small particles were created. These smaller fragments are easily 
subjected to torque. Also, the amount of tissue spillage was not linearly related to uterine 
weight, suggesting that after a certain point the risk of tissue spill increases significantly. 
Finally, it was found that larger diameters of the morcellation instruments (up to 20mm) 
and an oscillating blade rather than a rotational mechanism all decreased the amount 
of spill. These findings offered valuable information regarding the shortcomings of the 
current morcellators that were previously unidentified. Although the devices have been 
improved through time regarding speed of morcellation, no initiatives were taken to 
assess other parameters.[29] For our study, beef tongue was used as a model for the 
human uterus. This cheap and easily obtainable material matches the consistency of the 
uterus well and was successfully used in other studies.[30-32] Also in our assessments, 
beef tongue resembled uterine tissue very well. Thus, for simple and straightforward 
testing of instrument characteristics expensive models are not necessary.   
Interestingly, the finding that larger instruments create less tissue spill and may therefore 
be safer appears to be in contrast to the ongoing developments in minimally invasive 
surgical techniques. More and more, the invasiveness of surgical procedures is reduced 
as much as possible as is shown by developments in laparoendoscopic single-site surgery 
(LESS) and natural orifice transluminal endoscopic surgery (NOTES). However, the 
benefits of these procedures are not always clear and possible risks have been described.
[33] Apparently, smaller is not always better. After identifying torque as the main cause 
of tissue spillage, it was quickly understood that morcellation instruments with a smaller 
diameter cause more spill since torque is applied earlier the process. 
The findings from chapter 5 and 6 were used to enhance the current morcellation 
mechanism. In chapter 7 a prototype is discussed that resolves the problem regarding 
torque. Inspired by the lamprey, a fish resembling eels that use their teeth and suction 
to attach themselves to other fish and feed of their blood, an instrument was developed 
with similar teeth that fixate the morcellated tissue as it is inserted in the teeth-lined 
instrument. As such, it prevents the uncontrollable rotation of tissue fragments due to 
torque, thereby reducing tissue spillage. 
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Prospective Risk Inventory 
In 2014, the Leidraad Nieuwe Interventies in de Klinische Praktijk was published by the 
Orde van Medisch Specialisten and the Zorginstituut Nederland with the support of the 
Kennisinstituut van Medisch Specialisten. [2] It aimed to structure the introduction of new 
technology into daily clinical practice to warrant safety, efficacy and cost-effectiveness, 
without raising thresholds for innovation. 
A roadmap was created that emphasizes a careful consideration before the new 
technology is introduced. An important component of this roadmap is the prospective 
risk inventory (PRI). A PRI is an important item of a safety management system and 
intends to foresee risks in health care processes rather than to remedy adverse events 
after they have occurred.[34,35] No fixed model for a PRI is provided, since possible 
risks depend on specific situations and thus may vary per hospital. The range of the PRI 
procedure is defined by the associated risk of the technology and the frequency of its 
use.[2] (Figure 1) Low risk medical devices that are used on a large scale may still imply 
that a significant amount of patients may suffer from associated adverse effects. For 
instance, glucose meters appear to be low risk and easy to use. However, should these 
instruments malfunction or be misinterpreted the consequences may be detrimental if 
this leads to an overdose of insulin. The chance of this occurring may be small, however 
these instruments are widely used by diabetes patients and medical personnel.  In 
contrast, high-risk medical devices that are used sporadically may not cause harm on a 
large scale, yet may cause severe damage to the individual. Power morcellators are an 
example of such high-risk devices. Both scenarios require an extensive PRI according to 
figure 1. 
Figure 1: Relationship between risk and volume of a new technology and the range of a 
prospective risk inventory. (From: Leidraad Nieuwe Interventies in de Klinische Praktijk)
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In this thesis, the concept of the PRI is applied to the morcellation issue as previously 
discussed. The high risk of encountering an unexpected uterine sarcoma led to 
the decision of the FDA discouraging the further use of power morcellators. It was 
previously calculated by the FDA that uterine sarcoma (US) and  leiomyosarcoma 
(ULMS) may be present in 1 in 350 and 1 in 458 women undergoing hysterectomy 
or myomectomy for presumed benign fibroids respectively.[4] However this number 
has been criticized. It was calculated based on a limited number of studies which all 
consisted of data coming from referral centres.[36] Furthermore, high-risk patients 
were included (such as postmenopausal women and women with known malignancies) 
and varying definitions of sarcoma were used.[36] Recently the FDA has updated 
this risk of occult ULMS to 1 in 495 to 1 in 1100 women undergoing surgery, using 
data from more recent studies.[37] However, the initial FDA statement resulted in 
a worldwide decrease in the use of morcellators and in an increase in the number of 
laparotomies.[38-41] These outcomes appear to be in contrast to the advantages 
of MIS over laparotomy, which have been well established.[42] In fact, studies show 
morbidity and mortality in favour of MIS in most cases, even when including the 
accidental morcellation of uterine sarcoma.[43-46] However, the outcome in these 
prediction models strongly depend on the incidence of ULMS, making them difficult to 
use as long as this incidence is not better defined. 
In chapter 8, we established the above mentioned risk of encountering unexpected 
ULMS during surgical procedures for presumed benign pathology. A nationwide cohort 
study was performed evaluating all ULMS diagnosed in The Netherlands between January 
2000 and September 2015 using the database from the nationwide network and registry 
of histo- and cytopathology in The Netherlands (PALGA).[47] By using a nationwide 
database including secondary and tertiary health care centres the previous mentioned 
shortcomings of the number estimated by the FDA were eliminated.  The risk of ULMS 
in women undergoing surgery was 1:385 or 0.26% for the whole group, and 1:795 or 
0.13% for unexpected ULMS. Moreover, the risk for receiving non-standard treatment 
for ULMS (meaning abdominal hysterectomy with or without bilateral oophorectomy) 
in the unexpected group was even lower at 0.03% or 1:3333 patients. Using our results 
in the mentioned prediction models, it is shown that overall morbidity and mortality 
are in favour of laparoscopic procedures with morcellation as opposed to laparotomy 
procedures.[46] In addition, our study demonstrated that women aged 40-50 years of 
age presenting with abnormal uterine bleeding (AUB) are most at risk for unexpected 
ULMS. Unfortunately, this age group belongs to the age range with the highest ULMS 
incidence. Therefore in these women, the surgical approach to the removal of uterus 
or fibroids should be carefully considered. Reassuringly, in almost all postmenopausal 
women a ULMS was expected and consequently these women were at a low risk to 
undergo non-standard surgical treatment for ULMS. Finally, ULMS were very rare under 
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the age of 40 (only 4% of all ULMS cases).  Therefore, minimally invasive or uterine 
sparing treatments could still be considered in these women.  
To preserve the minimally invasive approach for the removal of uterus or fibroids, 
gynecologists are seeking to enhance the safety of power morcellation. In-bag morcellation 
is proposed as the main solution to the current safety issues and this technique appears 
to be promising. The results of in vitro tests regarding the efficacy of containing tissue 
are favourable and the clinical feasibility has been demonstrated.[30,48-50] However, 
long-term results are lacking and the oncological safety has yet to be proven. [51-54] In 
this light, results from in-bag morcellation techniques from other specialties should be 
considered. In urology it has been demonstrated that for low stage and low grade renal 
cell carcinoma laparoscopic nephrectomy with in-bag morcellation of the renal specimen 
appears to be a safe alternative to open radical nephrectomy. [55,56] However, there is 
evidence suggesting that this is not true for high stage/grade tumors (often displaying 
sarcoma-like characteristics).[57, 58] Given the aggressive nature of ULMS, in-bag 
morcellation should therefore be implemented with caution. Notwithstanding these 
limitations however, in-bag morcellation is currently nearly regarded as the gold standard 
for morcellation. As such, there is a risk that serious adverse events are overlooked and 
may reveal themselves in the future. In Chapter 9 the rationale behind in-bag morcellation 
for myomectomy specimens was examined. It was hypothesized that tissue spillage 
occurs regardless of in-bag techniques. Leiomyosarcoma are heterogeneous tumours 
and malignant cells may be located anywhere in the leiyomyosarcoma, including at the 
cleavage plane used for myomectomy. Indeed, we demonstrated that myoma cells are 
spilled into the abdomen even before morcellation is performed. This observation has 
been substantiated in another study.[59] Therefore it can be concluded, that in-bag 
morcellation after myomectomy does not fully guarantee safety in case of unknown 
ULMS.   
The PRI of in-bag morcellation was finalized in chapter 10. A Health Failure Mode and 
Effects analysis (HFMEA) was performed to prospectively identify moments in the 
morcellation procedure that are at risk for tissue spill.[60] The main finding was that 
although the spillage of larger particles can be avoided, the risk of spillage of small particles 
or microscopically amounts of spill remains due to contamination by instruments that 
came into contact with the morcellated tissue. Unfortunately, the clinical consequences 
of macro- versus micro-spillage are still unknown. For instance, in endometrial carcinoma 
the spread of malignant cells in the abdominal cavity via the fallopian tubes during 
hysteroscopy or dilation and curettage, does not appear to negatively influence the 
oncological outcome.[61-63]  Yet, the negative impact of the morcellation of uterine 
sarcoma on the oncological outcome have been described, although not undisputable.
[64] For instance, in one study characterized by a longer than average follow up, the 
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same recurrence rate was found in women with sarcoma confined to the uterus as in 
other studies with morcellated specimens.[65] 
It should be questioned if our PRI would have revealed the adverse events of tissue 
spillage in its implemental phase in 1991. An important shortcoming exists of qualitative 
prospective methods such as the HFMEA. Insufficient knowledge of a procedure and the 
associated risks can lead to hazards not being identified or being over- or underestimated 
.[66,67] Recently, the FDA admitted its awareness of the possible spread of cancerous 
tissue when it approved the morcellation device.[68] However it was estimated that the 
chance of this occurring amounted between 1:1000 and 1:10.000 cases. Consequently 
this was not considered a significant risk. Already in 1997, only 2 years after the FDA 
approval of power morcellators, a report was published warning against the morcellation 
of undiagnosed malignancies.[69] In the following decade, similar studies were published 
on the topic, but up until 2014 these warnings were not acknowledged. Unfortunately, 
several developments were not considered in the initial risk estimation. For instance, 
uterus-sparing modalities are increasingly applied for the treatments of fibroids and 
abnormal uterine bleeding. One explanation for the surprisingly high incidence of ULMS 
in surgical specimens is, that as a result of this development nowadays only cases that 
are resistent to conservative treatment are treated surgically.[70] Furthermore, power 
morcellators have allowed the minimally invasive removal of increasingly large uteri, 
which previously would have been removed in total via laparotomy, thus the indications 
for a minimally invasive approach have extended.
Because of the limitations regarding risk estimations, it is suggested that an HFMEA 
is unsuited to study patient safety interventions.[67] However, the same study also 
demonstrated that the identification of hazards was valid and reproducible.[67] To 
overcome this flaw of underestimation of important hazards, the HFMEA method 
regards apparently small but possibly severe hazards as a “single point of weakness” that 
must be addressed before new technology can be implemented.[60]  Another important 
critique is that the HFMEA is too time consuming and too demanding for hospital 
resources. Indeed, we spent over 12 hours discussing the in-bag morcellation procedure 
with 7 persons coming from 3 different departments of our hospital. In addition, time 
was spent to finalize the procedure via email. However, in our opinion the time that has 
been spent and is still spent on the morcellation subject since the FDA statement in 2014 
quickly refutes this argument. Moreover, when patient safety is involved it should be 
questioned if too much time can be spent.  
In all, it can be concluded that a timely PRI would perhaps not have resulted in a general 
warning regarding the spreading of cancerous cells, however it would have allowed a 
general awareness regarding this risk. With a more careful post-market surveillance, 
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early signs of adverse events may possibly have been taken seriously sooner. In addition, 
better insight in the actual incidence of ULMS would have alerted gynecologists to take 
caution when performing minimally invasive procedures in high-risk patients. Finally and 
most importantly, it would have allowed informed consent of the patient in the pre-
operative workup. In a recent study it was demonstrated that patients were not averted 
from minimally invasive surgery when provided with information regarding the risks of 
morcellation during laparoscopic hysterectomy.[71] 
 
Conclusion
The clinically driven approach to the development of new surgical instruments allows 
a close collaboration between clinicians and engineers. Several methods can be used 
to enhance a prototype before it is used on live humans for the first time. Surveys and 
literature reviews regarding instruments that resemble the proposed prototype are 
simple but effective tools to identify areas for improvement and gain insight in possible 
risks. Cheap and easily acquired materials such as beef tongue are valid models to assess 
favourable characteristics of new instruments. However proper models, including animal 
models, that resemble real-life circumstances are lacking in gynecology.  Unfortunately, 
shortcomings regarding anatomical variations, the effects of freezing and thawing on 
tissue properties or the presence of pathology prevent human cadavers from becoming 
the gold standard model in stage 0 pre-human trials. 
The prospective risk inventory offers a better understanding of a new procedure or 
surgical instrument and can therefore provide information regarding possible hazards. 
Performing an elaborate PRI is time consuming however. Since no strict guidelines exist 
regarding the extent and contents of the PRI and which procedures and instruments 
should be assessed, there may still remain a grey area where new instruments can escape 
a PRI before their implementation in daily clinical practice. Hospital-wide collaboration 
with respect to these aspects can eliminate this grey area and may reduce time by 
delegating tasks among this collaboration. To promote the sense of shared responsibility 
by hospitals, the implementation process could be organised into a so called “think-tank” 
where representatives of all hospitals participate. Recommendations derived from such a 
collaboration, can be swiftly applied in all hospitals without extensive additional scrutiny. 
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Future Perspectives
It is clear that still much can be gained regarding patient safety during the development and 
implementation of new surgical instruments.  The clinically driven approach as evaluated 
in this thesis resulted in a close collaboration between clinicians and engineers. This 
allowed quick feedback and input with respect to necessary modifications to the tested 
surgical instrument prototypes. Still, a large gap was discovered between the workings of 
new instruments in in-vitro models and their efficacy in human-like conditions. To close 
this gap, future research should focus on the development of easily accessible and life-
like models. As such, 3D printed models are promising. However several shortcomings 
need to be addressed before they can successfully act as human-like models, mainly 
improving the resemblance to the natural compliance of human tissue.  Enhancements 
in synthetics and biomaterials are therefore needed. Furthermore, virtual reality tools 
and computerized models can be valuable additions to hands-on testing of instruments, 
once these techniques are further improved to realistically reflect real life situations.
Regarding the power morcellator controversy, further research should be performed 
regarding the oncological effects of the spillage of microscopically small tissue fragments. 
Mouse models could provide a suited model to test the ability of a ULMS to metastasize 
via these spilled particles. The results of such research will finish the PRI of (in-bag) 
morcellation.   
Several initiatives to further facilitate the clinically driven approach have already been 
installed. For instance, the University of Technology in Delft, The Netherlands has 
commenced a Bachelor of Clinical Technology, which aims to equip students with 
medical and technical knowledge, so they can form a link between technology and 
patients. Furthermore, a medical delta exists in the province of Zuid-Holland and the 
Twente region in which universities and colleges collaborate in health care innovations. 
The next step in this collaboration would be the creation of centralized one-stop shops 
in hospitals where new innovations can be presented to a dedicated team who are 
educated to assess the safe implementation of the innovation in daily practice. These 
one-stop-shops should facilitate clinicians to present their innovations to engineers, thus 
providing an impetus to enhancing medical technology.  
A prospective risk inventory should be an important item of this assessment, as its value 
was successfully demonstrated in this thesis. However, important questions need to be 
addressed. It is yet unclear if all innovations should undergo an elaborate PRI. Furthermore 
it is unclear who is responsible for the performance of a PRI: the manufacturer, 
engineer or physician. Since resources are limited, these are valid questions. It should 
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be attempted to coordinate a PRI as much as possible, to prevent several institutes 
performing the same procedure. To promote the sense of shared responsibility by 
hospitals, the implementation process could be organised into a so called “think-tank” 
where representatives of all hospitals participate. Recommendations derived from such a 
collaboration, can be swiftly applied in all hospitals without extensive additional scrutiny. 
Finally, it should be realised that even with all the efforts as described in this thesis, 
hazards to patient safety cannot be fully eliminated. The purpose of a clinically driven 
approach and of a prospective risk inventory should be to reduce the number of possible 
hazards. To quickly identify residual hazards after the implementation of new instruments 
in clinical practice a post-market surveillance system should be installed. Currently, the 
registration of complications is only mandatory in research settings. In addition, this 
surveillance system should proactively intervene in case a trend is registered regarding 
an increase in adverse effects after a new instrument is implemented. 
Finally, although not a research topic in this thesis, it is apparent that the safety of new 
surgical devices in daily clinical practice can only be warranted by proper handling. 
Therefore, education and training should be mandatory for every new user. 
By identifying and reducing hazards before new technology is implemented together 
with an early identification of adverse effects after its implementation, a serious step can 
be taken to safer innovation in health care.  
18046 Lucas van den Haak.indd   175 03-10-18   20:04




18046 Lucas van den Haak.indd   177 03-10-18   20:04
178 Chapter 12|
Summary 
This thesis was initiated to explore different methods that can be used during the 
pre-clinical stage of the development of surgical innovations, more specifically new 
medical devices. Ideally, major hazards to patient safety are eliminated before these 
innovations are tested in human subjects. We used laparoscopic hysterectomy as a 
starting point for this thesis. The research questions in this thesis were approached 
from both a clinical as well as a technical point of view.  Two concepts were assessed: 
the clinically driven approach to enhancing surgical instruments or techniques and the 
prospective risk inventory of new technology before its introduction in daily clinical 
practice. 
Clinically driven approach 
In chapter 2 we established that during total laparoscopic hysterectomy (TLH) the 
colpotomy step (meaning the separation of the vagina from the cervix, typically 
the final step of TLH)  is regarded as the most difficult and time consuming step by 
specialists in minimally invasive gynecologic surgery (MIGS). This was substantiated 
by the measurements of operation time and colpotomy time. The long duration of the 
colpotomy step was even more pronounced with increasing BMI. In close cooperation 
with engineers from the University of Technology, Delft The Netherlands, these findings 
resulted in a proposal for the vaginal approach to the colpotomy step with the aid of a 
new uterine manipulator. 
To explore the required characteristics that the envisaged prototype should meet, a 
literature review was performed in chapter 3. The shortcomings of existing manipulators 
were used to improve the prototype. It was found that few manipulators offer lateral 
movement of the uterus, whereas at the same time this movement is regarded as 
important during ligation of the uterine arteries. Surprisingly, little evidence was found 
regarding the efficacy of uterine manipulators even though currently the use of these 
instruments during TLH is regarded as standard procedure. 
After the results from chapter 3 were incorporated in the prototype, a model to test the 
functionality of the prototype was searched. On account of positive experiences with 
the use of human cadavers for teaching purposes, in chapter 4 we decided to assess 
human cadavers as a model for testing new surgical instruments. Serious shortcomings 
in the design of the prototype were revealed that were not noticed during previous in-
vitro tests in training-box models. As such, the cadaver tests added essential information 
to the developmental phase of the manipulator. However, significant limitations were 
encountered of cadavers as models due to anatomical shortcomings that prevent 
cadavers from being used on a larger scale for the purpose of testing new medical devices. 
18046 Lucas van den Haak.indd   178 03-10-18   20:04
179Summary / Samenvatting |
Next, the current controversies regarding the use of power morcellators in laparoscopic 
hysterectomy and myomectomy were addressed. Tissue spillage, which occurs when 
tissue is morcellated in the abdominal cavity, most likely leads to upstaging of disease 
in case of the presence of an occult uterine malignancy (more specifically uterine 
sarcoma). To overcome the problems regarding tissue spillage, chapter 5 and chapter 
6 examined the onset and characteristics of tissue spillage during morcellation and 
instrument characteristics that could influence this onset. Torque was found to be the 
cause of tissue spillage. Furthermore, we found that during the majority of the procedure 
(60%) only small particles were created which are easily subjected to torque. Also, the 
amount of tissue spillage was not linearly related to uterine weight, suggesting that after 
a certain point the risk of tissue spill increases significantly. Finally, it was found that 
larger diameters of the morcellation instruments (up to 20mm) and an oscillating blade 
rather than a rotational mechanism all decreased the amount of spill.
The findings from chapter 5 and 6 were used to enhance the current morcellation 
mechanism. In chapter 7 a prototype is discussed that resolves the problem regarding 
torque. Inspired by the lamprey, a fish resembling eels that use their teeth and suction 
to attach themselves to other fish and feed of their blood, an instrument was developed 
with similar teeth that fixate the morcellated tissue as it is inserted in the teeth-lined 
instrument. As such, it prevents the uncontrollable rotation of tissue fragments due to 
torque, thereby reducing tissue spillage. 
Prospective Risk Inventory
A prospective risk inventory (PRI) is an important item of a safety management system 
and intends to foresee risks in health care processes rather than to remedy adverse 
events after they have occurred.  The PRI is an important part of the Leidraad Nieuwe 
Interventies in de Klinische Praktijk, which was published in 2014. In this thesis, the 
concept of the PRI is applied to further enhance the morcellation procedure.
To better understand the risks of morcellation in daily practice, in chapter 8 we established 
the risk of encountering unexpected uterine leiomyosarcoma (ULMS) during surgical 
procedures for presumed benign pathology. The risk of ULMS in women undergoing 
surgery was 1:385 or 0.26% for the whole group, and 1:795 or 0.13% for unexpected 
ULMS. Moreover, the risk for receiving non-standard treatment for ULMS (meaning 
abdominal hysterectomy with or without bilateral oophorectomy) in the unexpected 
group was even lower at 0.03% or 1:3333 patients. In addition, it was demonstrated that 
women aged 40-50 years of age presenting with abnormal uterine bleeding (AUB) are 
most at risk for unexpected ULMS. Moreover, ULMS are rare in women under 40 years 
of age. 
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To solve the occurrence of tissue spillage into the abdominal cavity, morcellation within 
a collection bag, or in-bag morcellation, is increasingly regarded as the new standard 
for morcellation. However, the evidence regarding the oncological safety and efficacy 
is lacking. In Chapter 9 the rationale behind in-bag morcellation for myomectomy 
specimens was examined. It was hypothesized that tissue spillage occurs regardless 
of in-bag techniques. Indeed, we demonstrated that myoma cells are spilled into the 
abdomen even before morcellation is performed. Reducing the risks of tissue spillage in 
myomectomy is therefore limited, even with the in-bag morcellation technique. 
The PRI of in-bag morcellation was finalized in chapter 10. A Health Failure Mode and 
Effects analysis (HFMEA) was performed to prospectively identify moments in the 
morcellation procedure that are at risk for tissue spill. The main finding was that although 
the spillage of larger particles can be avoided, the risk of spillage of small particles or 
microscopically amounts of spill remains due to contamination of instruments that 
came into contact with the morcellated tissue. The clinical consequences of macro- 
versus micro-spillage are yet unknown. Secondly, requirements of morcellation bags 
are defined to minimize the occurrence of tissue spillage. Only materials should be used 
that can withstand forces applied during power morcellation, including instrument and 
tissue manipulation, as well as pressure and airflow caused by insufflation of the bag. In 
addition, bags should remain impermeable to tissue cells under these conditions. Finally, 
the design of containment bags should be able to accommodate the camera, morcellator 
and possibly a third instrument in the bag so that the iatrogenic puncture of bags can be 
avoided. 
In conclusion, this thesis assessed different methods that can be used to examine 
the safety of new medical technology during the early pre-clinical stage of surgical 
innovations. The combination of a clinically driven approach to difficulties from daily 
clinical practice with the prospective risk inventory resulted in prototypes of surgical 
instruments that better meet the demands of clinical practice and allowed an early 
identification of patient safety hazards of the instruments that were used as a template 
in this thesis. 
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Samenvatting
Dit proefschrift heeft verschillende methoden onderzocht die gebruikt kunnen worden 
om risico’s van nieuwe chirurgische instrumenten op het gebied van patientveiligheid te 
evalueren alvorens hun introductie in de klinische praktijk. Idealiter worden deze risico’s 
herkend en waar mogelijk geëlimineerd voordat de klinische testfase aanvangt. De 
laparoscopische hysterectomie (LH) diende hiervoor als uitgangspunt. Het onderzoek 
werd zowel vanuit een medisch klinisch, als vanuit een technisch oogpunt bekeken.  Twee 
concepten werden geëvalueerd: de kliniek-geïniteerde benadering voor het ontwikkelen 
van nieuwe technieken of instrumenten, en de prospectieve risico inventarisatie van 
nieuwe technologie voordat deze in de praktijk wordt geïntroduceerd.  
Kliniek-geïnitieerde benadering
In hoofdstuk 2 stelden we vast dat tijdens LH de colpotomie stap (het separeren van de 
vagina en cervix, doorgaans de laatste stap waarna de uterus kan worden verwijderd) 
door specialisten in minimaal invasieve gynaecologische chirurgie (MIGC) wordt gezien 
als de moeilijkste en meest tijd rovende stap van de procedure. Dit werd onderbouwd 
door onze metingen van de colpotomie tijd en totale operatieduur. Tevens werd een 
sterke positieve correlatie gevonden tussen de colpotomie duur en Body Mass Index. 
De resultaten uit dit hoofdstuk werden gebruikt om samen met ingenieurs van de 
Technische Universiteit Delft een prototype te ontwikkelen van een uterus manipulator 
waarbij de colpotomie middels een vaginale benadering kan worden uitgevoerd. 
Om de eigenschappen te bepalen voor de nieuwe uterusmanipulator, werd in hoofdstuk 
3 de bestaande literatuur over dit onderwerp onderzocht. De tekortkomingen van 
bestaande manipulatoren werden gebruikt om het prototype te verbeteren. Slechts 
weinig bestaande manipulatoren bieden een onafhankelijke laterale beweging van de 
uterus, terwijl deze beweging juist als belangrijk wordt beschouwd tijdens het coaguleren 
van de arteriae uterinae. Opvallend weinig bewijs werd gevonden met betrekking tot de 
effectiviteit van deze manipulatoren, ondanks dat het gebruik ervan wordt gezien als 
standaard procedure. 
Na optimalisatie van het prototype werd vervolgens een model gezocht voor de eerste 
testfase. Gebaseerd op de positieve resultaten van het gebruik van humane kadavers 
voor educatieve doeleinden (zoals het aanleren van chirurgische procedures), werd in 
hoofdstuk 4 het gebruik van humane kadavers als model voor het testen van nieuwe 
chirurgische instrumenten geëvalueerd. Hierbij kwamen serieuze tekortkomingen van 
het prototype naar voor, welke niet gezien werden bij voorgaande in-vitro testen in 
een laparoscopische oefenbox. De testen in het humane kadaver model brachten dus 
essentiële informatie aan het licht. Echter, door anatomische tekortkomingen van de 
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verschillende kadavers werd het gebruik ervan op grote schaal voor het ontwikkelen van 
nieuwe chirurgische instrumenten niet geschikt geacht. 
Vervolgens werden de controverses met betrekking tot het gebruik van power 
morcellatoren tijdens LH en laparoscopische myomectomie (LM) onderzocht. Tijdens 
morcelleren worden kleine weefselfragmenten gemorst in de buik (weefsel spill). In de 
aanwezigheid van een niet onderkende maligniteit, in het bijzonder een sarcoom van de 
uterus, is er door weefsel spill kans op verslechtering van de prognose van de patiënt. 
Om het optreden van weefsel spill beter te begrijpen, werd in hoofdstuk 5 en hoofdstuk 
6 het optreden van dergelijke spill en factoren die hierop van invloed zijn onderzocht. 
Tevens werd de invloed van eigenschappen van het instrument op het optreden van spill 
onderzocht.
Torque bleek de oorzaak van het optreden van spill. Gedurende het grootste gedeelte van 
de procedure (60%) werden slechts kleine fragmenten gecreëerd door de morcellator en 
deze kleine fragmenten waren gevoelig voor torque. Er was geen lineair verband tussen 
de hoeveelheid spill en het gewicht van de uterus, wat suggereert dat er een afkappunt 
is, waarbij de hoeveelheid spill significant toeneemt. Tot slot stelden we vast, dat minder 
spill optreedt bij het gebruik van morcellatoren met een grotere diameter (20mm) en bij 
het gebruik van een oscillerend mes in plaats van een roterend mes. 
De bevindingen uit hoofdstuk 5 en 6 werden gebruikt om het mechanisme van de 
huidige morcellatoren te verbeteren. In hoofdstuk 7 werd een prototype gepresenteerd 
dat het probleem van torque oplost. Het prototype werd gebaseerd op de prik, een 
vis die tanden en zuigkracht gebruikt om zich te bevestigen aan andere vissen en zich 
voedt met hun bloed. In de schacht van het prototype zijn tanden bevestigd welke het 
gemorcelleerde weefsel grijpen en fixeren, waardoor er geen torque optreedt en spill 
voorkomen kan worden. 
Prospectieve Risico Inventarisatie
Een prospectieve risico inventarisatie (PRI) is een belangrijk onderdeel van een 
veiligheidsmanagementsysteem en heeft als doel potentiële risico’s in (gezondheids)
processen te voorkomen, in plaats van schade te herstellen nadat deze is opgetreden. 
De PRI is een belangrijk onderdeel van de Leidraad Nieuwe Interventies in de Klinische 
Praktijk, welke is gepubliceerd in 2014. Het concept van de PRI werd in dit proefschrift 
toegepast om de morcelleer techniek te verbeteren. 
Om het risico van morcelleren beter in te kunnen schatten, werd in hoofdstuk 8 de kans 
vastgesteld op het aantreffen van een (onverwacht) uterussarcoom tijdens operatieve 
ingrepen wegens verondersteld benigne pathologie. Het risico voor vrouwen die een 
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dergelijke ingreep ondergingen op een uterussarcoom bleek 1:385 of 0.26% voor de 
gehele groep, en 1:795 of 0.13% voor onverwachte uterussarcomen. Vrouwen in de 
leeftijd tussen 40-50 jaar met abnormaal uterien bloedverlies hadden de grootste kans 
op een onverwacht uterussarcoom. Onder de leeftijd van 40 jaar was een uterussarcoom 
zeldzaam. 
Om te voorkomen dat tijdens morcelleren spill optreedt, wordt het morcelleren in een zak 
(in-bag morcelleren) in toenemende mate gezien als nieuwe goudstandaard voor deze 
procedure. Echter, de oncologische effectiviteit en veiligheid van deze nieuwe techniek 
is nog niet bekend. In hoofdstuk 9 werd de rationale voor het in-bag morcelleren na LM 
geëvalueerd. Onze hypothese was, dat spill tijdens LM al optreedt alvorens het myoom 
in de zak wordt gemorcelleerd. Er werden inderdaad al myoomcellen aangetroffen in de 
buik, nog voor het weefsel werd gemorcelleerd. Het reduceren van spill bij LM is daarom 
zelfs met in-bag morcelleren beperkt. 
De PRI van in-bag morcelleren werd afgerond in hoofdstuk 10. Een Health Failure Mode 
and Effects Analysis (HFMEA) werd verricht om prospectief de risico’s van het in-bag 
morcelleren met betrekking tot het optreden van spill te identificeren. Hoewel de spill 
van grotere stukken weefsel kan worden voorkomen, blijft het risico op spill van heel 
kleine stukjes of microscopische deeltjes aanwezig door contaminatie van de gebruikte 
instrumenten met het gemorcelleerde weefsel. Echter, op dit moment is niet bekend wat 
de klinische consequentie is van spill van grote danwel kleine weefselpartikels. Verder 
werden op basis van deze studie materiaaleisen van de morcelleerzakken geformuleerd. 
De zakken dienen bestand te zijn tegen de krachten die worden toegepast op de zak, 
zoals tijdens weefselmanipulatie of door het opblazen van de zak met CO2 gas. Bovendien 
moet het materiaal onder al deze omstandigheden impermeabel voor cellen blijven. Tot 
slot moet de zak een opening bieden voor de camera, de morcellator en wellicht een 
derde instrument om te voorkomen dat de zak dient te worden geperforeerd. 
Concluderend, heeft dit proefschrift verschillende methoden geëvalueerd die gebruikt 
kunnen worden om de veiligheid van nieuwe medische technologie te onderzoeken in 
de vroege pre-klinische fase van de ontwikkeling. De kliniek-geïnitieerde benadering van 
nieuwe chirurgische instrumenten resulteerde in prototypes die voldoen aan de vraag 
uit de kliniek. De prospectieve risico inventarisatie maakte een vroegtijdige identificatie 
mogelijk van potentiële risico’s op het gebied van patiëntveiligheid van de chirurgische 
instrumenten die dienden als uitgangspunt in dit proefschrift.. 
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Dankwoord
Dit proefschrift is tot stand gekomen met behulp van velen. Graag wil ik iedereen 
bedanken die betrokken is geweest bij dit onderzoek, in het bijzonder ook alle personen 
die betrokken waren bij de ontwikkeling van MobiSep.  De volgende personen bedank ik 
graag afzonderlijk. 
Frank Willem, ik heb enorme bewondering voor de manier waarop jij je promovendi op 
waarde weet te schatten en hen tegelijk in hun waarde weet te laten. Door jouw manier 
van begeleiding heb ik kunnen groeien als persoon. 
Johann, zonder jouw idee en uitwerking van de MobiSep was dit proefschrift er niet 
geweest. Het was fijn samenwerken en ik kijk met veel plezier terug op onze overleg 
momenten in je keuken met de hond aan mijn voeten. 
Bertho, ik heb veel geleerd van je wetenschappelijke kijk op onze klinische testen en de 
artikels die hieruit zijn voortgekomen. Ondanks de geografische afstand, heb je je steeds 
als een heel betrokken co-promotor getoond. 
Cor, bij jou is het enthousiasme voor het verrichten van wetenschappelijk onderzoek 
begonnen. Wat fijn dat je betrokken kon blijven bij dit proefschrift. 
De endo-club, voor de wetenschappelijke kruisbestuiving, tips & tricks en de sociale 
activiteiten.
Mede onderzoekers  Mathijs, Linda, Edith, Inge, Suus, Femke, Joost, Ada, Tess, Kim en 
Jeroen voor de noodzakelijke ontspanning tijdens het harde werken op de J7 en K6 
Alle wetenschapsstagestudenten en ANIOS die mij bij mijn onderzoek hebben geholpen. 
John, Jenny, Ewout, met veel plezier kwam (en kom!) ik naar de TU Delft voor altijd 
leerzame, maar vooral ook leuke en gezellige overleg momenten. Ik heb veel bewondering 
voor jullie ingenieurs-blik op onze medische problemen.  
Saar en Eef, stelling 11: al het goede komt in drieën! Wat was mijn onderzoekstijd zonder 
jullie geweest? We grappen nog wel eens dat er een soort ‘magie’ is geweest op de K6. 
Ons fotobord spreekt boekdelen. Naast alle gezelligheid heb ik op wetenschappelijk 
vlak ontzettend veel van jullie geleerd. Ik kan me dit proefschrift zonder jullie input niet 
voorstellen. Ik kijk uit naar al onze komende servettendiners! 
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Joost en An, alle drie werkten we ongeveer tegelijk aan ons proefschrift.  An gaf recent 
als eerste het goede voorbeeld met haar promotie. Joost, nu is het aan ons! Ik ben 
ontzettend trots dat ik peter van Céline mag zijn, en (suiker)oom van Mathis! 
Schoonouders, Rinus en Meggie, voor jullie continue interesse in en betrokkenheid bij 
mijn onderzoek en werk. 
Zusje, de manier waarop jij steeds een positieve kijk op het leven weet te houden, heeft 
mij helpen doorzetten bij de moeilijke momenten in mijn opleiding en onderzoekstijd.  
Emillia, mijn “halve” dochter! Wat heerlijk dat je zo betrokken bent in ons leven. Je gaat 
nu zelf studeren, ik kan niet wachten tot de zoete inval in Utrecht! 
Papa, ik weet zeker dat je mijn onderzoek geweldig interessant zou hebben gevonden. 
Ik heb vaak gedacht wat jouw oplossing voor bepaalde vraagstukken zou zijn geweest. 
Mama, mijn successen waaronder dit proefschrift heb ik voor een groot deel aan jou 
te danken. Steeds heb je de lange termijn in het oog gehouden, ook op de momenten 
waarop ik dat nog niet kon. Wat ben ik achteraf blij dat je ervoor hebt gezorgd dat de 
weg om arts te worden open bleef. 
Bart, dank voor al je onvoorwaardelijke liefde, advies en steun, bij elk pad dat ik kies. Je 
zorgt voor de glans op de behaalde successen in dit onderzoek, in mijn werk als arts en 
in ons leven samen. 
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